{
    "__type__": "Deck",
    "children": [
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "96995a49-7dd0-11eb-bedc-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-54ee8d36443a2c01bdc9034e41cd9d82a0568ab3.jpg",
                "paste-60fd306326dd6436b68b2fbd082edfb2a6bece1b.jpg",
                "paste-66380030c70b63942931b8bca4a54dafe427f38b.jpg",
                "paste-b8aeb6599ca50cbc08ea6b5c55af29fa44b7e510.jpg",
                "paste-c7ab4b4a3705c4b49371df4eaf4577a772d2ec34.jpg",
                "paste-de91a7ac21cd455c08219ddcb00b9c7d3fa3b00d.jpg"
            ],
            "mid": 1602236504918,
            "name": "02/08 Immunopharm 1",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "{{c1::Autoimmune disease}}: Immune system cannot distinguish between self and non-self<br><div><br></div><div>{{c1::Chronic inflammatory diseases}}: Over activation of the immune system<br></div>",
                        "<div>Autoimmune</div>Rheumatoid arthritis<br>Systemic lupus erythematosus<div><br></div><div>Chronic Inflammatory&nbsp;</div><div>Inflammatory bowel disease<br>Vasculitis</div><div>Psoriasis<br></div>"
                    ],
                    "guid": "Qf{)1Y%nFW",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Is it innate or adaptive immunity?<div><br></div><div>Higher organisms only&nbsp;{{c1::a}}<br><div>Pathogen-associated molecular patterns (PAMPs){{c1::i}}<br></div></div><div>Non-specific{{c1::i}}</div><div>T-lymphocytes&nbsp;{{c1::a}}</div><div>Monocytes{{c1::i}}</div><div>Polymorphonuclear leukocytes{{c1::i}}<br></div><div>Neutrophils{{c1::i}}</div><div>Barrier defenses{{c1::i}}</div><div>Antibodies&nbsp;{{c1::a}}</div>",
                        ""
                    ],
                    "guid": "t*-r@de/YB",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Why would you use an immunosupressant?",
                        "Autoimmune disease, Chronic inflammatory disease, Organ Transplant"
                    ],
                    "guid": "IS0!6I%}jf",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Opportunistic Infections:{{c1::Infections that do not normally occur in patients with a normal immune system}}<div><br></div><div>Most {{c1::immune suppressant}} drugs increase the risk of opportunistic<br>infections<br></div>",
                        "Immunosuppressants may also lower vaccine efficacy."
                    ],
                    "guid": "p%5K)|0X=m",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Which statement about<br>Immunosuppression is true?<br><br><div>1. It increases the risk of opportunistic infections<br>2. It only affects the adaptive immune system<br>3. It should be employed in patients with infections<br>4. Transplant recipients don’t need it<br>5. Vaccines are immunosuppressants</div>",
                        "1"
                    ],
                    "guid": "Fuo(I3tSp2",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What sort of organ failure does it cause?<div><br></div><div>{{c1::Chronic Kidney Disease}}: Diabetes, glomerulonephritis, hypertension, others<br></div><div><br></div><div>{{c1::Chronic cirrhosis}}: Alcohol, Hepatitis C, NAFLD, autoimmune<br></div><div><br></div><div>{{c1::Acute liver failure}}: Paracetamol overdose, Hepatitis A, others....<br></div>",
                        ""
                    ],
                    "guid": "EdnLe]G}Yb",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Liver transplantation</b><br>Most commonly performed for complications of {{c1::cirrhosis}}, such as:<br>Hepatic encephalopathy:{{c1::confused thinking}}<br>Refractory ascites:{{c1::Buildup of fluid in the abdomen}}<div>{{c1::Variceal}} haemorrhage<br>Liver cancer</div><div><br></div><div>Transplant can be cadaveric or living related<br></div><div>Must be ABO&nbsp;{{c1::compatible}}</div>",
                        ""
                    ],
                    "guid": "AjQE4sHj_B",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Complications of liver transplantation</b><br>Acute cellular rejection<br>Recognition of {{c1::allo}}antigens<br>Lymphocyte activation<br>Clonal expansion of lymphocytes",
                        "<img src=\"paste-54ee8d36443a2c01bdc9034e41cd9d82a0568ab3.jpg\">"
                    ],
                    "guid": "Mkf)W*31A8",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Corticosteroids</b><br><br><div>Hydrocortisone (cortisol) produced in the adrenal cortex<br>&nbsp;</div><div>Essential for health – deficiency results in a disease: {{c1::Addisons disease}}<br><br></div><div>Excess endogenous hydrocortisone results in adisease: {{c1::Cushings syndrome}}<br><br></div><div>Secretion controlled by pituitary hormone: {{c1::ACTH}}</div><div><br></div><div>Is it a corticosteroid target?</div><div>Glucocorticoid receptors{{c1::y}}<br></div><div>Mineralocorticoid{{c1::n}}</div><div>Monocytes{{c1::y}}<br></div><div>Endothelial cells{{c1::y}}</div><div>B-Lymphocytes{{c1::n}}</div><div>T-Lymphocytes{{c1::y}}</div><div>Neutrophils{{c1::y}}</div><div><br></div><div>Is it an acute or chronic side effect?</div><div>Hypertension{{c1::a}}<br>Oppurtunistic Infections{{c1::a}}</div><div>Adrenal suppression{{c1::C}}<br>Muscle atrophy{{c1::c}}<br>Osteoporosis{{c1::c}}<br>Psychosis{{c1::a}}<br>Weight gain{{c1::a}}</div><div>Striae{{c1::c}}<br>Increased triglycerides{{c1::a}}<br>Diabetes{{c1::a}}<br>Hirsutism{{c1::a}}<br>Acne{{c1::a}}<br></div><div>Cataracts{{c1::c}}<br>Growth retardation{{c1::c}}<br></div><div><br></div><div>Side effects of corticosteroids mimic&nbsp;{{c1::Cushings Syndrome}}</div><div><br></div><div>{{c1::Topical}} administration minimizes systemic adverse effects allowing chronic use<br>With chronic {{c1::systemic}} administration, adverse effects outweigh benefits<br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div>",
                        "<img src=\"paste-60fd306326dd6436b68b2fbd082edfb2a6bece1b.jpg\"><div>Hirsutism=unwanted hair growth</div><div>Striae= Stretch marks</div><div><img src=\"paste-66380030c70b63942931b8bca4a54dafe427f38b.jpg\"><br></div><div>Topical corticosteroids: Uses<br>z Inflammatory skin diseases<br>z Asthma<br>z Inflammatory bowel disease – controlled ileal-release<br>budesonide<br>z Uveitis<br></div><div><br></div><div>Systemic corticosteroids: Uses<br>z Life-saving in severe asthma exacerbations<br>z Use coincided with reduction in mortality from ulcerative colitis – a form of<br>inflammatory bowel disease<br>z Vasculitis<br>z Inflammatory arthritis<br>z Blood cancers<br>z Glomerulonephritis<br>z Multiple sclerosis<br>z Vasculitis<br>z Autoimmune hepatitis<br></div>"
                    ],
                    "guid": "Q<:L;YZnvk",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Which statement about corticosteroids is correct?</b><br><br>1. Anti-inflammatory effects are mediated by the mineralocorticoid receptor<br>2. They are hydrophilic and traverse plasma membranes poorly<br>3. They must be administered systemically<br>4. Their actions affect both innate and adaptive immune cells<br>5. Side effects are uncommon even with prolonged administration",
                        "4"
                    ],
                    "guid": "l?+(1:_v|,",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Cyclosporine or Tacrolimus?<br><br>Binds FKBP&nbsp;{{c1::t}}<br><div>Fungal metabolite{{c1::c}}<div>Binds cyclophilin{{c1::c}}<br>Inhibits T cell activation{{c1::both}}</div></div><div>Macrolide antibiotic{{c1::t}}</div><div><br></div><div>How Cyclosporine and Tacrolimus inhibit T-cell activation</div><div><br></div><div>-Cyclosporine A and Tacrolimus inhibit&nbsp;{{c1::calcineurin}}</div><div>-The transcription factor&nbsp;{{c1::NFAT}} cannot be dephosphorylated</div><div>-{{c1::IL-2}} is not produced leading to inhibition of t-cell&nbsp; activity</div><div><br></div><div>Cyclosporine and Tacrolimus<br>Major Uses:<br>Prevention of organ transplant {{c1::rejection}}<br>Autoimmune &amp; Inflammatory diseases<br>{{c1::- Vasculitis<br>- Arthritis<br>- IBD<br>- Psoriasis<br>- Eczema}}(5)<br></div><div><br></div><div><br></div>",
                        "<img src=\"paste-b8aeb6599ca50cbc08ea6b5c55af29fa44b7e510.jpg\">"
                    ],
                    "guid": "N4i+,B~A4$",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Cyclosporine:</b><div><b><br></b></div><div>-{{c1::Unpredictable}} oral biovailability due to&nbsp;{{c1::Emulsion formulation}}<b><br></b></div><div><br></div><div>-&nbsp;{{c1::Narrow}} therapeutic index</div><div><br></div><div>Blood concentration monitoring essential<br></div><div><br></div><div>Side Effects:</div><div>Oppurtunistic infections</div><div>{{c1::Nephro}}toxicity<br>{{c1::Hyper}}tension<br>Gum {{c1::hyperplasia}}<br>{{c1::Skin}} cancer<br>Seizures<br>Neuropathy<br></div><div><br></div><div>Cyclosporine is metabolized by&nbsp;{{c1::CYP3A4}}.</div><div>Patients should not drink&nbsp;{{c1::grapefruit juice}}</div><div><br></div>",
                        "<img src=\"paste-de91a7ac21cd455c08219ddcb00b9c7d3fa3b00d.jpg\">"
                    ],
                    "guid": "B?[6@AM;}z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>Cyclosporine and Tacrolimus:<br></div><div><br></div>Have few adverse effects<br>Have a low therapeutic index<br>Block the binding of IL-2 to its receptor<br>Are considered \"designer\" drugs<br>Cause bone marrow suppression",
                        "2"
                    ],
                    "guid": "Cx%^{%ySHX",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><b>Polyclonal Anti-Thymocyte Globulin</b></div><div><b><br></b>Developed by immunising <b>rabbits</b> with human thymocytes<br><br></div><div>{{c1::Gamma globulins}} purified from serum<br><br></div><div>Polyclonal mixture of antibodies reactive against lymphocyte expressed surface antigens<br><br></div><div>Administration results in profound killing of {{c1::host lymphocytes}}<br><br></div><div>{{c1::Profound}} immunosuppression – {{c1::loads of}} opportunistic infections<br><br></div><div>Effective treatment for {{c1::acute kidney transplant rejection}}<br></div><div><br></div><b>Monoclonal Anti IL-2 receptor antibodies</b><br><br><div>Drug names: {{c1::Daclizumab}} and {{c1::basiliximab}}<div><div><br></div><div>&nbsp;IL-2 is a pivotal cytokine in the development of acquired<br>immune responses<div>&nbsp;</div><div>Effective treatment for {{c1::acute rejection}}</div><div><br></div><div>{{c1::Less}} profound immunosuppression than polyclonal anti-</div><div>thymocyte globulin<br><br>{{c1::Less}} opportunistic infections</div><div><br></div><div><br></div></div></div></div>",
                        "<img src=\"paste-c7ab4b4a3705c4b49371df4eaf4577a772d2ec34.jpg\">"
                    ],
                    "guid": "h5z;5AQJia",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "activeTags": [],
            "children": [],
            "crowdanki_uuid": "969b06d1-7dd0-11eb-90ff-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "inactiveTags": [],
            "media_files": [
                "paste-0e2c9412ce0aca914f907704cd19b83a6326c549.jpg",
                "paste-21d1fc81c1df399811bf77b1fc25cbca52e86529.jpg",
                "paste-2c16030f7bbad0aae58469728e9ec99ad70e754a.jpg",
                "paste-349deda8407f33fddff82f32c7fc68bce04e6e16.jpg",
                "paste-521e34d1481afc8f77546d5f5f63d6ee034d6d8d.jpg",
                "paste-5a3f1da69e87543b5e326b2e8b34f1547ffb52a8.jpg",
                "paste-6e11f86a3a2f079914e586feb06e318572c9d599.jpg",
                "paste-70c1f3f5ee73f098af0130b689a0e46e41293d27.jpg",
                "paste-78a7b028675910c3caf97435028307ab132e9e56.jpg",
                "paste-8b7e889ebcb82dfebf8b6318f737b424c680509d.jpg",
                "paste-db1e580a6cc12279fcd69fc4b9a01885235c8265.jpg",
                "paste-e21e877e9b74fdaa51531524267b04ba43fb419e.jpg",
                "paste-f9774e4df0afe6979adf00357fd159d02b7bf277.jpg",
                "paste-fadc0bc99d401125fb76db8c2a92ed4801aa03b6.jpg"
            ],
            "mid": 1602236504918,
            "name": "02/09 Immunopharm 2",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "IBD: Histology<br><br><div>{{c1::Epithelium}} is ulcerated<br><br></div><div>{{c1::Lamina propria}} is infiltrated with acute and chronic inflammatory cells<br><br></div><div>Crypts have {{c1::abscesses}}</div><div><br></div><div><img src=\"paste-0e2c9412ce0aca914f907704cd19b83a6326c549.jpg\"><br></div><div>For extra points, where is the ulcer</div>",
                        "Ulcer is the big crypt with the white outline<div><img src=\"paste-8b7e889ebcb82dfebf8b6318f737b424c680509d.jpg\"><br><div><br></div><div><br></div></div>"
                    ],
                    "guid": "dKxe?|0,)T",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Thiopurines (immunosupressants)&nbsp;</b><div><br></div><div>Mechanism of action:<br>Deplete {{c1::purine nucleotides}}<br><br></div><div>Inhibits:<br></div><div>- {{c1::DNA}} synthesis<br>- {{c1::RNA}} synthesis<br><br></div><div>Results in:<br>- Apoptosis of {{c1::activated lymphocytes}}<br>- Impaired cell-mediated immunity, specifically {{c1::adaptive}} cell-mediated immunity<br></div><div><br></div><div>{{c1::chronic}} Immunosuppression.<br></div><div><br></div><div><br></div><div><b>Azathioprine (A thiopurine)</b><br></div><div><br></div><div>Originally developed as an anti-leukemia drug<br></div><div>Pro-drug of {{c1::6-mercaptopurine}}<br></div><div><br></div><div>Has a&nbsp;{{c1::narrow}} therapeutic index</div><div>{{c1::oral}} administration<br></div><div>{{c1::slow}} onset of action<br></div><div><br></div><div>Is the side effect acute or chronic?</div><div>Opportunistic infections&nbsp;{{c1::b}}<br></div><div>Allergy: Fever, skin rash&nbsp;{{c1::a}}</div><div>EBV-associated lymphomas&nbsp;{{c1::c}}<br>Bone marrow suppression, esp. leukopenia&nbsp;{{c1::a}}<br>Pancreatitis&nbsp;{{c1::a}}<br>Liver injury&nbsp;{{c1::c}}</div><div><br></div><div>Azathiopurine dose is based on the patients levels of the enzyme&nbsp;{{c1::thiopurine methyltransferase}}</div><div><br></div><div>If there is low levels of this enzyme, Azathiourine is&nbsp;{{c1::more}} effective, but there are more&nbsp;{{c1::ADRs}} such as&nbsp;{{c1::myelosuppression}}</div><div><br></div><div><br>AZATHIOPURINE IS CONVERTED TO&nbsp;{{c1::6-MERCAPTOPURINE}} WHICH IS CONVERTED TO&nbsp;{{c1::6-THIOGUAMINE}}</div>",
                        "Azathiprine is apparently a prototype<div>Leukopenia= Too little WBCs</div><div>EBV=Epstein Barr Virus</div><div>TPMT levels are genetic</div><div><img src=\"paste-fadc0bc99d401125fb76db8c2a92ed4801aa03b6.jpg\"><br></div><div><img src=\"paste-78a7b028675910c3caf97435028307ab132e9e56.jpg\"><br></div>"
                    ],
                    "guid": "Kx~%f6R6H`",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Which statement is false?&nbsp;<div> Azathioprine is a pro-drug&nbsp;</div><div> Hereditary factors affect responses to thiopurines&nbsp;</div><div> Azathioprine does not cause significant immunosuppression&nbsp;</div><div> Thiopurines are administered orally&nbsp;</div><div> Patients full blood count should be monitored</div>",
                        "3"
                    ],
                    "guid": "IrZ-Y:4#}D",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Methotrexate:</b><br><br>Competitive analog of {{c1::folic acid}}<br>Blocks&nbsp;{{c1::dihydrofolate reductase}}<br>Prevents accumulation of {{c1::4H-folic acid}}<br>Blocks {{c1::purine}} biosynthesis<br>{{c1::S}}-phase cells most sensitive to methotrexate&nbsp;<div><br></div><div>Causes:</div><div>Apoptosis of {{c1::activated lymphocytes}}</div><div>Inhibition of {{c1::neutrophil}} functions<br></div><div><br></div><div>Methotexate is given once weekly, why?</div><div>{{c1::Because it accumulates in cells}}<br></div><div><br></div><div><br></div><div>{{c1::oral, SC or IM}} Administration<br></div><div>SLow onset of action</div><div><br></div><div>Adverse effects<br>Bone marrow suppression which leads to&nbsp;{{c1::leukopenia}}<br>{{c1::Liver}} toxicity<br>Hypersensitivity {{c1::pneumonitis}}<br></div><div><br></div>",
                        "<img src=\"paste-db1e580a6cc12279fcd69fc4b9a01885235c8265.jpg\"><div><img src=\"paste-21d1fc81c1df399811bf77b1fc25cbca52e86529.jpg\"><br></div>"
                    ],
                    "guid": "lA.^J?njhM",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Which statement is true about\nmethotrexate?&nbsp;<div> Methotrexate blocks accumulation of dihydrofolate&nbsp;</div><div> It is structurally similar to purine nucleotides&nbsp;</div><div> Methotrexate can only be administered parenterally&nbsp;</div><div> Adverse effects include kidney damage&nbsp;</div><div> Administered once weekly</div>",
                        "5"
                    ],
                    "guid": "KZtu$Svam$",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Monoclonal antibodies&nbsp;</b><div>Advantages:&nbsp;<div> Highly {{c1::specific}} to their target&nbsp;</div><div> {{c1::Long}} duration of action&nbsp;</div><div> Most side effects are intrinsic ie\nextensions of the action of the drug\nat its target&nbsp;</div><div> New drug targets available&nbsp;</div><div>&nbsp; &nbsp; -{{c1::Extracellular}} proteins&nbsp;</div><div>&nbsp; &nbsp; -{{c1::Cell surface}} proteins&nbsp;</div><div> Big in immune-mediated disease\nand {{c1::oncology}}</div></div><div><br></div><div>Disadvantages&nbsp;</div><div> Expensive&nbsp;</div><div> Parenteral administration&nbsp;</div><div> Immuno{{c1::genicity&nbsp;}}</div><div> Infusion reactions<br></div><div><br></div><div>{{c1::parenteral injection (Iv or sc)}} administration.<br></div><div><br></div><div>Extravasation dependant on&nbsp;{{c1::convection}} rather than&nbsp;{{c1::diffusion}}.</div><div>&nbsp;</div><div>Transcytosis via {{c1::Fc}} receptors\nalso relevant<br></div><div><br></div><div>Antigen binding takes place in {{c1::tissues}}<br></div><div><br></div><div>Eliminated by Receptor-mediated {{c1:: endocytosis}}</div><div>Intracellular catabolism by\n{{c1::lysosomal}} degradation<br></div><div>Protective effect of FcRn\nleading to some {{c1::recycling}}<br></div><div><br></div><div>If there is an anti-drug immune response:</div><div>Drug clearance is&nbsp;{{c1::faster}}</div><div>{{c1::loss}} of clinical efficacy<br></div><div>Increased risk of&nbsp;{{c1::allergic-type\nreactions}}</div><div><br></div><div><br></div><div><br></div>",
                        "Immunogenicity=immune response can be mountded against it<div><img src=\"paste-2c16030f7bbad0aae58469728e9ec99ad70e754a.jpg\"><br></div><div><img src=\"paste-e21e877e9b74fdaa51531524267b04ba43fb419e.jpg\"><br></div>"
                    ],
                    "guid": "bQ[D$N^a>@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "TNF-alpha is central in Pathogenesis of many\ndiseases eg {{c1::IBD}}, {{c1::RA}}, {{c1::psoriasis}}",
                        ""
                    ],
                    "guid": "F:A0;TqMo@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Which statement about monoclonal\nantibodies is false?&nbsp;<div> They are highly selective in binding their target&nbsp;</div><div> They are much more complex and costly to produce than small molecule\ndrugs</div><div>&nbsp; They must be administered parenterally (by injection)&nbsp;</div><div> They are metabolized by cytochromes P450 in the liver&nbsp;</div><div> They are dosed much less frequently than small molecule drugs</div>",
                        "4"
                    ],
                    "guid": "r(hYwSbA4q",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "TNF-alpha can stimulate production of&nbsp;{{c1::TNF-alpha}}",
                        "<img src=\"paste-521e34d1481afc8f77546d5f5f63d6ee034d6d8d.jpg\">"
                    ],
                    "guid": "e4Y;@@&`#;",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Etanercept&nbsp;<div> Soluble TNFalpha receptor\n{{c1::fusion}} protein&nbsp;</div><div> Affectively neutralises\nbiological activity of TNF alpha</div><div> Does not bind to {{c1::membrane}}\nassociated TNF alpha</div><div> Does not induce apoptosis\nof TNF alpha expressing cells&nbsp;</div><div> Effective in {{c1::RA}} but not {{c1::IBD}}</div><div>Is it a monoclonal antibody?&nbsp;{{c1::no}}</div><div><br></div><div>Infliximab</div><div>{{c1::mouse}}-human chimeric antibody<br></div><div>Binds to TNF-alpha expressing cells and induces&nbsp;{{c1::apoptosis}}</div><div>Why do they lose their effectiveness over time?&nbsp;{{c1::anti-inflixamab antibodies}}</div>",
                        "<img src=\"paste-5a3f1da69e87543b5e326b2e8b34f1547ffb52a8.jpg\"><div><img src=\"paste-349deda8407f33fddff82f32c7fc68bce04e6e16.jpg\"><br><div><br></div></div>"
                    ],
                    "guid": "NGSt#YM.VT",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Adverse Effects of TNFalpha Inhibitors:<div>Reactivation of {{c1::latent tuberculosis }}&nbsp;</div><div>Increased risk of {{c1::opportunistic infections&nbsp;}}</div><div>Emergence of {{c1::Multiple Sclerosis}}&nbsp;</div><div>Injection and infusion reactions<br></div>",
                        ""
                    ],
                    "guid": "LRzrsyCzP{",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "True statements concerning anti-TNF\nbiologics include&nbsp;<div> Infliximab is a mouse-human chimeric anti-TNF monoclonal antibody&nbsp;</div><div> Patients should be screened for latent tuberculosis before starting any anti-TNF drug&nbsp;</div><div> Loss of response to anti-TNF biologics is often due to their immunogenicity&nbsp;</div><div> These drugs have proved highly beneficial in treating several chronic inflammatory diseases&nbsp;</div><div> All of the above</div>",
                        "5"
                    ],
                    "guid": "c;#!r2c`5z",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anti-integrin biologics: Leukocyte extravasation inhibitors<div><br></div><div>Block the binding of&nbsp;{{c1::leukocyts}} to&nbsp;{{c1::vascular cell adhesion molecules}}</div>",
                        "<img src=\"paste-6e11f86a3a2f079914e586feb06e318572c9d599.jpg\">"
                    ],
                    "guid": "b.wjSl~R_&",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Natalizumab: anti-{{c1::α4}} integrin<br>Vedolizumab: specific anti-{{c1::α4β7}} integrin<div><br></div><div>Treat&nbsp;{{c1::IBD}} and&nbsp;{{c1::MS}}&nbsp;</div>",
                        "<img src=\"paste-f9774e4df0afe6979adf00357fd159d02b7bf277.jpg\">"
                    ],
                    "guid": "Phk~nJjtcB",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Anti-cytokine biologics</b><br>Drug Name: Ustekinumab<br><div>Monoclonal {{c1::anti-p40}} subunit<br></div><div><br></div><div>Inhibits:</div><div>IL-{{c1::12/23}}<br><br></div><div>T/F this IL is:</div><div>Derived from hepatocytes&nbsp;{{c1::F}}<br>Elevated in only Rheumatic Arthrits{{c1::F}}<br>Stimulate Th1 and Th17 signalling{{c1::T}}<br><br><br></div>",
                        "Derived from many types of<br>immune cells<br>Elevated in many inflammatory<br>diseases<br>Stimulate Th1 and Th17<br>signalling<div><img src=\"paste-70c1f3f5ee73f098af0130b689a0e46e41293d27.jpg\"><br></div>"
                    ],
                    "guid": "s`Ojf`q3=I",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anti-B lymphocyte biologics<br>B cells involved in pathogenesis of RA<br>B cell malignancies ie lymphoma common<br>Rituximab<br>Anti-CD20 monoclonal<br>Blocks B cell activation<br>&nbsp;Kills B cells by multiple<br>mechanisms",
                        ""
                    ],
                    "guid": "PaP|FF}lUY",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [
                {
                    "__type__": "Deck",
                    "children": [],
                    "crowdanki_uuid": "5235f631-872b-11eb-8da3-b10d551bd690",
                    "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
                    "desc": "",
                    "dyn": 0,
                    "extendNew": 0,
                    "extendRev": 0,
                    "media_files": [
                        "paste-9f4a3c6ed368210df719db3091aba16c81edacdd.jpg",
                        "paste-b38d69c994278815cf149d87e68d527141d373a2.jpg",
                        "paste-c536f1fde99ba424ef2fb86dfa8a032d14de5606.jpg"
                    ],
                    "mid": 1602236504915,
                    "name": "02/15 IMMUNOPHARM 3 ALLERGIES V2",
                    "notes": [
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Anaphylaxis</b><br>Severe acute allergic, {{c1::IgE}}-mediated,immediate {{c1::hypersensitivity}} reactions<br>Accounts for 1% A&amp;E visits<br>Life-threatening (5000-10,000 deaths per year in US)<br><br><div>Commonest allergens<br>{{c1::z Insect stings<br>z Foods<br>z Drugs<br>z Protein drugs (such as infliximab)<br>z Radiocontrast agents}} (5)<br></div><div><b><br></b></div><div><b>Milder allergic reactions</b><br>Confined to body surfaces<br>{{c1::Sites of contact}} with allergens<br>Very common<br>&nbsp;Symptoms trivial and recurrent<br><br></div><div>Commonest allergens<br>{{c1::Pollen</div>z House dust mite dander<br><div>z Latex}} (3)<br></div>",
                                ""
                            ],
                            "guid": "u%Dk^K?@]8",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<div>Examples of Allergic reactions:</div><div><br></div><b>Food allergy</b><br>Cause:{{c1::Peanut, shell fish, kiwi, strawberry..........}}<div>Rxn; GI upset to {{c1::Anaphylaxis}}<br><br><div><b>Asthma</b><br>Cause: {{c1::House dust mite dander, pollen.......}}<br>Rxn: {{c1::Wheezing}}, can be life threatening<br><br></div><div><b>Allergic rhinitis</b><br></div><div>Cause: {{c1::Fungal spores...}}<br>Rxn: {{c1::Nasal congestion, mild}}<br><br></div><div><b>Drug allergy</b><br>Cause: {{c1::PCN.......}}<br>Rxn: Rash to {{c1::Anaphylaxis}}<br><b><br></b></div><div><b>Contact dermatitis</b><br>Cause: {{c1::Latex.....}}<br>Rxn: {{c1::Rash}}</div></div>",
                                ""
                            ],
                            "guid": "v+wh7(D8!4",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Hypersensitivity type I:</b><div><b><br></b></div><div>{{c1::IgE}} anti-bodies binds to the allergen, IgE corss links allergen with mast cell by binding onto the {{c1::Fc}} receptor.&nbsp; The mast cell releases {{c1::histamine}} and eicanosoids such as {{c1::Lymphotoxins}} and {{c1::Prostoglandins}}</div><div><br></div><div>This reaction is called&nbsp;{{c1::degranulation}}</div>",
                                "<img src=\"paste-b38d69c994278815cf149d87e68d527141d373a2.jpg\">"
                            ],
                            "guid": "v*:OS]|ire",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Histamine</b><br><br>Basic {{c1::amine}}<br>Stored in {{c1::mast}} cell granules<div>&nbsp;Acts on specific histamine receptors H1, H2.... which are {{c1::G protein couples}} receptors<br></div><div><br></div><div>&nbsp;H1 receptors present on<br>-{{c1::Bronchial}} smooth muscle – contraction<br>- {{c1::Endothelial}}&nbsp;cells – vasodilatation &amp; vascular permeability<br>- {{c1::Vomiting}} centres in brain<br><br><br></div>",
                                "<img src=\"paste-c536f1fde99ba424ef2fb86dfa8a032d14de5606.jpg\">"
                            ],
                            "guid": "qFgS(b~[#.",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Hypersensitivity type I reactions</b><br><br><div>Anaphylactic or immediate {{c::1hypersensitivity}} reaction<br>Develops only in genetically susceptible individuals<br>Mediated by allergen-specific {{c1::IgE}} antibodies<br>Central role of local histamine release in mild allergic reactions<br><br></div><div>Increased capillary permeability which causes {{c1::Wheal}} and {{c1::urticarial (hives)}}<br><br></div><div>Vasodilatation which causes {{c1::Erythema}}<br><br></div><div>Itch caused by {{c1::Sensory nerve irritation}}<br><br></div>",
                                ""
                            ],
                            "guid": "GQ;;iVu$f_",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Anaphylaxis: Clinical presentation&nbsp;</b><div><br></div><div>{{c1::5-60}} minutes after exposure to allergen<br><br></div><div>{{c1::Urticaria}} and {{c1::angioedema}} due to Capillary leakage of plasma<br><br></div><div>Bronchospasm causing wheezing due to {{c1::Histamine}}-induced {{c1::bronchoconstriction}}<br><br></div><div>{{c1::Hypo}}tension and CV collapse due to {{c1::Hypo}}volemia, myocardial depression</div><div><br></div><div>Vomiting, diarrhea&nbsp;</div>",
                                ""
                            ],
                            "guid": "bCQV&!IU<R",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Concerning allergy, which statement is false?</b><div><b><br></b></div><div>1. Allergic reactions are antigen-specific<br>2. IgE triggers histamine release from mast cells<br>3. Histamine acts on H1 receptors to cause bronchodilatation and vasoconstriction<br>4. Allergic diseases range from mild everyday symptoms to life-threatening emergencies<br>5. Can to diagnosed by skin prick testing<b><br></b></div>",
                                "3"
                            ],
                            "guid": "j+(;#ox.vI",
                            "note_model_uuid": "afe9bf23-7dce-11eb-b4f3-a0b2d6ecb02c",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Epinephrine</b><div><b><br></b>Stimulates:<br></div><div>{{c1::beta2}} adrenoceptors – bronchodilation<br>{{c1::beta1}} adrenoceptors – increased cardiac contractility<br>{{c1::alpha}} adrenoceptors - vasoconstriction<br><br></div><div>Life saving<br>No absolute contraindication<br>Needs to be administered {{c1::rapidly}}&nbsp;</div>",
                                ""
                            ],
                            "guid": "v^e1~+uQKD",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Anaphylaxis after Epinephrine:</b><div>Anti-histamines<br>Drug Name: {{c1::Diphenhydramine}}<br>{{c1::H1}} receptor inverse agonist<br>Administered {{c1::IV}} or {{c1::orally}}<br>Continue for duration of symptoms<br>Inhibit {{c1::vasodilation}}, vascular leakage and bronchospasm<b><br></b></div><div><br></div><div>Beta 2 adrenoceptor agonists<br>Given to {{c1::Wheezing}} patients<br>Drug Name: {{c1::Salbutamol}}<br>{{c1::Nebulised}} administration<br>Not a substitute for epinephrine<br></div><div><br></div><div><br>2nd phase of {{c1::anaphylaxis}} often occurs 8-72 hours after initial symptoms<br>Markedly inflammatory<br>Mediated in part by {{c1::eicosanoids}} and {{c1::cytokines}}<br><br>Corticosteroids<br>Inhibit the 2nd phase<br>Must be administered {{c1::early}}<br>Drug Name: {{c1::Methylprednisolone&nbsp;}}</div><div>Administered IV, high dose<br></div><div><br></div><div>Agressive fluid&nbsp;{{c1::resuscitation}}</div><div>Airway Management</div>",
                                ""
                            ],
                            "guid": "p_>8BhV/!4",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Anaphylaxis</b><br>1. Is difficult to diagnose<br>2. Should only be treated in a hospital setting<br>3. Causes severe hypertension<br>4. Requires immediate administration of anti-histamines and corticosteroids<br>5. Should be treated with IM adrenaline",
                                "5"
                            ],
                            "guid": "B_54Fl}U6F",
                            "note_model_uuid": "39db5048-81a3-11eb-b5a8-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Atopic diseases</b><br>Skin: {{c1::eczema}}<br>Airways: {{c1::asthma}}<br>GIT: {{c1::food allergy}} (differentiate disease from common use of this term)<br>Eyes: {{c1::conjunctivitis}}<br>Nose: {{c1::allergic rhinitis}}",
                                ""
                            ],
                            "guid": "tC/I%ZA!?Z",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Drugs for atopy</b><br><br>Corticosteroids<br><br><div>&nbsp;Administered at time/season of symptoms<br><br><div>&nbsp;Slow-acting – must be used {{c1::prophylactically}}<br><br><div>&nbsp;Inhibit recruitment of {{c1::immune cells eg mast cells, lymphocytes etc}}<br><br><div>&nbsp;Topical use minimizes systemic exposures<br>z Nasal spray<br>z Cream/ointment<br>z Eye drops&nbsp;</div></div></div></div><div><br></div><div><br>Drug Name: {{c1::Fluticasone, triamcinolone, beclomethasone}}<br><br></div><div>Structural modification of {{c1::hydrocortisone}} to<br>{{c1::increase}} lipophilicity<br>{{c1::increase}} first-pass metabolism<br> Glucocorticoid potency &gt; mineralocorticoid<br><br></div><div>z ADR:<br>z Some systemic exposure even with topicals<br>z Skin – {{c1::thinning}} with chronic use<br></div>",
                                ""
                            ],
                            "guid": "lY!_xgvC#`",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "Mast cell stabilizers<br>Drug Names: {{c1::Cromolyn sodium}} and {{c1::nedocromil}}<br>z Inhibit {{c1::Cl}} channel on mast cells, and others<br>z Prevents mast cell {{c1::degranulation}} and {{c1::histamine}} release<br>z Ineffective once that has already happened<br>z Used {{c1::prophylactically}}<div><br></div><div>Route of administration</div><div>z {{c1::Inhalation}}: Allergic asthma<br>z {{c1::Nasal spray}}: Allergic rhinitis<br>z {{c1::Ophthalmic drops}}: Allergic conjunctivitis<br>z {{c1::Oral}}: Mastocytosis<br></div><div><br></div>",
                                ""
                            ],
                            "guid": "DQOOz_KQ<C",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "<b>Anti-histamines: H1 receptor partial agonists:</b><div><b><br></b><div>First Generation<br>Drug Name: {{c1::diphenhydramine, chlorpheniramine}}<br>z Lipop{{c1::hilic}}, cross BBB<br>z Act as “{{c1::inverse agonists}}”<br>z Drug that binds to the same receptor as an agonist but induces a pharmacological response opposite to that of the agonist<br><br></div><div>Used for<br>z {{c1::Anaphylaxis}}<br>z Nausea and vomiting<br><br></div><div>Adverse effects<br>z {{c1::Sedation}}<br>z {{c1::Dry mouth}}<b><br></b></div></div><div><br></div><div>Second generation:<br>Drug Names: {{c1::Cetirizine}}, {{c1::loratadine}}, {{c1::fexofenadine}}<br>z Lipo{{c1::phobic}}, don’t cross BBB<br>z Additional anti-inflammatory effects<br><br></div><div>Uses:<br>z {{c1::Allergic rhinitis}} (↓ sneezing, rhinorrhoea)<br>z {{c1::Urticaria}}<br><br></div><div>Orally administered</div><div><br></div><div>&nbsp;Available OTC<br></div><div><br></div><div>Why Don't second-gen Anti-histamines cause sedation?&nbsp;{{c1::They don't cross the blood brain barrier}}</div>",
                                "<img src=\"paste-9f4a3c6ed368210df719db3091aba16c81edacdd.jpg\">"
                            ],
                            "guid": "f3SlmKh(#+",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "What was the name of the first non-sedating anti-histamine that got pulled due to suddden cardiac deaths?",
                                "Terfenadine"
                            ],
                            "guid": "h4+.ifPJ~G",
                            "note_model_uuid": "39db5048-81a3-11eb-b5a8-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "Topical calcineurin inhibitors<br>{{c1::Tacrolimus}} (FK506) ointment<br>z Inhibits production of {{c1::IL-2}} by activated T lymphocytes<br><br><div>Uses:<br>z Atopic eczema dependent on {{c1::corticosteroids}}<br><br></div><div>&nbsp;ADR:<br>z {{c1::Burning sensation in skin}}<br>z Possibly&nbsp;{{c1::lymphoma}}</div><div><br></div>",
                                ""
                            ],
                            "guid": "j?#uOb<jl;",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "Which statement about anti-histamines is<br>false?<br><br>1. Diphenhydramine is a H1 receptor antagonist<br>2. Diphenhydramine crosses the blood brain barrier<br>3. Loratadine does not cross the blood brain barrier<br>4. Terfenadine can be subject to a clinically significant drug-drug interaction<br>5. Many anti-histamines are available over the counter",
                                "1"
                            ],
                            "guid": "jTq47*,%e#",
                            "note_model_uuid": "39db5048-81a3-11eb-b5a8-af478fea30f9",
                            "tags": []
                        }
                    ]
                }
            ],
            "crowdanki_uuid": "969fe5ce-7dd0-11eb-8411-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-1-A.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-1-Q.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-2-A.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-2-Q.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-3-A.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-3-Q.svg",
                "1544a2db81e54eb3aea4ea1f5f3af765-oa-O.svg",
                "d1f829bd93fa4637b526c3ffbd0c2069-oa-1-A.svg",
                "d1f829bd93fa4637b526c3ffbd0c2069-oa-1-Q.svg",
                "d1f829bd93fa4637b526c3ffbd0c2069-oa-O.svg",
                "tmphj6msyzl.png",
                "tmpvsmuyas5.png"
            ],
            "mid": 1602236504914,
            "name": "02/15 IMMUNOPHARM 3: Allergies",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "1544a2db81e54eb3aea4ea1f5f3af765-oa-1",
                        "",
                        "<img src=\"tmphj6msyzl.png\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-1-A.svg\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-O.svg\" />"
                    ],
                    "guid": "GkI9gYkEaA",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1544a2db81e54eb3aea4ea1f5f3af765-oa-2",
                        "",
                        "<img src=\"tmphj6msyzl.png\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-2-A.svg\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-O.svg\" />"
                    ],
                    "guid": "vERa%nE~.w",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1544a2db81e54eb3aea4ea1f5f3af765-oa-3",
                        "",
                        "<img src=\"tmphj6msyzl.png\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-3-A.svg\" />",
                        "<img src=\"1544a2db81e54eb3aea4ea1f5f3af765-oa-O.svg\" />"
                    ],
                    "guid": "s_Ghr#zRE`",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "{{c1::IgE}} binds to an Allergen, then&nbsp;{{c1::IgE}} binds to the&nbsp;{{c2::FC}} receptor on the mast cell, causing the release of&nbsp;{{c3::Histamine}}<br>",
                        ""
                    ],
                    "guid": "NIXG`tQK!j",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "d1f829bd93fa4637b526c3ffbd0c2069-oa-1",
                        "",
                        "<img src=\"tmpvsmuyas5.png\" />",
                        "<img src=\"d1f829bd93fa4637b526c3ffbd0c2069-oa-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"d1f829bd93fa4637b526c3ffbd0c2069-oa-1-A.svg\" />",
                        "<img src=\"d1f829bd93fa4637b526c3ffbd0c2069-oa-O.svg\" />"
                    ],
                    "guid": "qhD]=Ua!)9",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Epinephrine stimulates&nbsp;{{c1::vasoconstriction}} on alpha-adrenoreceptors,&nbsp;{{c1::increased cardiac contractility}} on beta-1 receptors and&nbsp;{{c1::bronchodilation}} on beta-2 adrenoceptors",
                        ""
                    ],
                    "guid": "m;Nd1?~}j|",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Atopic individuals often have&nbsp;{{c1::multiple allergies}}",
                        ""
                    ],
                    "guid": "lPP/3y,1-e",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "For Atopy, corticosteroids should be administered&nbsp;{{c1::prophylactally}} as they are slow acting, and&nbsp;{{c1::topically}} to minimize systemic exposure",
                        ""
                    ],
                    "guid": "-d+eCU8^m",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Corticosteroids such as fluticasone, triamcinolone, beclomethasone are structurally modified&nbsp;{{c1::hydrocortisone}} and they have high&nbsp;{{c1::lipophilicity}}, high&nbsp;{{c1::first-pass metabolism}} and are more potent at&nbsp;{{c1::glucocorticoid}} receptors",
                        ""
                    ],
                    "guid": "p|,0e4h2l$",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Mast cell stabilizers inhibit&nbsp;{{c1::sodium channels}} on mast cells which prevent {{c1::degranulation}} and&nbsp;{{c1::histamine}} release.",
                        ""
                    ],
                    "guid": "ik&v|AiIBQ",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1st generation&nbsp; anti-histamines are lipo{{c1::phillic}}and they act as&nbsp;{{c1::inverse agonists}} (effect on receptor)",
                        ""
                    ],
                    "guid": "c(64x=H#ua",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is anaphylaxis mediated by?",
                        "IgE"
                    ],
                    "guid": "H&w35r.AP*",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Where is the effect of a mild allergic reaction felt?",
                        "At the site of contact with the allergen"
                    ],
                    "guid": "fiF,Hvx.O{",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Name 5 clinical examples of allergic diseases",
                        "Food allergy, Asthma, Allergic Rhinitis, Drug Allergy, Contact dermatitis"
                    ],
                    "guid": "uoD!cIX>zZ",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What sort of cells produce IgE?",
                        "Plasma Cells"
                    ],
                    "guid": "yS_Ms_[Vmu",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is the process of mast cells releasing Histamine called?",
                        "De-granulation"
                    ],
                    "guid": "Hc2I^#C{/1",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What other substances are produced by the mast cells?",
                        "Eicosanoids"
                    ],
                    "guid": "vjZXOa;tot",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What does H1 agonism cause in the bronchial smooth muscle?",
                        "Contraction"
                    ],
                    "guid": "Go[l5s+,p3",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What does H1 agonism cause in endothelial cells",
                        "? Vasodilation and vascular permeability"
                    ],
                    "guid": "i/~tBX,ec/",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What cohort of people does type 1 hypersensitivity reactions affect?",
                        "Those who are genetically susceptible"
                    ],
                    "guid": "wT|7)hnyDW",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is the itch caused by, in mild allergic reaction?",
                        "Sensory Nerve irritation"
                    ],
                    "guid": "fm6Sx*6ey/",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is urticaria?",
                        "Hives"
                    ],
                    "guid": "Iov{rk9A?@",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is angioedema?",
                        "Rapid oedema of the area beneath the skin or mucosa."
                    ],
                    "guid": "K>XEz}rto",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "How long after exposure to allergen does anaphylaxis occur?",
                        "5-60mins"
                    ],
                    "guid": "jP=r9ZXe@o",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What substance should you administer straight away if someone has anaphylaxis?",
                        "Epinephrine"
                    ],
                    "guid": "gg9gKORe).",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Why is there only a limited benefit of giving anti-histamines during anaphylaxis?",
                        "The histamine is already in the body."
                    ],
                    "guid": "eg|L=ve54{",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are three other types of drugs that can be given to those who suffer from anaphylaxis?",
                        "Anti-histamines, beta-2 adrenoceptors, corticosteroids"
                    ],
                    "guid": "d6)m*kh[.x",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "When does the 2nd phase of anaphylaxis occur?",
                        "8-72 hours after initial symptoms"
                    ],
                    "guid": "prnQe|i~=|",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What drugs inhibit the 2nd phase of anaphylaxis?",
                        "Corticosteroids."
                    ],
                    "guid": "nuuEY)l3_(",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Why can corticosteroids&nbsp; diffuse through membranes and get to the affected tissues easily",
                        "They ar lipophillic&nbsp;"
                    ],
                    "guid": "rWJ>c{Mc;&",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What affect does chronic use of topical corticosteroids have on the skin?",
                        "It thins the skin"
                    ],
                    "guid": "gEK34XTOqb",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Name two mast cell stabilisers",
                        "Cromolyn sodium and nedocromil"
                    ],
                    "guid": "Hx#|LuguwA",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Name two 1st generation anti-histamines",
                        "diphenhydramine and chlorpheniramine"
                    ],
                    "guid": "MA7z&&]3^f",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are 1st generation anti-histamines used for?",
                        "Anaphylaxis and nausea"
                    ],
                    "guid": "cB5)whh^v6",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Why do 1st geration anti-histamines cause sedation but 2nd generation don't?",
                        "Because 1st cross the blood brain barrier"
                    ],
                    "guid": "t4q}*ycuuT",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Name three 2nd gen anti-histamines",
                        "Cetirizine, loratadien and fexofenadine"
                    ],
                    "guid": "f00&ez9qyR",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the uses for 2nd gen anti-histamines?",
                        "Allergic rhinitis and urticaria"
                    ],
                    "guid": "PkP0&|aebm",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is allergic rhinitis?",
                        "Inflammation on the inside of the nose due to an allergen"
                    ],
                    "guid": "EnjkZg2Uq!",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What drug interacted with terfenadine that caused a build up of it?",
                        "Erythromycin"
                    ],
                    "guid": "to_c;iD|-X",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is the MoA for topical calcineuron inhibitors?",
                        "Inhibits production of IL-2 by activated T lymphocytes"
                    ],
                    "guid": "gUve:QM_5[",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [
                {
                    "__type__": "Deck",
                    "children": [],
                    "crowdanki_uuid": "5237cb5f-872b-11eb-805f-b10d551bd690",
                    "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
                    "desc": "",
                    "dyn": 0,
                    "extendNew": 0,
                    "extendRev": 0,
                    "media_files": [
                        "paste-d97c47d5b40b9b2d047a17e0481165984b50f014.jpg"
                    ],
                    "mid": 1602236504918,
                    "name": "02/16 IMMUNOPHARM 4 ALLERGIES V2",
                    "notes": [
                        {
                            "__type__": "Note",
                            "fields": [
                                "<div>Traditional attenuated virus</div><div><br></div><div>{{c1::2.}} The cultured virus is used to infect monkey cells<br></div>{{c1::1}}.Pathogenic virus is isolated from a patient and grown in human cultured&nbsp;<div>{{c1::4.}} The virus no longer grows well in human cells and can be used in a vaccine</div><div>{{c1::3}}&nbsp;The virus acquires many mutations that allow it to grow well in&nbsp; monkey cells<br></div>",
                                ""
                            ],
                            "guid": "snyF9fKhWt",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "With recombinant DNA techniques, attenuation can be achieved by removing the&nbsp;{{c1::virulence}} part of pathogen, but leaving behind the&nbsp;{{c1::receptor binding protein}} and&nbsp;{{c1::core proteins}}",
                                ""
                            ],
                            "guid": "j?eXlUEpzV",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "What sort of vaccine is it?<div><br></div><div>MMR&nbsp;{{c1::LAV}}</div><div>HEP B&nbsp;{{c1::SUB/CON}}</div><div>Passed Through cell cultures&nbsp;{{c1::LAV}}</div><div>HEP A&nbsp;{{c1::Inactivated}}</div><div><br></div>",
                                ""
                            ],
                            "guid": "K;7rpnQp5#",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "{{c1::Antigen}} provides specificity of response to adaptive immunity<br><br><div>{{c1::Adjuvant}} provides innate immune activity to boost adaptive immunity</div><div><br></div><div>Adjuvants bind to&nbsp;{{c1::Toll-like}} receptors on&nbsp;{{c1::antigen presenting}} cells or it can be&nbsp;{{c1::phagocytosed}}</div><div><br></div><div>Inflammasomes induce production of {{c1::cytokines}}</div><div><br></div><div>{{c1::APC}} presents the antigen which activates the immune response</div>",
                                "<img src=\"paste-d97c47d5b40b9b2d047a17e0481165984b50f014.jpg\">"
                            ],
                            "guid": "p,VE%AeC+$",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "Which immune response<div><br></div><div>Slow and not strong{{c1::primary}}</div><div><br></div><div>Fast and Strong&nbsp;{{c1::secondary}}</div>",
                                ""
                            ],
                            "guid": "NY{Qb-/XJ&",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "Reasons for inability to develop effective<br>vaccines: HIV<br><br>z Lack of {{c1::natural immunity}} to HIV<br>z {{c1::Variability}} of HIV types<br>z Lack of correlates of protective immunity<br>z Lack of an {{c1::animal model}} that reliably predicts vaccine efficacy in humans",
                                ""
                            ],
                            "guid": "Ais5c]%xS^",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "HPV is a common STI<br>Infection at sexual debut<br>Most infected persons clear<br>HPV infection<br>Chronic HPV16 infection causes certain cancers:<br>{{c1::z Cervical<br>z Anal<br>z Penile<br>zHead and neck}} (4)<br>",
                                ""
                            ],
                            "guid": "Ou7~`U3mXd",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        },
                        {
                            "__type__": "Note",
                            "fields": [
                                "1.{{c1::APC}} takes up antigen&nbsp;<div>2. {{c1::T helper cell}} exposed to antigen</div><div>3.&nbsp;{{c1::Naive}} T and B lymphocytes activated</div><div>4.{{c1::B-cells}} make antibodies,&nbsp;{{c1::T-cells}} kill the infected cells</div><div>5.&nbsp;{{c1::memory b-cells, memory t-cells and memory helper t-cells}}(3) stay behind</div>",
                                ""
                            ],
                            "guid": "H`0R;;t,XT",
                            "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                            "tags": []
                        }
                    ]
                }
            ],
            "crowdanki_uuid": "96a16b70-7dd0-11eb-be8a-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "0505c55ce9654e369f14c06fdd858660-oa-1-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-1-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-2-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-2-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-3-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-3-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-4-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-4-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-5-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-5-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-6-A.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-6-Q.svg",
                "0505c55ce9654e369f14c06fdd858660-oa-O.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-1-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-1-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-2-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-2-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-3-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-3-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-4-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-4-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-5-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-5-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-6-A.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-6-Q.svg",
                "20f1b859b3f3462b9cee1c8101813127-oa-O.svg",
                "Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG"
            ],
            "mid": 1602236504914,
            "name": "02/16 IMMUNOPHARM 4",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Who did the experiment of smallpox and cowpox?",
                        "Edward Jenner"
                    ],
                    "guid": "GX27QRm+vE",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "How many laboratories in the world hold smallpox?",
                        "2"
                    ],
                    "guid": "CfY+cbdii]",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-1",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-1-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "HZ[|~D:}JQ",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-2",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-2-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "y@LnEK^*a%",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-3",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-3-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "j]_Vg1_*9I",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-4",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-4-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "O2[*Pts9j@",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-5",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-5-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-5-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "m(op>`!W:;",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "20f1b859b3f3462b9cee1c8101813127-oa-6",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-6-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-6-A.svg\" />",
                        "<img src=\"20f1b859b3f3462b9cee1c8101813127-oa-O.svg\" />"
                    ],
                    "guid": "G?@nB4h:_N",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-1",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-1-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "pF2ld2#v0s",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-2",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-2-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "uKy}_z7Ux(",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-3",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-3-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "l|Usy:*G_4",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-4",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-4-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "d;HQEC7F/J",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-5",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-5-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-5-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "tIQ-NBTDY>",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "0505c55ce9654e369f14c06fdd858660-oa-6",
                        "",
                        "<img src=\"Capture-0bf8086f674b1ec1c41fc3d467f8ef9b052900fd.PNG\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-6-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-6-A.svg\" />",
                        "<img src=\"0505c55ce9654e369f14c06fdd858660-oa-O.svg\" />"
                    ],
                    "guid": "qkiie]/_?E",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "In traditional vaccines, virus is isolated from{{c1::humans}} and is used to infect&nbsp;{{c1::animal}} cells, the virus acquires many mutations that do not allow it to grow in&nbsp;{{c1::human}} cells anymore.",
                        ""
                    ],
                    "guid": "j$V1OeqNmt",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the three parts of a virus DNA?",
                        "Receptor binding protein.<div>Virulence</div><div>Core proteins</div>"
                    ],
                    "guid": "ySm@5DeIfO",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "With recombinant DNA techniques the&nbsp;{{c1::virulence}} gene of the virus is deleted.",
                        ""
                    ],
                    "guid": "h-`pFVhA}A",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "In a live attenuated vaccine the&nbsp;{{c1::virus}} is selected. It is passed through tissue cultures and a&nbsp;{{c2::weakened strain}} of the virus is used.",
                        ""
                    ],
                    "guid": "QfaU(NS],y",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give an example of a live attenuated vaccine",
                        "MMR"
                    ],
                    "guid": "Q5_jn>sM[S",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Who should a live attenuated vaccine not be given to?",
                        "People with weak immune systems"
                    ],
                    "guid": "z9!1,o8*>?",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "In an inactivated vaccine, a&nbsp;{{c1::bacterial}} or&nbsp;{{c1::viral}} strain is isolated, it is&nbsp;{{c1::inactivated}} using heat or chemicals.",
                        ""
                    ],
                    "guid": "jAr~<|}XHo",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give an example of an inactivated vaccine",
                        "Hepatitis A"
                    ],
                    "guid": "b;b&QZW)30",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is different about a subunit/conjugated vaccine, compared to the rest?",
                        "Only the part of pathogen that provokes an immune response is used"
                    ],
                    "guid": "tgZJXSbG!2",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What sort of immune response does an antigen evoke?",
                        "An adaptive immune response"
                    ],
                    "guid": "ho(TvU6`zG",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What sort of immune response does an adjuvant evoke?",
                        "AN innate imkune response."
                    ],
                    "guid": "d_)i=22?8J",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What type of cell takes up the vaccine?",
                        "APC"
                    ],
                    "guid": "K<g(H=Pv%z",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What sort of diseases are affected by herd immunity?",
                        "Diseases that spread from human to human contact.<div><br></div>"
                    ],
                    "guid": "e[&B!vLdj=",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give some reasons why HIV is unable to be vaccinated against?<div><br></div>",
                        "Lack of natural immunity against it<div>Variability of HIV types</div><div>Lack of correlates of protective immunity&nbsp;</div><div>Lack of an animal model that reliably predicts vaccine efficacy in humans</div>"
                    ],
                    "guid": "mDn6hc`NoY",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is passive immunity?",
                        "Administration of antibodies from an exposed donor specific to the infectious agent."
                    ],
                    "guid": "Q+Y4u(d{e5",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is the name of the vaccine for HPV?",
                        "Gardasil."
                    ],
                    "guid": "p<=HuU^_K~",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "96a27bd7-7dd0-11eb-bab2-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 50,
            "media_files": [
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-1-A.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-1-Q.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-2-A.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-2-Q.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-3-A.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-3-Q.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-4-A.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-4-Q.svg",
                "2f59fdaa166c419fb0afa5d0a3d6316e-ao-O.svg",
                "573b238c9bcd409eb3e1cc105c7694d2-ao-1-A.svg",
                "573b238c9bcd409eb3e1cc105c7694d2-ao-1-Q.svg",
                "573b238c9bcd409eb3e1cc105c7694d2-ao-2-A.svg",
                "573b238c9bcd409eb3e1cc105c7694d2-ao-2-Q.svg",
                "573b238c9bcd409eb3e1cc105c7694d2-ao-O.svg",
                "Capture-d97a4aec839f97ed34efc1c4e421661ed3ffd1bf.PNG",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-1-A.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-1-Q.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-2-A.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-2-Q.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-3-A.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-3-Q.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-4-A.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-4-Q.svg",
                "a3bf7cc25e9a4de3b592994e432039c6-ao-O.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-1-A.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-1-Q.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-2-A.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-2-Q.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-3-A.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-3-Q.svg",
                "a866c98ccddb4d9f8ee8934854b9af52-ao-O.svg",
                "b06073520ebe46d38482969be733a8f6-ao-1-A.svg",
                "b06073520ebe46d38482969be733a8f6-ao-1-Q.svg",
                "b06073520ebe46d38482969be733a8f6-ao-2-A.svg",
                "b06073520ebe46d38482969be733a8f6-ao-2-Q.svg",
                "b06073520ebe46d38482969be733a8f6-ao-O.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-1-A.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-1-Q.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-2-A.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-2-Q.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-3-A.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-3-Q.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-4-A.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-4-Q.svg",
                "e2b20fec8fb242c0b97ba631a70e14ed-ao-O.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-1-A.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-1-Q.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-2-A.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-2-Q.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-3-A.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-3-Q.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-4-A.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-4-Q.svg",
                "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-O.svg",
                "f8968587c7b04c86a378c679301108d5-ao-1-A.svg",
                "f8968587c7b04c86a378c679301108d5-ao-1-Q.svg",
                "f8968587c7b04c86a378c679301108d5-ao-2-A.svg",
                "f8968587c7b04c86a378c679301108d5-ao-2-Q.svg",
                "f8968587c7b04c86a378c679301108d5-ao-O.svg",
                "ff17189e02f44a3da6fd7c1b9f060933-ao-1-A.svg",
                "ff17189e02f44a3da6fd7c1b9f060933-ao-1-Q.svg",
                "ff17189e02f44a3da6fd7c1b9f060933-ao-2-A.svg",
                "ff17189e02f44a3da6fd7c1b9f060933-ao-2-Q.svg",
                "ff17189e02f44a3da6fd7c1b9f060933-ao-O.svg",
                "paste-0d2756215775a5261efd3f41fb4a6a35a0ae28a8.jpg",
                "paste-1dde4f442d303b53a70387313522fa9212e73744.jpg",
                "paste-41e82ef870068aea652215b939aee75720ef16f0.jpg",
                "paste-44af17c986fdc1d9a6b5db867d9de4c65cf23900.jpg",
                "paste-5919a7fe2153dc365a7d2b98536f60c48b0b1f71.jpg",
                "paste-854dac1f54a21a3026dc78215d4949c8f71f810f.jpg",
                "paste-8e6c84ba755d94c51d3946488f0710fb06b14080.jpg",
                "paste-f8ed57f377933dc5de967a98b519cf08ed3da6ba.jpg",
                "tmp1t7h0jab.png",
                "tmp62gv7z57.png",
                "tmpbk8kbydk.png",
                "tmppkgd49wt.png",
                "tmpqsrwmzoe.png",
                "tmpz7vvox8i.png",
                "tmpzxuh_fh8.png"
            ],
            "mid": 1602236504918,
            "name": "02/21 Resp Pharm 1+2",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Asthma is common: affects up to&nbsp;{{c1::10%}} of children<div>Wheezing due to airflow&nbsp;{{c1::limitation}}</div><div>Is episodic , meaning that airflow&nbsp;{{c1::limitation}} is&nbsp;{{c1::reversible}}</div><div>Triggers<br>{{c1::z Allergens<br>z Exercise<br>z Cold air<br>z Virus infections}} (4)<br></div>",
                        "Limitation due to narrow bronchi<div>Goes from mild and occasional, to serious and persistent</div>"
                    ],
                    "guid": "f28vE+Yj+v",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "In asthma, the airflow limitation arises as a result of the&nbsp;{{c1::bronchi}} being too narrow.<div>It is felt mainly at&nbsp;{{c1::exhalation}} as the positive pressure in the chest cavity when the&nbsp;{{c1::diaphragm}} and the&nbsp;{{c1::intercostal muscles}} relax constricts the&nbsp;{{c1::bronchii}} even further.</div>",
                        "<img src=\"paste-44af17c986fdc1d9a6b5db867d9de4c65cf23900.jpg\"><div>Lungs full and diaphragm flattened</div><div><img src=\"paste-854dac1f54a21a3026dc78215d4949c8f71f810f.jpg\"><br></div><div>Exhalation much slower in asthma</div><div><br></div>"
                    ],
                    "guid": "m)nxlv>9!>",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Causes of asthma<div>1. Allergic effect:&nbsp;{{c1::Mast}} cells, that release&nbsp;{{c1::histamine}} which constrict bronchial smooth muscle cells.</div><div><br></div><div>2. Neurological cause:{{c1::Vagus}} nerve acts on bronchial smpoth muscle cells through the neurotransmitter&nbsp;{{c1::Ach}}</div>",
                        ""
                    ],
                    "guid": "RfT3K<8?,-",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "FEV1 stands for&nbsp;{{c1::forced expiratory volume in 1second}}<div><br></div><div>During an asthma attack the FEV1 can decrease to as low as&nbsp;{{c1::75%}} (% of normal fev1)</div><div><br></div><div>Phase 1 asthma attack, Mast cell releasing histamine or Vagus nerve problem</div><div><br></div><div>Phase 2: CHronic&nbsp;{{c1::inflammation}}: Mast cells, eosinophils, neutrophils etc. infiltrate the bronchial&nbsp;{{c1::submucosa}} and {{c1::lamina propria}} which narrows the airway even more.</div><div><br></div><div><br></div>",
                        "<img src=\"paste-1dde4f442d303b53a70387313522fa9212e73744.jpg\"><div>CD4+ T lymphocytes contribute to the inflammation</div>"
                    ],
                    "guid": "RdWP=WEvY2",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e2b20fec8fb242c0b97ba631a70e14ed-ao-1",
                        "",
                        "<img src=\"tmpbk8kbydk.png\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-1-A.svg\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-O.svg\" />"
                    ],
                    "guid": "lAm&|rycq9",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e2b20fec8fb242c0b97ba631a70e14ed-ao-2",
                        "",
                        "<img src=\"tmpbk8kbydk.png\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-2-A.svg\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-O.svg\" />"
                    ],
                    "guid": "E%RNEP/M=>",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e2b20fec8fb242c0b97ba631a70e14ed-ao-3",
                        "",
                        "<img src=\"tmpbk8kbydk.png\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-3-A.svg\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-O.svg\" />"
                    ],
                    "guid": "n>(#M<H,AY",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e2b20fec8fb242c0b97ba631a70e14ed-ao-4",
                        "",
                        "<img src=\"tmpbk8kbydk.png\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-4-A.svg\" />",
                        "<img src=\"e2b20fec8fb242c0b97ba631a70e14ed-ao-O.svg\" />"
                    ],
                    "guid": "vEB[.W1c},",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "COPD, {{c1::COAD}}, {{c1::chronic bronchitis}}, {{c1::emphysema}}<br>&nbsp;Almost universally linked with {{c1::cigarette smoking}}<br>{{c1::Irreversible}} damage to airways<br><br>",
                        "Airflow limitation<br>Susceptibility to lower respiratory tract infections<br>Loss of lung function"
                    ],
                    "guid": "tRvOl_`CFr",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Emphysema<div>Loss of&nbsp;{{c1::alveoli}} in centrilobar or {{c1::acinar}} area.</div><div>Oxygen and gas exchange is compromise, chronically&nbsp;{{c1::hypoxemic}}</div>",
                        "<img src=\"paste-41e82ef870068aea652215b939aee75720ef16f0.jpg\">"
                    ],
                    "guid": "HcJ3%d(d-h",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a3bf7cc25e9a4de3b592994e432039c6-ao-1",
                        "",
                        "<img src=\"tmpz7vvox8i.png\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-1-A.svg\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-O.svg\" />"
                    ],
                    "guid": "wu62~iUgRL",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a3bf7cc25e9a4de3b592994e432039c6-ao-2",
                        "",
                        "<img src=\"tmpz7vvox8i.png\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-2-A.svg\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-O.svg\" />"
                    ],
                    "guid": "tI6gH5diK-",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a3bf7cc25e9a4de3b592994e432039c6-ao-3",
                        "",
                        "<img src=\"tmpz7vvox8i.png\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-3-A.svg\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-O.svg\" />"
                    ],
                    "guid": "N$W53mMpCz",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a3bf7cc25e9a4de3b592994e432039c6-ao-4",
                        "",
                        "<img src=\"tmpz7vvox8i.png\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-4-A.svg\" />",
                        "<img src=\"a3bf7cc25e9a4de3b592994e432039c6-ao-O.svg\" />"
                    ],
                    "guid": "w./U7U6x=+",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "f8968587c7b04c86a378c679301108d5-ao-1",
                        "",
                        "<img src=\"Capture-d97a4aec839f97ed34efc1c4e421661ed3ffd1bf.PNG\" />",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-1-A.svg\" />",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-O.svg\" />"
                    ],
                    "guid": "sx%mFKRf4s",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "f8968587c7b04c86a378c679301108d5-ao-2",
                        "",
                        "<img src=\"Capture-d97a4aec839f97ed34efc1c4e421661ed3ffd1bf.PNG\" />",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-2-A.svg\" />",
                        "<img src=\"f8968587c7b04c86a378c679301108d5-ao-O.svg\" />"
                    ],
                    "guid": "iAaEzILp%&",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "573b238c9bcd409eb3e1cc105c7694d2-ao-1",
                        "",
                        "<img src=\"tmpzxuh_fh8.png\" />",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-1-A.svg\" />",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-O.svg\" />"
                    ],
                    "guid": "J=CN-G:Y?M",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "573b238c9bcd409eb3e1cc105c7694d2-ao-2",
                        "",
                        "<img src=\"tmpzxuh_fh8.png\" />",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-2-A.svg\" />",
                        "<img src=\"573b238c9bcd409eb3e1cc105c7694d2-ao-O.svg\" />"
                    ],
                    "guid": "KHU@V#Y;06",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "ff17189e02f44a3da6fd7c1b9f060933-ao-1",
                        "",
                        "<img src=\"tmpqsrwmzoe.png\" />",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-1-A.svg\" />",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-O.svg\" />"
                    ],
                    "guid": "rFK@KTXGKH",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "ff17189e02f44a3da6fd7c1b9f060933-ao-2",
                        "",
                        "<img src=\"tmpqsrwmzoe.png\" />",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-2-A.svg\" />",
                        "<img src=\"ff17189e02f44a3da6fd7c1b9f060933-ao-O.svg\" />"
                    ],
                    "guid": "vjW[Lk*{c?",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a866c98ccddb4d9f8ee8934854b9af52-ao-1",
                        "",
                        "<img src=\"tmp1t7h0jab.png\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-1-A.svg\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-O.svg\" />"
                    ],
                    "guid": "h|tEc9><.A",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a866c98ccddb4d9f8ee8934854b9af52-ao-2",
                        "",
                        "<img src=\"tmp1t7h0jab.png\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-2-A.svg\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-O.svg\" />"
                    ],
                    "guid": "c>xDgy)%{R",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "a866c98ccddb4d9f8ee8934854b9af52-ao-3",
                        "",
                        "<img src=\"tmp1t7h0jab.png\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-3-A.svg\" />",
                        "<img src=\"a866c98ccddb4d9f8ee8934854b9af52-ao-O.svg\" />"
                    ],
                    "guid": "G4y2>>gek1",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "b06073520ebe46d38482969be733a8f6-ao-1",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-1-A.svg\" />",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-O.svg\" />"
                    ],
                    "guid": "pX$Wen`~[L",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "b06073520ebe46d38482969be733a8f6-ao-2",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-2-A.svg\" />",
                        "<img src=\"b06073520ebe46d38482969be733a8f6-ao-O.svg\" />"
                    ],
                    "guid": "s#m:8mm?=b",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "2f59fdaa166c419fb0afa5d0a3d6316e-ao-1",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-1-A.svg\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-O.svg\" />"
                    ],
                    "guid": "EX6-;[ddHP",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "2f59fdaa166c419fb0afa5d0a3d6316e-ao-2",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-2-A.svg\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-O.svg\" />"
                    ],
                    "guid": "m-x#V#fe~4",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "2f59fdaa166c419fb0afa5d0a3d6316e-ao-3",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-3-A.svg\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-O.svg\" />"
                    ],
                    "guid": "smj<,dA]MU",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "2f59fdaa166c419fb0afa5d0a3d6316e-ao-4",
                        "",
                        "<img src=\"tmp62gv7z57.png\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-4-A.svg\" />",
                        "<img src=\"2f59fdaa166c419fb0afa5d0a3d6316e-ao-O.svg\" />"
                    ],
                    "guid": "MMjc9GuU3",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Salbutamol and terbutaline are selective beta 2&nbsp;{{c1::agonists}}<div><br></div><div>How much of the drug (cannisters being measurement) suggests the treatment of asthma is inadequate?&nbsp;{{c1::more than one}}</div><div><br></div><div>SHould only be used for bouts of asthmatic symptoms, if used regularly it may&nbsp;{{c1::lower effectiveness}} or increase {{c1::airway hyper responsivenss}}</div><div><br></div><div>Side effects<br>{{c1::z Tremor<br>z Tachycardia<br>z Nausea<br>z Light-headedness}} (4)<br></div>",
                        "side effects mostly related to stimulation of Beta1 receptors in<br>CVS, would need to take a lot tho for this to happen"
                    ],
                    "guid": "jksI+U-/N;",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "{{c1::salmeterol}} is a long acting b-adrenoceptor agonist<br><div>Has a&nbsp;{{c1::slower}} onset of action</div><div>It is not used for&nbsp;{{c1::acute}} symptoms</div>",
                        ""
                    ],
                    "guid": "mkH|g|T[Ep",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "MUSCARINIC RECEPTOR ANTAGONISTS<br>Anticholinergic<br>Target is {{c1::vagally}}-mediated, acetylcholine-dependent<br>{{c1::parasympathetic}}(type of neuron) airway smooth muscle tone<br>Inhibits muscarinic receptors<br>&nbsp;Example: ipratropium bromide<br>T/F More useful in asthma than COPD&nbsp;{{c1::false}}<div>T/F Inhaled&nbsp;{{c1::True}}<br>T/F Many clinically significant side effects&nbsp;{{c1::False}}</div>",
                        ""
                    ],
                    "guid": "A&SB>dl)-]",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>Methylxanthines<br></div>{{c1::Phosphodiesterase}} inhibitors<br>Examples:{{c1::Theophylline}} (oral) and {{c1::Aminophylline}} (IV)<br>Cause relaxation of bronchial smooth muscle<br>May have other mechanisms of action<br>Anti-inflammatory effects<br><br><br>Side effects<br>Narrow therapeutic index<br>{{c1::Nausea}}<br>Gastro-oesophageal reflux<br>{{c1::Tachycardia}}<br>Agitation",
                        "This is for when the patient cannot take any other medication whatsoever, it is shit compared to the others"
                    ],
                    "guid": "r-)CcVk9,T",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<img src=\"paste-5919a7fe2153dc365a7d2b98536f60c48b0b1f71.jpg\"><div>Why does Albuterol(salbutamol) and ipratropium have an additive effect on their change in FEV1?</div>",
                        "Two different mechanisms of action producing the same effect<div><br></div>"
                    ],
                    "guid": "gmek$wxq&T",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-1",
                        "",
                        "<img src=\"tmppkgd49wt.png\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-1-A.svg\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-O.svg\" />"
                    ],
                    "guid": "O*ZTPJe@^Q",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-2",
                        "",
                        "<img src=\"tmppkgd49wt.png\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-2-A.svg\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-O.svg\" />"
                    ],
                    "guid": "jdq=62<Hx1",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-3",
                        "",
                        "<img src=\"tmppkgd49wt.png\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-3-A.svg\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-O.svg\" />"
                    ],
                    "guid": "rK{w5)A%ka",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-4",
                        "",
                        "<img src=\"tmppkgd49wt.png\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-4-A.svg\" />",
                        "<img src=\"e96d54f2bd3e47c3b75ee0f2c8aab2df-ao-O.svg\" />"
                    ],
                    "guid": "mt6IQ;h+Go",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Corticosteroid treatment in asthma patients is primarily used as prophylactic&nbsp;{{c1::anti-inflammatory}} to prevent the&nbsp;{{c1::2nd phase }} of an asthma attack.<div><br></div><div>They are taken prophylactically because corticosteroids are relatively&nbsp;{{c1::slow}} acting</div><div><br></div><div><br>{{c1::Glucocorticoid}} receptors&nbsp;<br>&nbsp;Innate immune cells such as&nbsp; {{c1::Monocytes}} and {{c1::macrophages}}<br>&nbsp;Adaptive immune cells<br>&nbsp;T lymphocytes<br>&nbsp;Non-immune cells<br>Endothelial cells<br><br>inalldifferentcelltypes<br><br>Inhaled corticosteroid side effects<br><br>z Local side effects<br>z Dysphonia Oropharyngeal candidiasis Cough<br>z Systemic side effects<br>z Adrenal suppression Growth suppression Bruising<br>Osteoporosis Cataracts Glaucoma Metabolic<br>abnormalities (glucose, insulin, triglycerides)<br>Psychiatric disturbances<br><br>bcitdampensdowntheIs<br>morepronetoinfectious<br><br>chronic<br><br>ofuoia q<br><br>hyperglycemia<br><br>Corticosteroid use in asthma and COPD<br><br>z By inhalation<br>z Often combined with inhaled E2-adrenoceptor agonist<br>z Slow onset of action (hours)<br>z Not used for immediate symptom relief<br>z Use to prevent attacks<br>z Long duration of benefit (hours)<br>z Systemically<br>z Oral or IV<br>z Used in more severe cases<br></div>",
                        "<img src=\"paste-8e6c84ba755d94c51d3946488f0710fb06b14080.jpg\"><div><img src=\"paste-0d2756215775a5261efd3f41fb4a6a35a0ae28a8.jpg\"><br></div>"
                    ],
                    "guid": "CXB*8MY2qo",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Corticosteroid Targets:<br>{{c1::Glucocorticoid}} receptors&nbsp;<br>Innate immune cells: Monocytes, {{c1::macrophages}}<br>Adaptive immune cells: {{c1::T lymphocytes}}<br>Non-immune cells: {{c1::Endothelial cells}}<br><br><br><br>Inhaled corticosteroid side effects<br>&nbsp;Local side effects:<br>&nbsp;Dysphonia:&nbsp;{{c1::hoarseness of voice}}<div>&nbsp;Oropharyngeal candidiasis:&nbsp;{{c1::thrush infection}}</div><div>&nbsp;Cough<br>&nbsp;</div><div>Systemic side effects:<br>&nbsp;{{c1::Adrenal}} suppression, {{c1::Growth}} suppression, Bruising<br>Osteoporosis, Cataracts, Glaucoma,&nbsp;</div><div>Metabolic abnormalities (glucose, insulin, triglycerides)<br>Psychiatric disturbances<br><br>Corticosteroid use in asthma and COPD T/F<br><br>&nbsp;By inhalation&nbsp;{{c1::true}}<br>&nbsp;Often combined with inhaled E2-adrenoceptor agonist&nbsp;{{c1::true}}<br>&nbsp;Slow onset of action (hours){{c1::True}}<br>&nbsp;Used for immediate symptom relief&nbsp;{{c1::False, is used prophylactilly}}<br>&nbsp;Use after phase 1 part of attacks&nbsp;{{c1::true, still before phase 2}}<br>&nbsp;Long duration of benefit (hours)&nbsp;{{c1::True}}<br>&nbsp;</div><div>Systemically:</div><div>&nbsp;Only used orally&nbsp;{{c1::False can be used IV}}</div><div>&nbsp;Used in more severe cases{{c1::True}}</div>",
                        "<img src=\"paste-0d2756215775a5261efd3f41fb4a6a35a0ae28a8.jpg\">"
                    ],
                    "guid": "xWN+)wKM9t",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "During an asthma attack, leukotrienes contribute to the&nbsp;{{c1::inflammaotry}} process. But they also further constrict the bronchial smooth muscle by acting on the&nbsp;{{c1::CysLT}} receptor.<div><br></div><div>Lukasts</div><div>{{c1::&nbsp;Inhibit}} these receptors expressed on respiratory epithelium and infiltrating leukocytes<br>Improve airflow in both early and late phases<br>{{c1::Orally}} administered<br>Well tolerated<br>Example: {{c1::Montelukast}}<br>Slow acting: used to prevent attacks<br></div>",
                        "<img src=\"paste-f8ed57f377933dc5de967a98b519cf08ed3da6ba.jpg\"><div>Lukasts quicker acting than corticosteroid, but shorter lasting</div>"
                    ],
                    "guid": "l>cOEItcl)",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Anti-IgE therapy of asthma</b><br>In some patients asthma triggers are {{c1::allergic}}<br><br><div>Anti-IgE treatment may be considered if:</div><div>-Moderate-to-severe {{c1::persistent}} asthma<br>-Asthma symptoms are inadequately controlled with inhaled<br>glucocorticoids<br><div>-A total serum IgE level is between {{c1::30}} and 1500 international units/mL, which is the range over which the drug can reduce enough free IgE to ensure a therapeutic effect<br>-Allergic sensitization demonstrated by positive skin testing or in vitro testing for allergen-specific IgE to an allergen that is present year-round e.g.&nbsp;{{c1::house dust mites, animal danders, cockroaches, or molds}}<br><br><br><br>{{c1::Omalizumab}} is a recombinant humanized anti-IgE antibody<br><br>Used in selected asthmatic patients&nbsp;</div><div>Results in marked fall in serum IgE&nbsp;</div><div>&nbsp;May be useful also in other IgE-mediated diseases eg {{c1::recurrent anaphylaxis}}</div></div>",
                        ""
                    ],
                    "guid": "gW}$kGrS=g",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "969cda51-7dd0-11eb-acdf-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-4301241840ed16771b4dc018189a975f932e9ddc.jpg",
                "paste-49d6a82bda0677d16d9eaab0aea03fc49a72bc98.jpg",
                "paste-e137da2c0499e34f58c7d3191720c5073a791963.jpg",
                "paste-e463ac68b4c3d6bf86769a48fab0e5038e923531.jpg",
                "paste-e95f601c181141294f3fb2a4ab05a57ff748b8ef.jpg"
            ],
            "mid": 1602236504918,
            "name": "03/01 GIT PHARM",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Mesalazine is used to treat IBD especially&nbsp;{{c1::ulcerative collitis}}<div>Another name for Mesalazine is&nbsp;{{c1::5-Aminosalicytic acid}}</div><div><br></div><div>Mesalazine is administered&nbsp;{{c1::orally}} or&nbsp;{{c1::rectally}}</div><div><br></div><div>The concentration of mesalazine achived in the large intestine is&nbsp;{{c1::10-30}}mmol/l this is a very&nbsp;{{c1::high concentration}}</div><div><br></div><div>It is&nbsp;{{c1::well}} tolerated</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "c,$aj|:M]=",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Corticosteroids are used sometimes in patients with&nbsp;{{c1::moderate to severe}} IBD<div><br></div><div>There are&nbsp;{{c1::many}} side effects associated with&nbsp;{{c1::long}} term use of corticosteroids</div>",
                        ""
                    ],
                    "guid": "V?8=_!~}g",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>IMMUNOSUPPRESSANTS:</div><div>{{c1::Slow}}-acting&nbsp;<br></div><div><br></div><div><br></div>Azathioprine/6-mercaptopurine&nbsp;<div> {{c1::Purine}} analogues&nbsp;</div><div> Decrease {{c1::nucleotide}} biosynthesis selectively in {{c1::lymphoid}} cells&nbsp;</div><div> S/Es: Bone marrow suppression, pancreatitis, allergy, lymphoma&nbsp;</div><div><br></div><div>Methotrexate&nbsp;</div><div> {{c1::Folic acid}} analogue&nbsp;</div><div> Competitive inhibitor of {{c1::dihydrofolate reductase}}</div><div>&nbsp; Induces apoptosis of activated {{c1::lymphocytes&nbsp;}}</div><div> S/Es: Liver fibrosis, pneumonitis, bone marrow suppressions</div><div><br></div>",
                        ""
                    ],
                    "guid": "E1il]@`8F9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "TNFalpha&nbsp;<div> Pro-inflammatory {{c1::cytokine&nbsp;}}</div><div> Produced by activated {{c1::macrophages}} in inflamed gut&nbsp;</div><div><br></div><div>ANTI-TNFalpha drugs</div><div>Infliximab&nbsp;</div><div> Neutralizes {{c1::soluble}} and {{c1::membrane-associated}} TNFalpha</div><div> Induces {{c1::apoptosis}} of cells expressing TNFalpha&nbsp;</div><div><br></div><div>Highly effective in induces and maintaining responses in {{c1::IBD}} patients&nbsp;<br></div><div><br></div><div><br></div><div>There is a loss of&nbsp; response to Infliximab over time, why?</div><div>{{c1::Production of anti infliximab antibodies}}<br></div><div><br></div><div>Adverse effects of TNFalpha inhibitors</div><div> Reactivation of latent {{c1::tuberculosis&nbsp;}}</div><div> Increased risk of opportunistic infections&nbsp;</div><div> Emergence of {{c1::Multiple Sclerosis&nbsp;}}</div><div> Injection and infusion reactions<br></div><div><br></div><div><br></div><div><br></div>",
                        "V#<img src=\"paste-4301241840ed16771b4dc018189a975f932e9ddc.jpg\">"
                    ],
                    "guid": "JOZt<go-o0",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anti-integrin Biologics for IBD patients<div>Drug Name:{{c1::Vedolizumab\n(Entyvio)}}</div><div> {{c1::Slow}} acting&nbsp;</div><div> {{c1::IV}} administered</div><div> {{c1::Good}} efficacy&nbsp;</div><div> {{c1::Very few}} side effects<br><div><br></div></div>",
                        "<img src=\"paste-e137da2c0499e34f58c7d3191720c5073a791963.jpg\">"
                    ],
                    "guid": "D+TNtPW]ep",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anti-cytokine biologics in IBD<div>Drug Name:&nbsp;{{c1::Ustekinumab (Stelara)}}</div><div> Combines IL-{{c1::12/23}}</div><div> Derived from many types of\nimmune cells</div><div> Elevated in many inflammatory\ndiseases</div><div> Stimulate {{c1::Th1}} and {{c1::Th17}}\nsignalling&nbsp;</div><div> Monoclonal anti-{{c1::p40}} subunit</div><div> Good efficacy&nbsp;</div><div> Well tolerated&nbsp;</div><div> First dose {{c1::IV}} then SC<br></div>",
                        "<img src=\"paste-49d6a82bda0677d16d9eaab0aea03fc49a72bc98.jpg\">"
                    ],
                    "guid": "O!4O:h@8LU",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Vomiting<div><br></div><div>GI Irritation:&nbsp;</div><div>Cytotoxic Drugs, Radiation &amp; other GI irritants release 5-HT from the\n{{c1::enterochromaffin}} cells&nbsp;</div><div>\nStimulation of the {{c::15-HT3}} Receptors present on vagal afferents</div><div>\nStimulation of {{c1::CTZ&nbsp;}}</div><div>\nVomiting<br></div><div><br></div><div>Vestibular Irritation:</div><div>-The vestibular apparatus generates impulses when body is\nrotated or {{c1::equilibrium}} is disturbed or when {{c1::ototoxic}} drugs\nact.&nbsp;</div><div>-These impulses reach the vomiting centre mainly relayed by\nthe {{c1::M}} and the {{c1::H1}}\nreceptors.&nbsp;</div><div>-Various sensory stimuli such as bad odour, ghastly sight,\nsevere pain as well as fear cause {{c1::nausea}} and vomiting by\ndirect stimulation of higher centres<br></div>",
                        "CTZ=Chemoceptor trigger zone<div><img src=\"paste-e463ac68b4c3d6bf86769a48fab0e5038e923531.jpg\"><br></div>"
                    ],
                    "guid": "t&&F!<`+3N",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>Vomiting Mediators and Receptors</div>5-HT: an important mediator involved in such\nsignals, many other mediators and peptides are also\ninvolved.&nbsp;<div><br></div><div>The CTZ expresses a variety of receptors e.g.\nHistamine H{{c1::1}}\n, Dopamine D{{c1::2}}\n, Cholinergic M, Opioid u and the Serotonin 5-HT{{c1::3}}\nreceptors, through which\nthe emetic signals are relayed.</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "P2O=UI*mhD",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>Anticholinergics,&nbsp;H1 Antihistamines,&nbsp;Neuroleptics,&nbsp;D2 Receptor Antagonist,&nbsp;5-HT3 Receptor Antagonist,&nbsp;Others<br></div><div><br></div><div> {{c1::D2 Receptor Antagonist}}: Domperidone, Metoclopramide&nbsp;<br></div><div> {{c1::Neuroleptics}}: Chlorpromazine, Haloperidol</div><div> {{c1::Anticholinergics}}: Hyoscine, Dicyclomine&nbsp;<br></div><div> {{c1::Others}}: Dexamethasone, BZD, Cannabinoids<br></div><div> {{c1::H1 Antihistamines}}: Promethazine, Cyclizine, Diphenhydramine, Cinnarizine<br></div><div> {{c1::5-HT3 Receptor Antagonist}}: Ondansetron, Granisetron&nbsp;<br></div><div><br></div>",
                        ""
                    ],
                    "guid": "G~E%%,93U4",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anticholinergics<div>Hyoscine is an effective drug for\n{{c1::motion sickness&nbsp;}}</div><div> Blocks {{c1::muscarinic}} receptors</div><div> suitable for short journeys</div><div> blocks the conduction of nerve impulses\nacross a cholinergic link pathway\nleading from the {{c1::vestibular apparatus}} to\nthe vomiting centre.&nbsp;</div><div> anticholinergic side effects such as {{c1::dry\nmouth}} and {{c1::sedation}}</div>",
                        ""
                    ],
                    "guid": "CD_[-bT+j;",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "H1 Antihistamines&nbsp;<div>Promethazine, Diphenhydramine&nbsp;</div><div> Anticholinergic, antihistaminic and {{c1::sedative}}\neffects&nbsp;</div><div> Protect from motion sickness for {{c1::4-6}} hrs.&nbsp;</div><div> {{c1::Cyclizine}}, {{c1::Meclizine}}, are less sedative&nbsp;</div><div> {{c1::Meclizine}} has a long duration of action used\nin sea sickness.</div>",
                        ""
                    ],
                    "guid": "mg~(U2=vAX",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Neuroleptics&nbsp;<div>prochlorpromazine&nbsp;</div><div>-Potent {{c1::antiemetics}}&nbsp;</div><div>-Block {{c1::D2}} receptors in the CTZ.&nbsp;</div><div>-Broad spectrum antiemetic effect and is\nuseful in&nbsp;</div><div> Drug induced and postanaesthetic {{c1::nausea}} and\nvomiting&nbsp;</div><div> Vomiting due to diseases: {{c1::gastroenteritis}},\nmigraine etc.&nbsp;</div><div> {{c1::Hyperemesis gravidarum}}</div><div>-Second line agents&nbsp;</div><div>-Sedation++</div>",
                        ""
                    ],
                    "guid": "r`_liF.^H?",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "D2 receptor antagonist:&nbsp;<div>-Metoclopromide&nbsp;<div> It increases GI {{c1::peristalsis}} leading\nto increased gastric emptying&nbsp;</div><div><br></div><div> The tone of {{c1::lower oesophageal\nsphincter}} is increased&nbsp;</div><div><br></div><div> ADR&nbsp;</div><div>&nbsp; &nbsp;  sedation, dizziness, movement\ndisorders (extrapyramidal)&nbsp;</div><div>&nbsp; &nbsp;  acute {{c1::dystonias}} eg spasmodic torticollis&nbsp;</div><div>&nbsp; &nbsp;  {{c1::occulogyric}} crisis&nbsp;</div><div>&nbsp; &nbsp;  Managed with antihistamines eg\ndiphenhydramine&nbsp;</div><div><br></div><div> Long term use can cause\n{{c1::Parkinsonism}} (tardive dyskinesia)&nbsp;</div><div><br></div><div>-Domperidone&nbsp;</div><div>&nbsp; &nbsp; &nbsp; Similar but does not cross BBB – fewer\nside effects but less&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;effective&nbsp;<br></div><div>&nbsp; &nbsp; &nbsp; Associated with long {{c1::QT}} Syndrome</div></div>",
                        "<b>Oculogyric crisis</b><span style=\"color: rgb(32, 33, 36);\">&nbsp;refers to spasms of extraocular muscles leading to tonic eye deviation</span>"
                    ],
                    "guid": "iMg6Wc&n)Q",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>5-HT3 Receptor Antagonists<br></div><div><br></div>Very effective in treating {{c1::Cancer\nChemotherapy/Radiotherapy}} induced vomiting&nbsp;<div><br></div><div>It is effective in vomiting due to any cause\n&nbsp;</div><div><br></div><div>Blocks the emetogenic impulses both at their\nperipheral origin and their central relay.\n&nbsp;</div><div><br></div><div>It has no {{c1::DA}} blocking effects\n&nbsp;</div><div><br></div><div>It is given {{c1::orally}} or {{c1::i.v}}\n&nbsp;</div><div><br></div><div>Generally well tolerated and very few side effects\n&nbsp;</div><div><br></div><div>Granisetron is {{c1::10}} times potent than Ondansetron</div>",
                        ""
                    ],
                    "guid": "ekH/K5GGA+",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Constipation usually the result of {{c1::slow colonic}} transit (lazy\nbowel)&nbsp;<div> Intermittent constipation is best prevented with a {{c1::high fibr}}e\ndiet, adequate fluid intake, regular exercise&nbsp;</div><div><br></div><div> Those not responding to the above measures should be\nmedically evaluated before started on laxatives</div>",
                        ""
                    ],
                    "guid": "zuakqU~yT!",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Does it cause constipation?<div>Opioid analgesics?&nbsp;{{c1::yes}}</div><div>Cationic Drugs?&nbsp;{{c1::yes}}</div><div>Anionic Drugs?&nbsp;{{c1::its not in the lecture so we'll say no}}</div><div>NSAID Drugs?&nbsp;{{c1::Nah}}</div><div>Calcium Channel blockers&nbsp;{{c1::Yes}}</div><div>Cholinergic&nbsp;{{c1::No, anti-cholinergic}}</div>",
                        ""
                    ],
                    "guid": "P!-Ih1~d.:",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Bulk Forming Laxatives&nbsp;<div><br></div><div> Indigestible, hydrophilic colloids that absorb\nwater, forming a bulky {{c1::emollient gel}} that\ndistends the colon and promotes {{c1::peristalsis}}&nbsp;</div><div><br></div><div> Natural plant products:&nbsp;</div><div>-{{c1::Psyllium}} husk&nbsp;</div><div>-{{c1::Methylcellulose}}&nbsp;</div><div><br></div><div> Synthetic fibres – Polycarbophil&nbsp;</div><div><br></div><div> ADR of these preparations include {{c1::bloating of\nabdomen}}</div>",
                        ""
                    ],
                    "guid": "PM~A<T(QDI",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Stool Softeners&nbsp;<div> Soften the stool material, permitting {{c1::water}} and {{c1::lipids}}\nto penetrate&nbsp;</div><div><br></div><div> They are administered {{c1::orally}} or {{c1::rectally}}.&nbsp;</div><div><br></div><div> Common agents</div><div>-Docusate (orally and as an enema)&nbsp;</div><div>-{{c1::Glycerine}} suppository&nbsp;</div><div><br></div><div> Mineral oil is a clear, viscous oil which lubricates\nfaecal material, retarding water absorption from the\nstool (for treating faecal impaction in {{c1::children}})</div>",
                        ""
                    ],
                    "guid": "rdXTI1Q`f@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Osmotic Laxatives&nbsp;<div> Osmotic laxatives are soluble but {{c1::nonabsorbable}}\ncompounds&nbsp;</div><div>&nbsp;-result in increased stool liquidity due to an increase in faecal\nfluid&nbsp;</div><div><br></div><div> Magnesium oxide – to be used with caution in patients with\n{{c1::renal}} impairment (may cause {{c1::hypermagnesemia}})&nbsp;</div><div><br></div><div> Sorbitol &amp; Lactulose –&nbsp;</div><div>-Treatment of {{c1::chronic}} constipation&nbsp;</div><div>-Metabolized by the colonic bacteria&nbsp;</div><div>-May cause severe {{c1::flatus}} and {{c1::cramps}}</div>",
                        ""
                    ],
                    "guid": "N?#)l&&Kdx",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Motility stimulant&nbsp;<div> Prucalopride&nbsp;</div><div>-{{c1::5HT4}} agonist&nbsp;</div><div>-Stimulates colonic\nsmooth muscle\n{{c1::contraction&nbsp;}}</div><div>When is it used?&nbsp;{{c1::The other treatments have failed}}</div>",
                        "<img src=\"paste-e95f601c181141294f3fb2a4ab05a57ff748b8ef.jpg\">"
                    ],
                    "guid": "m[a%Y<J7n*",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "WHen should anti-diarrhoetic drugs NOT be used?",
                        "When there is stool in the diarrhoea"
                    ],
                    "guid": "F,Iw,U1`#k",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Opioid Agonists (for diarrhoea)<div><br></div><div> These agents have significant constipating effects&nbsp;</div><div><br></div><div> Inhibition of {{c1::pre}}synaptic cholinergic nerves in {{c1::submucosal}} and\n{{c1::myenteric}} plexus and lead to increased colonic transit time.&nbsp;</div><div>-Loperamide&nbsp;&nbsp;</div><div>-{{c1::Diphenoxylate&nbsp;}}</div><div><br></div><div> Less CNS effect than conventional opiates, why?&nbsp;{{c1::Doesn't usually cross the BBB}}</div><div><br></div><div> At higher than recommended doses, CNS effects can occur&nbsp;</div><div><br></div><div> Codeine can also be used (morphine pro-drug)</div>",
                        ""
                    ],
                    "guid": "H@qYQ<XY6U",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Anti-cholinergics (for diarrhoea)<div><br></div><div>Atropine&nbsp;</div><div><br></div><div> Combined with opioids in certain pharmaceutical preparations</div><div>-Low dose&nbsp;</div><div>-Uncertain benefit at such low doses&nbsp;</div><div><br></div><div>What happnes at doses sufficient to inhibit diarrhoea?&nbsp;{{c1::Many bad side effects Dry mouth, tachycardia, sedation}}</div><div><br></div>",
                        ""
                    ],
                    "guid": "O=rr/X;&h9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "969eadd5-7dd0-11eb-9fbb-af478fea30f9",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "1ad708726cb340fabbd48a89a486f940-ao-1-A.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-1-Q.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-2-A.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-2-Q.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-3-A.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-3-Q.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-4-A.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-4-Q.svg",
                "1ad708726cb340fabbd48a89a486f940-ao-O.svg",
                "paste-0df824779fe0fd45e809249e1e283d49489e328f.jpg",
                "paste-4a5a63dedccb023ede42c065be9707f2979c8937.jpg",
                "paste-4aadf770ecaa2186ef02bc180460e81420380e28.jpg",
                "paste-833c5702fc009736b1ec143329d762ce03850f30.jpg",
                "paste-f351da7749cb8c28dcaf7246b7ed24f940bb1b97.jpg",
                "tmpye0sogmy.png"
            ],
            "mid": 1602236504918,
            "name": "03/02 GIT Pharm, Ulcers",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Peptic Ulcer Disease:<div><br></div><div>Three areas where ulcers occur in it;&nbsp;{{c1::Esophagus}}(due to acid reflux),&nbsp;{{c1::stomach}} and{{c1::small intestine}} .</div><div><br></div><div>Most common symptom of PUD is&nbsp;{{c1::a gnawing pain}} &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<br></div>",
                        ""
                    ],
                    "guid": "nm[%*`@jFw",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "PUD: Pathogenesis&nbsp;<div><br></div><div>Normal defences against ulcers T/F</div><div><br></div><div>Peristalsis&nbsp;{{c1::F}}</div><div>Mucus&nbsp;{{c1::t}}</div><div>Cell renewal&nbsp;{{c1::t}}&nbsp;</div><div>Blood flow&nbsp;{{c1::t}}<br></div><div>Secretin&nbsp;{{c1::f}}</div><div>Cytokines&nbsp;&nbsp;{{c1::f}}</div><div>Bicarbonate layer&nbsp;&nbsp;{{c1::t}}</div><div>Sphincters&nbsp;&nbsp;{{c1::f}}</div><div>Prostaglandins&nbsp;{{c1::t}}<br></div><div>Cell renewal&nbsp;&nbsp;{{c1::t}}</div><div><br></div><div>Pathogenic Factors:</div><div><br></div><div>Most Common:</div><div>{{c1::helicobacter}} infection and&nbsp;{{c1::NSAIDs}}<br></div><div><br></div><div>Least Common:&nbsp;</div><div>Excess {{c1::Acid}}<br></div><div><br></div><div><br></div><div>ULCER OCCURS WHEN&nbsp;{{c1::PATHOGENIC}} FACTORS OUTWEIGH&nbsp;{{c1::DEFENSES}}</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "rQ;)x1WMa8",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<img src=\"paste-0df824779fe0fd45e809249e1e283d49489e328f.jpg\"><div>Helicobacter&nbsp;{{c1::Pylori}}</div><div><br></div><div>Gram&nbsp;{{c1::negative}} bacillus</div><div>Causes&nbsp;{{c1::Chronic Gastritis}}</div><div><br></div><div>Present in most patients with a non-NSAID linked&nbsp;{{c1::duodenal}} Ulcer</div><div><br></div><div><br></div><div><br></div>",
                        "H. pylori infection is detectable before the occurrence of DU\nand appears to be a risk factor for the disorder.<div><br></div><div>Eradication of H. pylori prevents disease recurrence<br></div>"
                    ],
                    "guid": "lKCwHKk&uA",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "PUD and NSAIDs<div><br></div><div>NSAIDs decrease protective {{c1::prostaglandin}} production in the\nstomach (systemic effect)<br></div><div><br></div><div>Maybe additional direct irritant effect (local effect)<br></div>",
                        ""
                    ],
                    "guid": "q^Ek|?*<`J",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is a Gastrinoma?<div>What disease causes Gastrinomas?</div><div>How can Gastrinomas cause Peptic Ulcers?</div>",
                        "Gastrin secreting tumour<div>Zollinger-Ellison Syndrome</div><div>Gastrin is acidic and excess acid causes ulcer.</div>"
                    ],
                    "guid": "j7qs<7X]:?",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1ad708726cb340fabbd48a89a486f940-ao-1",
                        "",
                        "<img src=\"tmpye0sogmy.png\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-1-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-1-A.svg\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-O.svg\" />"
                    ],
                    "guid": "G>ztJ7ogmd",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1ad708726cb340fabbd48a89a486f940-ao-2",
                        "",
                        "<img src=\"tmpye0sogmy.png\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-2-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-2-A.svg\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-O.svg\" />"
                    ],
                    "guid": "L<I5nGhZEp",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1ad708726cb340fabbd48a89a486f940-ao-3",
                        "",
                        "<img src=\"tmpye0sogmy.png\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-3-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-3-A.svg\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-O.svg\" />"
                    ],
                    "guid": "to[n/dzM-q",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1ad708726cb340fabbd48a89a486f940-ao-4",
                        "",
                        "<img src=\"tmpye0sogmy.png\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-4-Q.svg\" />",
                        "",
                        "",
                        "",
                        "",
                        "",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-4-A.svg\" />",
                        "<img src=\"1ad708726cb340fabbd48a89a486f940-ao-O.svg\" />"
                    ],
                    "guid": "q-hhml@QYB",
                    "note_model_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "The Three Gastric Acid Secretagogues are<div>{{c1::Histamine}}: Produced by&nbsp;{{c1::M}} cells</div><div>{{c1::Ach}}: Produced by&nbsp;{{c1::Cholinergic}} Nerves<br></div><div>{{c1::Gastrin}}: Delivered via Blood vessels<br></div>",
                        "<img src=\"paste-4aadf770ecaa2186ef02bc180460e81420380e28.jpg\">"
                    ],
                    "guid": "nED1=O+X[A",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Inhibition Of Gastric Acid:<div><br></div><div><b>ANTACIDS</b>:</div><div><br></div><div>-{{c1::Neutralizes}} Gastric Acids and {{c1::raises}} pH</div><div><br></div><div>-Contains:</div><div>&nbsp; &nbsp; &nbsp; &nbsp;{{c1::Magnesium}} salts,which can cause diarrhoea</div><div>&nbsp; &nbsp; &nbsp; &nbsp;{{c1::Aluminium}} salts, which can cause constipation</div><div>&nbsp; &nbsp; &nbsp; &nbsp; {{c1::Sodium Hydroxide}}</div><div>Most preparations use various anatacids together.</div><div><br></div><div><b>H2 receptor antagonists&nbsp;</b></div><div><br></div><div> {{c1::Competitive}} antagonists of the receptor&nbsp;</div><div><br></div><div> Inhibit {{c1::basal acid}} secretion&nbsp;</div><div><br></div><div> Decrease acid secretion in response to&nbsp;</div><div>- Histamine&nbsp;</div><div>- Gastrin&nbsp;</div><div>- Acetylcholine&nbsp;</div><div>Why?&nbsp;{{c1::All have an effect on m cells}}</div><div><br></div><div> Examples&nbsp;</div><div>- {{c1::Cimetidine}}&nbsp;</div><div>- {{c1::Ranitidine}}<br></div><div>Very Effective</div><div><br></div><div><b>Proton pump inhibitors</b><br></div><div><br></div><div>Irreversible inhibition of the {{c1::H+/K+-ATPase (the proton pump}})&nbsp;</div><div><br></div><div>&nbsp;Final common pathway of basal and induced acid secretion&nbsp;</div><div><br></div><div>Are administered as {{c1::prodrugs}}</div><div><br></div><div>Weak bases, accumulate in the acid environment of the canaliculi of\nthe stimulated parietal cell where they are activated</div><div><br></div><div>Examples:&nbsp;{{c1::Omeprazole, lansoprazole, rabeprazole}} (3)</div><div><br></div><div><br></div>",
                        "Antacid example:&nbsp;Maalox:\nEach 5 ml of oral solution contains:\nAluminium hydroxide 175mg\nMagnesium hydroxide 200mg<div><br></div><div><img src=\"paste-833c5702fc009736b1ec143329d762ce03850f30.jpg\"><br></div>"
                    ],
                    "guid": "y(mL?C-&z0",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Cimetidine and ranitidine&nbsp;<div><br></div><div> {{c1::High}} oral bioavailability&nbsp;</div><div> Usually given twice daily&nbsp;</div><div> Low side effect profile :{{c1::Diarrhoea}} and {{c1::Rash}}&nbsp;</div><div><div> Available OTC&nbsp;</div><div> Renal excretion – reduce dose in renal insufficiency</div></div><div><br></div><div>Cimetidine inhibits {{c1::CYP450&nbsp;}}</div><div> Drug interactions (Higher {{c1::Warfarin}} and {{c1::TCA}} levels)&nbsp;</div><div><br></div>",
                        ""
                    ],
                    "guid": "QC<m#WC(M9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Omeprazole&nbsp;<div> Best taken 30 minutes before a meal&nbsp;</div><div> Also IV&nbsp;</div><div><br></div><div> Adverse effects are {{c1::Very well}} tolerated:&nbsp;</div><div> {{c1::Diarrhoea&nbsp;}}</div><div> {{c1::Allergic skin rash&nbsp;}}</div><div><br></div><div> S-enantiomer available also (esomeprazole)&nbsp;</div><div> Metabolized by {{c1::CYP2C19}}</div>",
                        ""
                    ],
                    "guid": "bKhGIs8?!s",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Proton Pump Inhibitors have a half life of 1-1.5 hours, yet their duration of action is 24-36 hours, how?",
                        "Canalicular trapping by protonation (weak base in an acidic pH)&nbsp;<div> Irreversible inhibition of H+/K+ ATPase so requires Requires new pump synthesis to start secreting acid again.</div>"
                    ],
                    "guid": "ILf8Zoi``,",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "The recurrent rate of PUD is &gt;&nbsp;{{c1::30%}}<div><br></div><div>Requires long-term {{c1::H2RA}} or {{c1::PPI}} therapy</div><div><div><br></div></div>",
                        " Expense&nbsp;<div> Inconvenience&nbsp;</div><div> Potential for side effects</div>"
                    ],
                    "guid": "dq(zhLFuz}",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1. Antacids block gastric acid\nsecretion&nbsp;<div>2. Cimetidine inhibits the final\ncommon pathway for acid\nsecretion&nbsp;</div><div>3. Acid inhibition causes\nmalabsorption&nbsp;</div><div>4. Omeprazole has a long\nplasma half life, explaining\nits 24h duration of action&nbsp;</div><div>5. Omeprazole is trapped in\nthe parietal cell and\nirreversibly inhibits the\nproton pump</div>",
                        "5. Omeprazole is trapped in\nthe parietal cell and\nirreversibly inhibits the\nproton pump"
                    ],
                    "guid": "n%u3iN+&nU",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "H. pylori eradication<div><br><div>{{c1::multi}} drug regimens<br></div></div><div><br></div><div>Answer Penicillin tolerant, penecillin allergic or both to treatrment options</div><div><br></div><div>Metronidazole&nbsp;{{c1::PCN allergic}}<br></div><div>Clarithromycin&nbsp;{{c1::both}}</div><div>Amoxicillin&nbsp;{{c1::PCN tolerant}}</div><div>PPI&nbsp;{{c1:: Both}}</div><div><br></div><div>7-14 days</div><div>{{c1::80-90}}% eradication rate.<br></div>",
                        " Variable efficacy&nbsp;<div> Gradual increase in prevalence of drug-resistant strains</div>"
                    ],
                    "guid": "HQD)Kps}:`",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>NSAIDs</b>&nbsp;&nbsp;<div>Aspirin and Non-aspirin anti-inflammatory pain killers&nbsp;</div><div> Used to treat pain, especially arthritic pain&nbsp;</div><div><br></div><div> Block the actions of {{c1::cyclo-oxygenase}}&nbsp;</div><div> {{c1::↓}} levels of PGE2&nbsp;</div><div> {{c1::↓}} Mucous and bicarbonate secretion&nbsp;</div><div>&nbsp;{{c1::increase}} acid production</div><div><br></div><div>To mitigate this you use&nbsp;</div><div><b>Misoprostol</b><br></div><div><b><br></b></div><div> Stable analogue of {{c1::PGE2}}&nbsp;</div><div> Oral – produces high concentration at gastro-duodenal\nmucosa&nbsp;</div><div> Mitigates harmful effects of NSAIDs on {{c1::PG}} production in\nstomach&nbsp;</div><div> Decreases rate of NSAID-induced {{c1::ulceration&nbsp;}}</div><div> Usefulness limited by\n {{c1::Diarrhoea}}\n Effects on {{c1::cervix}}<b><br></b></div>",
                        ""
                    ],
                    "guid": "NKi&:<F5`t",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "1. Peptic ulcers can be caused by an\ninfection with H pylori&nbsp;<div>2. Eradication of H pylori with 2\nantibiotics and a PPI is 100%\neffective&nbsp;</div><div>3. Misoprostol blocks prostaglandin\nreceptors&nbsp;</div><div>4. NSAIDs decrease gastro-protective\nprostaglandins&nbsp;</div><div>5. PPIs are available over the counter</div>",
                        "2 and 3 smh Larry"
                    ],
                    "guid": "ehx0t>3i1o",
                    "note_model_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Gastro-oesophageal reflux disease</b>&nbsp;<div> Incompetence of {{c1::lower\noesophageal sphincter}} (obesity,\ndrugs, heredity…….)&nbsp;</div><div> Reflux of acidic gastric contents\ninto lower oesophagus</div><div> Heartburn&nbsp;</div><div><br></div><div> Complications&nbsp;</div><div>&nbsp; &nbsp; -{{c1::Stricture&nbsp;}}</div><div>&nbsp; &nbsp; -{{c1::Barretts oesophagus &amp; cancer}}</div><div><br></div><div>Diagnosis:&nbsp;</div><div> {{c1::Heartburn}} symptoms&nbsp;</div><div> Reflux oesophagitis&nbsp;</div><div><br></div><div> Gold standard test</div><div>&nbsp;-24 hour oesophageal pH</div><div>&nbsp;-{{c1::De Meester}} score<br></div>",
                        "<div><img src=\"paste-f351da7749cb8c28dcaf7246b7ed24f940bb1b97.jpg\"><br></div><img src=\"paste-4a5a63dedccb023ede42c065be9707f2979c8937.jpg\">"
                    ],
                    "guid": "j|#%5|3!Q4",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "GORD: Treatment&nbsp;<div> Prevent acid reflux&nbsp;</div><div> Weight loss, drug avoidance, elevate head of bed etc&nbsp;</div><div> Surgical {{c1::fundoplication&nbsp;}}</div><div> Increase tone of {{c1::LOS&nbsp;}}</div><div><br></div><div> Medical&nbsp;</div><div> Suppress gastric acidity (requires chronic therapy)&nbsp;</div><div> {{c1::PPI}} or {{c1::H2RA}}<br></div>",
                        ""
                    ],
                    "guid": "U-Zk|]xw?",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "13665ee2-948a-11eb-971c-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-2c6d1a0e917bf340f56af66d6997d02564bdbbac.jpg",
                "paste-6e3250f7d98c3ae816a51e6065c47512f2f52393.jpg",
                "paste-b00dffe6f2f58c1ab8a50b3b588f5904bb60bad2.jpg"
            ],
            "name": "03/19 NSAIDS",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Name the 3 dimensions of experience of pain,<div>{{c1::Sensory/discriminative&nbsp;<div>Motivational/affective&nbsp;</div><div>Cognitive/evaluative}}</div></div>",
                        ""
                    ],
                    "guid": "PS%qOZ?tl0",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the two types of chronic pain?<div>{{c1::inflammatory and neuropathic}}<br></div>",
                        ""
                    ],
                    "guid": "L{sl=kgSjt",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Ascending pain pathway:</b><div><br></div><div>The painful stimulus is picked up by&nbsp;{{c1::C nociceptor}} and&nbsp;{{c1::A delta nociceptor}} (types of receptor)</div><div><br></div><div>The nerve enters the spinal cord in the&nbsp;{{c1::dorsal horn}}</div><div>It then decussates and ascends in the&nbsp;{{c1::spinothalamic}} tract</div><div><br></div><div>It passes through the&nbsp;{{c1::brainstem}} and&nbsp;{{c1::midbrain}} before synapsing at the&nbsp;{{c1::VP}} or&nbsp;{{c1::IL}} nuclei of the thalamus.<br><br></div><div>The pathway then divides into 3 pathways, leading to the&nbsp;{{c1::somatosensory cortex}},{{c1::cingulate cortex}} and&nbsp;{{c1::limbic system}}</div><div><br></div><div>Is it a substant released from adamged cells? Y/N</div><div>Bradykinin</div><div>Haemoglobin</div><div>Cations</div><div>Anions</div><div>Free radicals</div><div>Histamine</div><div>Choline</div><div>Prostanoids</div><div>Purines</div><div>Serotonin</div><div>GABA</div><div>Tachykinins</div><div><br></div><div>{{c1::everything except Hb, anions, GABA and choline}}<br><div><b><br></b></div></div>",
                        "<img src=\"paste-6e3250f7d98c3ae816a51e6065c47512f2f52393.jpg\">"
                    ],
                    "guid": "NB6|Q$!o$|",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Descending Pain Pathway<div>Begins at the {{c1::Periaqueductal grey matter}} and synapses in the {{c1::Nucleus Raphe Magnus}}, is carried by {{c1::A beta}} afferent fibres<br></div>",
                        "<img src=\"paste-b00dffe6f2f58c1ab8a50b3b588f5904bb60bad2.jpg\">"
                    ],
                    "guid": "mwl682iT.l",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What does NSAID stand for?{{c1::Non Steroidal Anti Inflammatory Drugs}}<div><br></div><div>Weaker or stronger than opiates?&nbsp;{{c1::weaker}}</div>",
                        ""
                    ],
                    "guid": "JF^l:!k4P9",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give two other beneficial actions of NSAIDs&nbsp;{{c1::Anti-inflammatory\nAnti-thrombotic\nAnti-pyretic\nAnti-cancer (}}(4)",
                        ""
                    ],
                    "guid": "xUkwJBxp4z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "This One's hard&nbsp;<div>Do it or don't, but like its here if you want it</div><div><br></div><div>Acetic Acid NSAIDs</div><div>{{c1::Diclofenac</div><div>Etodolac</div><div>Indomethacin</div><div>Sulindac</div><div>Tolmetin}} (5)</div><div><br></div><div>Fenamate NSAIDs</div><div>{{c1::Meclofenamate</div><div>Meclofenamic Acid}} (2)</div><div><br></div><div>Naphthylalkanone</div><div>{{c1::Nabumetone}} (1)</div><div><br></div><div>Oxicam</div><div>{{c1::Piroxicam</div><div>Meloxicam}} (2)</div><div><br></div><div>Propionic Acid</div><div>{{c1::Fenoprofen</div><div>Flurbiprofen</div><div>Ibuprofen</div><div>Ketoprfen</div><div>Naproxen</div><div>Oxaproxen}} (6)</div><div><br></div><div>Salicylate</div><div>{{c1::Aspirin</div><div>Diflunisal}} (2)</div><div><br></div><div>Choline Magnesium Trisalicylate</div><div>{{c1::Salsalate}} (1)</div><div><br><div><br></div></div>",
                        ""
                    ],
                    "guid": "OCu]C5UQ2t",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "NSAIDs inhibit&nbsp;{{c1::Cycloxygenase}} (COX)<div><br></div><div>COX-1 has&nbsp;{{c1::Homeostatic}} Functions</div><div>Give 2 examples of this function,{{c1::fxn on GI tract, Renal Tract, Platelet finction and Macrophage differentiation}} (4)</div><div><br></div><div>COX-2 has {{c1::inflammatory&nbsp;}} functions</div><div>Specifically the production of&nbsp;{{c1::prostaglandins}}</div><div><br></div><div>Traditional NSAIDs block&nbsp;{{c1::both}} COX channels</div><div>COX-2 inhibitors are&nbsp;{{c1::too big}} so cannot be used on COX-1 channels</div>",
                        "<img src=\"paste-2c6d1a0e917bf340f56af66d6997d02564bdbbac.jpg\">"
                    ],
                    "guid": "g:!K/vs[<O",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give three advantages of Prostaglandin inhibition,<div>{{c1::Analgesia</div><div>Antipyresis</div><div>Anti-inflammatory</div><div>Antithrombotic</div><div>Closure of ductus arteriosus}} (5)<br></div><div><br></div><div>Give three disadvantage of prostaglandin inhibition,</div><div>{{c1::Gastric mucosal damage</div><div>Bleeding,due to platelet problems</div><div>Limitations of renal blood flow</div><div>Prolongation of labour</div><div>Asthma and anaphylactoid reactions in susceptible individuals}} (5)<br></div><div><br></div><div> Prostaglandins themselves do not cause pain but they\npotentiate the pain producing effects of\nother inflammatory mediators such as\n{{c1::5-HT}} and {{c1::Bradykinin}}<br></div>",
                        ""
                    ],
                    "guid": "hGvgeD&r5d",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Other Benefits of NSAIDs apart from Analgesia.<div><b>ANTIPYRESIS&nbsp;</b></div><div> NSAIDs {{c1::reduce}} body temperature in {{c1::fever}} but do\nnot cause {{c1::hypothermia}}&nbsp;</div><div> Fever during infection is produced through the\ngeneration of pyrogen {{c1::ILs}}, {{c1::TNF}}, {{c1::Interferons&nbsp;}}</div><div> Induction of PG in {{c1::hypothalamus}} raises body\ntemperature</div><div><br></div><div><b>Anti-inflammatory action&nbsp;</b></div><div> The most important mechanism of anti-inflammatory action of NSAIDs is {{c1::inhibition\nof PGs at the site of injury&nbsp;}}</div><div><br></div><div> The anti-inflammatory potency of\ncompounds corresponds to their potency\nto inhibit {{c1::COX}}&nbsp;<br></div><div><br></div><div><b>Actions in dysmenorrhoea&nbsp;</b></div><div> Role of PG in dysmenorrhoea has been clearly\ndemonstrated\n The levels of {{c1::PGF2alpha}}(specific pg) are raised in\ndysmenorrhoeic women&nbsp;</div><div> NSAIDs lower uterine PG levels and afford\nsignificant relief in {{c1::60-70}} % of patients&nbsp;</div><div> The ancillary symptoms of dysmenorrhoea such\nas {{c1::headache}}, {{c1::backache}} and {{c1::nausea}} are also\nrelieved<br></div><div><br></div><div>What is Dysmenorrhoea?&nbsp;{{c1::period pains}}</div><div><br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "J.t.,co-C0",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Aspirin&nbsp;<div>{{c1::Acetylsalicylic}} acid&nbsp;</div><div>Analgesic&nbsp;</div><div>Anti-{{c1::pyretic}}&nbsp;</div><div>Anti-{{c1::inflammatory}}&nbsp;</div><div>Inhibits {{c1::platelet aggregation}}&nbsp;</div><div>causes irreversible inactivation of {{c1::COX-1&nbsp;}}</div><div>Oral, {{c1::rapid}} absorption, 75 % metabolism in\nliver&nbsp;</div><div>Half life = {{c1::4}} hours</div>",
                        ""
                    ],
                    "guid": "7{RT1c~.B",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Bad Effects of NSAIDs<div><br></div><div><b>Antiplatelet action</b>&nbsp;</div><div> NSAIDs inhibit the pro-aggregatory {{c1::TXA2&nbsp;}}</div><div> Bleeding time is {{c1::prolonged&nbsp;}}</div><div> Aspirin is highly active, acetylates {{c1::platelet\nCOX}} irreversibly&nbsp;</div><div> Small doses are able to exert\n{{c1::antithrombotic}} effect for {{c1::several days}} (how long)<br></div><div><br></div><div><b>Gastric mucosal damage</b><br></div><div>Defieciency of Prostaglandins decreases the amount of&nbsp;{{c1::mucus}} and&nbsp;{{c1::HCO3-}} so gastric mucosal damage happens<br></div><div><br></div><div>Give two effects of Gastric mucosal damage of NSAIDs</div><div>{{c1::Gastric pain, mucosal erosion, ulceration and\nblood loss}}<br></div><div><br></div><div>Two ways to counteract this</div><div>1.&nbsp;{{c1::Acid secretion}} inhibition by using {{c1::PPIs or H2RA}}</div><div><br></div><div>2.&nbsp;{{c1::PG}} analogues, such as&nbsp;{{c1::misoprostol}}</div><div><br></div><div><b>Renal Effects</b></div><div>Do healthy individuals have to worry about the renal ADRs of NSAIDs? {{c1::nah man}}</div><div><br></div><div>What conditions would make someone at risk for the renal ADRs of NSAIDs?</div><div>{{c1::CHF,\nhypovolemia, hepatic cirrhosis and renal\ndisease}}<br></div><div><br></div><div>The effects are due to inhibition of&nbsp;{{c1::Prostaglandins}} synthesis</div><div><br></div><div><b>Normal ADRs at Analgesic doses:</b></div><div><b><br></b></div><div>-{{c1::nausea, vomiting and epigastric distress}}(3) (relating to GI tract)<br></div><div><br></div><div>-Blood loss in stool</div><div><br></div><div>-{{c1::rash, worse asthma, fixed drug eruptions}} (3) (relating to hypersensitivity)</div><div><b><br></b></div><div><b>Salicylism</b><br></div><div>{{c1::Anti-inflammatory}} doses cause a\nsyndrome called as salicylism&nbsp;</div><div> Dizziness, {{c1::tinnitus}}, vertigo, {{c1::reversible}}\nimpairment of hearing&nbsp;</div><div> Mental confusion and {{c1::hyper}}ventilation can\noccur<b><br></b></div><div><br></div><div><b>Acute salicylate poisoning</b></div><div>More common in kids or adults?</div><div>{{c1::kids}}<br></div><div><br></div><div>What is the adult fatal dose?&nbsp;{{c1::15-30g}}</div><div><br></div><div>Is it an effect of ASP?</div><div><br></div><div>dehydration,&nbsp;</div><div>vomiting,</div><div>diarrhoea</div><div>electrolyte disturbances,&nbsp;</div><div>frequent urination,</div><div>restlessness and\ndelirium, hallucinations,</div><div>chest pain</div><div>convulsions&nbsp;&nbsp;</div><div>coma<br></div><div>{{c1::everything except diarrhoea, chest pain and frequent urination}}<br></div><div><br></div><div>Death is due to {{c1::respiratory failure}} and\n{{c1::cardiovascular collapse}}<br></div>",
                        ""
                    ],
                    "guid": "dk:[0+l:9f",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Precautions and CI&nbsp;<div> Contraindicated in hypersensitive and {{c1::peptic\nulcers&nbsp;}}</div><div> Chronic {{c1::liver disease }}</div><div> Aspirin should be stopped {{c1::1 week}} before\nsurgery&nbsp;</div><div> During pregnancy may cause premature\nclosure of {{c1::ductus arteriosus&nbsp;}}</div><div> Administration during pregnancy also may\ncause {{c1::low birth weight}} babies&nbsp;</div><div> Should be avoided in {{c1::breast feeding}} women</div>",
                        ""
                    ],
                    "guid": "NRa+Fmna4i",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Is it a non-specific COX inhibitor or a COX-2 specific?<div>Rofecoxib<br></div><div>Ibuprofen&nbsp;</div><div>Celecoxib<br></div><div>Diclofenac&nbsp;</div><div>Etoricoxib<br></div><div>Indomethacin&nbsp;</div><div>Valdecoxib<br></div><div>Mephenamic acid&nbsp;</div><div>Piroxicam&nbsp;</div><div>Ketorolac<br></div><div><br></div><div>{{c1::Celecoxib\n Etoricoxib&nbsp;Rofecoxib&nbsp;Valdecoxib are all COX-2 }}<br></div>",
                        ""
                    ],
                    "guid": "gjDA=<HD:N",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Paracetemol<div>&nbsp;•{{c1::Weak}} inhibitor of COX-1 and COX-2&nbsp;</div><div>•Analgesic&nbsp;</div><div>•Anti-{{c1::pyretic&nbsp;}}</div><div>•{{c1::Very weak}} anti-inflammatory effects&nbsp;</div><div>•Lacks gastrointestinal side effects&nbsp;</div><div>•Metabolized in {{c1::liver}}, half life = {{c1::2-4}}\nhours&nbsp;</div><div>•Hepatotoxic in very high doses</div>",
                        ""
                    ],
                    "guid": "QHnZk[Ac*V",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Advantages of COX-2 Specific Analgesics?<div>Even at {{c1::high doses}} they have less effect\non the {{c1::gastric mucosa&nbsp;}}</div><div> {{c1::Tolerability}} is better than the older NSAIDs&nbsp;</div><div> Longer duration of action (half-life {{c1::11-13}}\nhrs&nbsp;<br></div>",
                        ""
                    ],
                    "guid": "E)-|.WNH!}",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        " Rofecoxib was withdrawn due to its\nassociation with higher cardiovascular\nincidents:<div><br></div><div>Increase {{c1::BP}}\nIncreased {{c1::risk of MI}}\n{{c1::Thromboembolism}}<br></div>",
                        ""
                    ],
                    "guid": "z6hL=[|;@T",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "13671026-948a-11eb-a4ed-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-679c4995006fba3d8c59324008eb0184a1599db4.jpg",
                "paste-70e8c6027bb30a08b10dcce76ec56a063aa16298.jpg"
            ],
            "name": "03/20 OPioids",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "Natural opium alkaloids: {{c1::Morphine,\ncodeine}} (2)<div>Semisynthetic opiates:\n{{c1::diacetylmorphine (Heroin)}} (1)</div><div>Synthetic opiates: {{c1::Pethidine, fentanyl,\ntramadol, methadone and\ndextropropoxyphene}}(5)</div>",
                        ""
                    ],
                    "guid": "pwkA?4)aUh",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "All opioid receptors are&nbsp;{{c1::g-protein coupled}} receptors<div><br></div><div>{{c1::mu}} receptors are responsible for most analgesic effects opioids as well as some additional affects<br></div><div><br></div><div>{{c1::delta}} receptors are more important in the\nperiphery<br></div><div><br></div><div>{{c1::kappa}}receptors are responsible for analgesia\nat the spinal level<br></div>",
                        ""
                    ],
                    "guid": "I=?mFISepe",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Endogenous opioid peptides</b>&nbsp;<div><br></div><div> These are peptides with opiate like pharmacological effects&nbsp;</div><div><br></div><div> There are four types of EOPs&nbsp;</div><div>{{c1::<div>1. Enkephalin&nbsp;</div><div>2. Dynorphin&nbsp;</div><div>3. Endorphin&nbsp;</div><div>4. Endomorphin</div>}}<br></div>",
                        ""
                    ],
                    "guid": "sH.f6D_|Uq",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Pain modulation: Descending inhibitory pathway</b><div><b><br></b></div><div>Opioids can act on the&nbsp;{{c1::periaquaductal grey matter}}, the {{c1::medulla}}, or spinal cord to activate the Desc. Inhib. pathway.</div>",
                        "<img src=\"paste-70e8c6027bb30a08b10dcce76ec56a063aa16298.jpg\"><div><img src=\"paste-679c4995006fba3d8c59324008eb0184a1599db4.jpg\"><br></div>"
                    ],
                    "guid": "Oha@,HY~dv",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>CNS Effects of Morphine:</b><div><b><br></b></div><div>{{c1::<div>Analgesia<b><br></b></div><div><br></div><div>Euphoria<br></div><div><br></div><div>Sedation<br></div><div><br></div><div>Respiratory Depression</div>}}(4)<br></div><div><br></div><div><br></div><div><br></div><div>Some questions,</div><div>Does morphine effect the sensory or emotional components of pain?{{c1::both}}</div><div><br></div><div>T/F&nbsp;</div><div>There is severe amnesia associated with morphine use{{c1::f}}</div><div>The respiratory center in the brain is acted on by morphine{{c1::t}}</div><div>Patients on morphine frequently feel a floating sensation{{c1::t}}</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "DpACU2-L$8",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Non-CNS actions of Opioids:</b><div><b><br></b></div><div>-Anti-tussive:&nbsp;{{c1::cough suppression}}</div><div>{{c1::codeine}} is very effective in this action<br></div><div><br></div><div>-{{c1::constriction}} of pupils</div><div><br></div><div>-{{c1::truncal}} rigidity:&nbsp;{{c1::intensification of tone in large trunk muscle}}</div><div>Can interfere with&nbsp;{{c1::ventilation}}</div><div>Usually due to high doses of lipid&nbsp;{{c1::soluble}} opioids like&nbsp;{{c1::fentanyl, sulfentanil}}(2)</div><div><br></div><div>-{{c1::Nausea and vomiting}}(learned about this in drugs and disease)</div><div>Due to&nbsp;Opioid receptors that are present in the {{c1::CTZ}}</div><div><br></div><div>-Vaso{{c1::dilation}}</div><div>Due to both depression of\n{{c1::vasomotor}} center and due to release of\n{{c1::histamine}}<br></div><div>This can cause Bradycardia, but does the heart stay bradycardiac? And why?&nbsp;{{c1::vasodilation and bradycardia lead to hypotension which causes reflex tachycardia , so heart actually becomes tachycardiac}}</div><div><br></div><div>-Constipation</div><div>Due to {{c1::Spasm}} of {{c1::pyloric}} and {{c1::ileocaecal}} sphincters and a&nbsp;{{c1::decrease}}&nbsp;in all intestinal secretions</div><div>What does this mean for opioid addicts?{{c1::its never easy to take a poo}}</div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div><div><br></div>",
                        "Release of histamine can be due to allergic affect"
                    ],
                    "guid": "Fp-%XEYT_m",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>MORPHINE</b><div>Oral absorption of Morphine is unreliable, why?{{c1::high\nfirst pass metabolism&nbsp;}}</div><div>T/F and if false give corrct answer</div><div>Morphine is widely distributed&nbsp;{{c1::t}}<br></div><div>Enters the brain within minutes {{c1::f v slowly}}</div><div>Does not enter placental barrier{{c1::f yes and quickly}}</div><div>Morphine-4-glycosulfide is the active metabolite{{c1::f Morphine-6-glucuronide}}</div><div>Most morphine is excreted in 24 hrs{{c1::t}}<b><br></b></div>",
                        ""
                    ],
                    "guid": "vfE`O:tOq!",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "ADRs of Morphine<div> {{c1::Sedation, mental clouding, lethargy&nbsp;}}(CNS 3)</div><div> {{c1::Vomiting }}(GIT1)</div><div> {{c1::Urinary retention, constipation&nbsp;}}(Excretion 2)</div><div> Idiosyncracy and allergy</div>",
                        ""
                    ],
                    "guid": "j&zfBqH$fm",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>MORPHINE POISONING:</b><div>acute lethal dose of humans is {{c1::250}} mg<b><br></b></div><div>{{c1::50}} mgs produces\nsevere toxicity<br></div><div><br></div><div><b>Treatment</b></div><div>-Respiratory support&nbsp;</div><div>-Maintenance of {{c1::BP}}</div><div>-Gastric lavage: {{c1::stomach pumping}}</div><div>-Specific antidote-&nbsp;</div><div>Name:{{c1::Naloxone}}&nbsp;</div><div>Dose: {{c1::0.4-0.8}} mg every 2-3 minutes until respiration picks up</div><div>Administration:&nbsp;{{c1::IV}}</div>",
                        ""
                    ],
                    "guid": "C[5<Y=C)Ay",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Morphine Addiction:</b><div>High degree of {{c1::tolerance}} and dependence is\nnoted with morphine<b><br></b></div><div>Addicts can tolerate morphine in {{c1::grams}}(unit of measurement)<br></div><div>Morphine produces both {{c1::physiological}} and\n{{c1::psychological}} dependence<br></div><div><br></div><div>Manifestations of withdrawal are:</div><div>lacrymation:&nbsp;{{c1::crying}}</div><div>sweating,</div><div>&nbsp;yawning,</div><div>&nbsp;anxiety,&nbsp;</div><div>fear,&nbsp;</div><div>restlessness,&nbsp;</div><div>goose flesh:&nbsp;{{c1::permanent goosebumps}}</div><div>mydriasis, :{{c1::<span style=\"color: rgb(32, 33, 36);\">unusual dilation or widening of the pupils</span>}}</div><div>tremor,&nbsp;</div><div>insomnia,&nbsp;</div><div>abdominal colic, :{{c1::<b>abdominal</b><span style=\"color: rgb(32, 33, 36);\">&nbsp;pain characterized by sudden onset and cessation</span>}}</div><div>diarrhea,</div><div>&nbsp;dehydration&nbsp;</div><div>rise in BP</div>",
                        ""
                    ],
                    "guid": "lDbKIKYd]-",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>{{c1::Fentanyl-}}&nbsp;</div><div>80-100 times more potent\nthan morphine&nbsp;</div><div> Short duration of action&nbsp;</div><div> IV, IT, transdermal&nbsp;</div><div> Used in anaesthesia with droperidol<br></div><div><br></div><div><br></div><div><br></div><div>{{c1::Heroin&nbsp;}}<br></div><div> It is {{c1::diacetylmorphine}}&nbsp;</div><div> 3 times more potent than morphine&nbsp;</div><div> More lipid soluble and so enters brain rapidly&nbsp;</div><div> More euphorient and has high addiction liability&nbsp;</div><div> Has less prominent sedative and emetic effect<br></div><div><br></div><div><br></div><div>{{c1::Pethidine (Meperidine)&nbsp;}}</div><div> Was synthesized as an atropine\nsubstitute in 1939&nbsp;</div><div> Chemically unrelated to morphine but has\nsimilar actions&nbsp;</div><div> Has a very good analgesic action&nbsp;</div><div> Poor cough suppressant action&nbsp;</div><div> Given i.m. and onset of action is very rapid&nbsp;</div><div> Used for postoperative pain relief and\nduring labour<br></div><div><br></div><div><br></div><div><br></div><div>{{c1::Codeine&nbsp;}}<br></div><div> It is {{c1::methyl morphine}}, occurs naturally in\nopium and is partly converted into\nmorphine</div><div> It is less potent than morphine&nbsp;</div><div> Selective cough suppressant&nbsp;</div><div> Has good oral bioavailability</div>",
                        ""
                    ],
                    "guid": "E>BI:VwS=_",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Pethidine: ADR&nbsp;<div> Overdose of pethidine causes many excitatory\neffects&nbsp;</div><div>Tremors,&nbsp;</div><div>mydriasis:&nbsp;{{c1::unusual dilation of pupils}}</div><div>hyperreflexia:{{c1::<span style=\"color: rgb(32, 33, 36);\">overactive or overresponsive reflexes</span>}}</div><div>delirium,&nbsp;</div><div>myoclonus:{{c1::sudden muscle spasm}}</div><div>convulsions.&nbsp;</div><div><br></div><div> This is due to accumulation of its metabolite\n{{c1::norpethidine}}</div>",
                        ""
                    ],
                    "guid": "b:{eR)yOqH",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Other opioid analgesics&nbsp;<div> Tramadol&nbsp;</div><div> Tapentadol&nbsp;</div><div> Buprenorphine</div><div>&nbsp; Meptazinol</div><div>Oxycodone&nbsp;</div><div> Hydrocodone wasn't really sure how to go about this one</div><div>{{c1::g}}<br></div>",
                        ""
                    ],
                    "guid": "H))gw%e7oQ",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Adjuvant Analgesics</b>&nbsp;<div> Defined as {{c1::drugs with other indications\nthat may be analgesic in specific\ncircumstances}}&nbsp;</div><div> Numerous drugs in diverse classes&nbsp;</div><div> Multipurpose or specific for {{c1::neuropathic}}\npain<br></div><div><br></div><div>Antidepressant Adjuvant Analgesics:{{c1::amitriptyline, desipramine,\nnortriptyline, duloxetine,\nvenlafaxine, paroxetine}}(6)</div><div><br></div><div>Alpha-2 adrenergic agonists:{{c1::tizanidine, clonidine}}<br></div><div><br></div><div>Corticosteroids:{{c1::prednisone,\ndexamethasone}}(2)<br></div><div><br></div><div>Good anti-covulsants:{{c1::gabapentin, pregabalin,}}(2)</div><div><br></div><div>Reasonable Anti-convulsants:{{c1::valproate, lamotrigine\nphenytoin, carbamazepine,\nclonazepam, topiramate,\ntiagabine, levetiracetam\noxcarbazepine,}}(10)</div><div><br></div><div>Local anesthetics: {{c1::mexiletine, tocainide}}<br></div>",
                        ""
                    ],
                    "guid": "LRIr<W4gjs",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "1367fa01-948a-11eb-a584-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [],
            "mid": 1602236504918,
            "name": "03/21 Dympna Pain",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "If a patient comes into to you with intense pain, what would your initial route of administration be?&nbsp;{{c1::continous subcutaneous infusion, because you know exactly how much will be absorbed}}<div><br></div><div>How long should oxynorm and morphine work for?{{c1::4-6 hours}}</div><div><br></div><div>Ask patient if opioids are working and for how long</div><div><br></div><div>What extra drugs would you give to patients on opioids?{{c1::anti-emetic and laxatives}}</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "AV?vi@i0E+",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give 4 drugs used for the treatment of cancer pain in ireland<div>{{c1::ketamine, methadone, NSAIDs, Steroids, Paracetamol, Tapentadol}}(6)<br></div><div><br></div><div>Cancer pain can be both&nbsp;{{c1::psychological and physiological}}</div><div><br></div><div>It is important to find the source of pain</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "Lc$:po.JUo",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "If a pateint on opioids gets full relief for 2 hours what is there perfect dose",
                        "Double that",
                        ""
                    ],
                    "guid": "pH/iA.{JSt",
                    "note_model_uuid": "136833ad-948a-11eb-b54e-ad9d49024ac7",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "How common is it to be allergic to opioids?",
                        "Incredibly rare",
                        ""
                    ],
                    "guid": "n=(!E3$;Q/",
                    "note_model_uuid": "136833ad-948a-11eb-b54e-ad9d49024ac7",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What is a rescue drug?",
                        "Drug you take as needed if normal pain relief isn't enough",
                        ""
                    ],
                    "guid": "CT>@F32i/a",
                    "note_model_uuid": "136833ad-948a-11eb-b54e-ad9d49024ac7",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What drug has no metabolites, is excretdby the GI tract, and has a neuropathic NMDA fxn?",
                        "Methadone",
                        ""
                    ],
                    "guid": "iy}/Xl*H9D",
                    "note_model_uuid": "136833ad-948a-11eb-b54e-ad9d49024ac7",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Cancer Pain:</b><div><div>Treatment is;</div>\n<div><span style=\"font-weight: bold;\">Individual</span></div>\n<div>Constantly reviewed</div>\n<div>Titrated safely</div></div><div><br></div><div><br></div>{{c1::55}}% of all cancer patients have pain<div>{{c1::66}}% of patients with advanced metastatic cancer have pain</div><div><br></div><div>Drugs used in cancer pain,{{c1::Ketamine</div>\n<div>Methadone</div>\n<div>NSAIDs</div>\n<div>Steroids</div>\n<div>Paracetamol</div>\n<div>Tapentadol}}(6)</div>",
                        ""
                    ],
                    "guid": "AnZ]$HBHYS",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "13685abc-948a-11eb-91c2-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-40535901d48a17ed27ec950248dfc3c040ea181d.jpg",
                "paste-e6b57c55602ea7f904bfdc18833c43f9a816e5d2.jpg"
            ],
            "name": "03/22 Local Anaesthetics",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><b>What class of anaesthesia?</b></div><div><br></div><div>{{c1::• General Anaesthesia}}: loss of sensory perception of the entire body<br></div><div><br></div>{{c1::Local Anaesthesia}}: loss of sensory\nperception over a small area of the body&nbsp;<div><br></div><div>{{c1::• Regional Anaesthesia:}}: loss of sensation over\na specific region of the body (e.g. lower trunk)&nbsp;</div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "qidy}FE&XV",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Local Anesthetics (History)</b>&nbsp;<div><br></div><div>• Local anaesthetics - {{c1::reversibly}}&nbsp;block conduction along\nnerve fibers&nbsp;</div><div><br></div><div>•Can produce anaesthesia w/o loss of {{c1::consciousness}}.&nbsp;</div><div><br></div><div>•In the beginning there was {{c1::cocaine •}}</div><div><br></div><div>{{c1::Procaine}} - the first synthetic ester LA (1905)&nbsp;</div><div><br></div><div>{{c1::•Lidocaine}} - the first “amide” LA (1943)</div>",
                        ""
                    ],
                    "guid": "D~hg1A5}OD",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div>Amide or Ester?</div>– Cocaine<div>– Bupivacaine&nbsp;</div><div>– Mepivacaine&nbsp;</div><div>– Ropivacaine&nbsp;<div>– Procaine&nbsp;</div><div>– Benzocaine&nbsp;</div><div>– Tetracaine&nbsp;</div><div>– Lidocaine&nbsp;</div><div>{{c1::all with two i's are amides}}<br></div></div><div><br></div><div>All local anasthetics have a&nbsp;{{c1::lipophillic}}and&nbsp;{{c1::hydrophillic}} portions, joined by either a ester or amide linkage</div><div><br></div><div>What LA isn't ionic at body pH?&nbsp;{{c1::benzocaine}}</div>",
                        "<img src=\"paste-e6b57c55602ea7f904bfdc18833c43f9a816e5d2.jpg\">"
                    ],
                    "guid": "C:JH3MXSPu",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Answer long action, short action, surface action and whether they're esters or amides<div><br></div><div>Lidocaine</div><div>Xylocaine&nbsp;{{c1::m,a}}</div><div><br></div><div>procaine</div><div>novocaine{{c1::sh,e}}</div><div><br></div><div>benzocaine</div><div>cocaine{{c1::su,e}}</div><div><br></div><div>tetracaine{{c1::l ,e}}</div><div><br></div><div>bupivacaine</div><div>ropivacaine{{c1::l,a}}</div>",
                        ""
                    ],
                    "guid": "j=n;txrN,G",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Esters - hydrolyzed by plasma (&amp; liver)\n{{c1::pseudocholinesterase}}&nbsp;<div>– {{c1::P-aminobenzoic acid}} (PABA) can cause\nallergic rxns (relatively rare)&nbsp;</div><div><br></div><div>• Amides - hepatic metabolism&nbsp;</div><div>– Liver damage. &amp; {{c1::decreased}} hepatic blood flow, {{c1::increased}} toxicity</div>",
                        ""
                    ],
                    "guid": "tD_;@ItRw,",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "T/F<div>The LA hydrophobic pathway involves access of nerve sodium channels from nerve cell cytoplasm&nbsp;{{c1::false, thats hydrophillic, hydrophobic is within cell membrane}}</div><div>Extracellular acidosis decreases LA effect{{c1::true}}</div><div>Hydrophillicity increases potency and duration of action{{c1::false, hydrophobicity}}</div><div>Bupivacaine&gt;lidocaine&gt;procaine in terms of potency{{c1::true}}</div><div><br></div><div>Explain Use/Frequency Block{{c1::LA is more effective when nerve is firing rapidly, so more pain makes LA work better}}</div>",
                        "<img src=\"paste-40535901d48a17ed27ec950248dfc3c040ea181d.jpg\">"
                    ],
                    "guid": "x+vk;g]C.K",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "LAs block conduction in which order:<div><br></div><div>nonmyelinated axons{{c1::2}}<br></div><div>Small myelinated axons{{c1::1}}<br></div><div>large myelinated\naxons{{c1::3}}<br></div><div><br></div><div><br></div><div>Order of sensory function block<br></div><div><br></div><div>• {{c1::1.}} pain&nbsp;</div><div>• {{c1::2.}} cold&nbsp;</div><div>• {{c1::3.}} warmth</div><div>• {{c1::4.}} touch</div><div>• {{c1::5.}} deep pressure&nbsp;</div><div>• {{c1::6.}} motor<br></div>",
                        ""
                    ],
                    "guid": "tIX1_)q,%q",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "• Numbness of {{c1::tongue}} &amp; {{c1::mouth}}&nbsp;<div>• <font color=\"#aa0000\">Behavioral &amp; sensory disturbances\n– ringing in ears, metallic taste, tingling\nsensations&nbsp;</font></div><div>• Seizures ({{c1::tonic clonic}}(type))&nbsp;</div><div>• Depression / Loss of {{c1::Consciousness&nbsp;}}</div><div>• {{c1::Respiratory}} Failure&nbsp;</div><div>• Arrhythmias*,hypotension, CV Collapse&nbsp;</div>",
                        ""
                    ],
                    "guid": "ze?8|Tf;wG",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "1368f581-948a-11eb-96ae-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-08e3eedd068308b54f2fcd399067951507c37afd.jpg",
                "paste-1d622ba9751021e17c01f31249d21a1b9575db38.jpg",
                "paste-3ad9601b849df4ce928d087ba84b4d80814e25f0.jpg"
            ],
            "mid": 1602236504918,
            "name": "03/23 General Anaesthetics",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "General Anaesthesia:{{c1::the loss of response to\n&amp; perception of all external stimuli}}<div><br></div><div>Components of General Anaesthesia:\n{{c1::</div><div>• Unconsciousness</div><div>&nbsp;• Analgesia (most GAs are poor analgesics)&nbsp;</div><div>• Attenuation of autonomic responses to painful stimuli&nbsp;</div><div>• Amnesia</div><div>&nbsp;• Immobility (neuromuscular relaxation)}}(5)<br></div><div><br></div><div>Phases of General Anaesthesia&nbsp;</div><div>Induction: {{c1::putting the patient to sleep}}&nbsp;</div><div>Maintenance: {{c1::keeping the patient asleep&nbsp;}}</div><div>Emergence: {{c1::waking the patient up}}<br></div><div><br></div><div>T/F<br>Only drugs with a very specific structure can be a general anaesthetic?{{c1::General anaesthesia\ncan be caused by a\nremarkable number\nof structurally\ndiverse molecules}}</div><div><br></div><div>Briefly what does the Meyer-Overton rule mean?{{c1::The correlation of anaesthetic potency with\nlipid solubility provides a means of predicting\nanaesthetic potency. This correlation has\ntraditionally been interpreted as meaning that\nprimary anaesthetic action sites are lipid portions of\nnerve membranes.}}</div><div><br></div><div><br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "C{UhjWN@3p",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "The old theory has something to do with lipid bylayers and miracles<div><br></div><div>BUT NOW.... THE MODERN UNDERSTANDING:</div><div><br></div><div>1. Enhanced GABA effect on {{c1::GABAA}} Receptors&nbsp;</div><div>Drugs that do this:</div><div>{{c1::– Inhaled anaesthetics - Etomidate\n– Barbiturates - Propofol\n– Benzodiazepines&nbsp;}}(5)</div><div><br></div><div>2. Block {{c1::nicotinic}} receptor subtypes (analgesia)\n–&nbsp;</div><div>Drugs that do this:Moderate to high concs of {{c1::inhaled anaesthetics&nbsp;}}</div><div><br></div><div>3. Activate {{c1::K+}} channels (hyperpolarize Vm)\n–&nbsp;</div><div>Drugs that do this:</div><div>{{c1:: Nitrous oxide, ketamine, xenon}}(3)<br></div><div><br></div><div>4. Inhibit {{c1::NMDA}} (glutamate) receptors\n–&nbsp;</div><div>{{c1::Nitrous oxide, ketamine, sevoflurane, xenon, high dose\nbarbiturates&nbsp;}}(5)</div><div><br></div><div>5. Inhibit {{c1::synaptic}} proteins&nbsp;</div><div>({{c1::decrease}} NT release)(amnesia)&nbsp;</div><div><br></div><div>6. Enhance {{c1::glycine}} effect on {{c1::glycine}} Receptor’s (immobility)<br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "f!-n_b=WSf",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Barbiturates &amp; Benzodiazepines MOA:&nbsp;&nbsp;<div>1) Both bind to {{c1::GABAA}} receptors, at different sites&nbsp;</div><div>• Both cause increase {{c1::Cl}}-influx in presence of GABA</div><div>• Benzodiazepine binding can be blocked by {{c1::flumazenil&nbsp;}}</div><div><br></div><div>2) Barbituates at high doses - are also {{c1::GABA}} mimetic,\nblock {{c1::Na}} channels &amp; {{c1::NMDA}}/glutamate Rs</div><div><br></div><div>T/F</div><div>Barbituates can never send a person beyond the anasthetic state{{c1::f, thats benzos, barbituates can go all the way to coma}}</div>",
                        ""
                    ],
                    "guid": "pbH!gPh7qV",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Parenteral Anaesthetics (Intravenous)&nbsp;<div>– Barbiturates ({{c1::Thiopental* &amp; Methohexital}}(2))&nbsp;</div><div>– Benzodiazepines ({{c1::Midazolam}}(1))&nbsp;</div><div>– Opioids ({{c1::Morphine &amp; Fentanyl}}(2))&nbsp;</div><div>– {{c1::Propofol*&nbsp;}}</div><div>– {{c1::Etomidate}}</div><div><br></div><div>Give two anaesthetics used mainly for induction{{c1::thiopental and propofol}}</div><div><br></div><div><b>Inhaled Anaesthetics&nbsp;</b></div><div>• Easily vaporized liquid {{c1::halogenated}}\nhydrocarbons&nbsp;</div><div>• Administered as gases<br></div><div><br></div><div>Partial pressure or “tension” in inspired air is a\nmeasure of their concentration&nbsp;</div><div>• The speed of induction of anaesthesia depends on:&nbsp;</div><div>&nbsp;{{c1:: -Inspired gas partial pressure (GA concentration)&nbsp;</div><div>– Ventilation rate&nbsp;</div><div>– GA solubility (less soluble GAs equilibrate more\nquickly with blood &amp; into tissues such as the brain) }}(3)<br></div><div><br></div><div>Are inhaled or IV General anaesthetics more common?</div><div>{{c1::IV}}<br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "h3{Lgpb`.u",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Classic Stages of Anaesthesia:</b><div><div><br></div><div>&nbsp;• Stage 1: {{c1::Analgesia}}\n– decreased awareness of pain, amnesia&nbsp;</div><div><br></div><div>&nbsp;• Stage 2: {{c1::Disinhibition}}\n– delirium &amp; excitation, enhanced reflexes,\nretching, incontinence, irregular respiration</div><div><br></div><div>&nbsp;• Stage 3: {{c1::Surgical Anaesthesia}}\n– unconscious, no pain reflexes, regular\nrespiration, BP is maintained</div><div><br></div><div>&nbsp;• Stage 4: {{c1::Medullary Depression}}\n– respiratory &amp; CV depression requiring\nventilation &amp; pharmacological support</div></div><div><br></div><div>This is the drug&nbsp;{{c1::ether}}</div>",
                        ""
                    ],
                    "guid": "w$~hLx`z4?",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What type up of anasthetic exerts its volume quicker?<div>Highly soluble or Low soluble&nbsp;{{c1::low}}</div><div><br></div><div>Blood:Gas coeffecient is&nbsp;{{c1::proportional}} to rate of which anaesthesia exerts its volume</div><div><br></div><div>Ventilation rate is {{c1::proportional}} to rate of which anaesthesia exerts its volume</div>",
                        "<img src=\"paste-08e3eedd068308b54f2fcd399067951507c37afd.jpg\"><div><img src=\"paste-3ad9601b849df4ce928d087ba84b4d80814e25f0.jpg\"><br></div><div><img src=\"paste-1d622ba9751021e17c01f31249d21a1b9575db38.jpg\"><br></div>"
                    ],
                    "guid": "m=ot/>Q9({",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Minimum Alveolar Concentration: {{c1::The alveolar anaesthetic concentration\nrequired to eliminate the motor response to a\npainful stimulus in 50% of patients}}<div><br></div><div>A measure of GA {{c1::potency}}<br></div><div>It’s <font color=\"#aa0000\">“a population average”</font><br></div><div><br></div><div>When several GAs are mixed, their MAC\nvalues are {{c1::additive}}<br></div><div>What does this mean clinically?{{c1::nitrous oxide is\ncommonly mixed w/ other anesthetics}}</div><div><br></div><div>MAC%</div><div>Nitrous Oxide {{c1::&gt;100&nbsp;}}</div><div>Halothane {{c1::0.75}}&nbsp;</div><div>Methoxyflurane {{c1::0.16}}<br></div><div><br></div><div>MAC values are very useful:&nbsp;</div><div>•Allow easy {{c1::comparison}} of anaesthetics&nbsp;</div><div>•Easily {{c1::measured&nbsp;}}</div><div>•Important clinical endpoints&nbsp;</div><div>•Consistent and reproducible<br></div>",
                        ""
                    ],
                    "guid": "I+$A=aIj}V",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Elimination&nbsp;</b><div><br></div><div>&nbsp;• Anaesthesia is most commonly terminated by {{c1::redistribution\nof drug from brain to the blood &amp; out through the lungs}}.</div><div><br></div><div>&nbsp;• The rate of recovery from anaesthesia for GAs with low\nblood:gas PCs is {{c1::faster}} than for highly soluble Gas.</div><div><br></div><div>&nbsp;- Time is $$ in the O.R. &amp; recovery room&nbsp;</div><div><br></div><div>Blood:Gas PCoeff&nbsp;</div><div>Halothane {{c1::2.30&nbsp;}}</div><div>Desflurane {{c1::0.42&nbsp;}}</div><div>Sevoflurane {{c1::0.69}}</div><div><br></div><div>&nbsp;• {{c1::Halothane}} &amp; {{c1::methoxyflurane}} undergo hepatic metabolism\n&amp; can cause {{c1::liver}} toxicity</div><div><br></div><div>•Margin of safety very small&nbsp;</div><div>•TI: {{c1::2-4}}</div><div>&nbsp;•dose that produces circulatory failure may be {{c1::2-4X}} that for anesthesia&nbsp;</div><div>•Most dangerous drugs in use<br></div>",
                        ""
                    ],
                    "guid": "L*`+0Vt,zt",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>NMJ Blockers</b><div>•Drug names: {{c1::Succinylcholine}}, {{c1::Pancuronium}}&nbsp;</div><div>• Used to:\n– relax skeletal muscle\n– facilitate intubation**\n– ensure immobility&nbsp;</div><div>• Effects of Pancuronium can be reversed\nby {{c1::neostigmine*}} &amp; {{c1::glycopyrrolate*}}\nduring post-op period</div>",
                        ""
                    ],
                    "guid": "gb7?P:r63%",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "13696a73-948a-11eb-93ff-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-13ce0d8ee78adde84df5cabb9cfb31a786e3a24d.jpg",
                "paste-1c60af787d2cc4ed5d4c683acdaf1d1c6810e8be.jpg",
                "paste-4cf616574eb517bd77dca52115982aabe88067ec.jpg",
                "paste-6226ed517b45b8fa32c4c64dc3ed4fb35f6b8d56.jpg",
                "paste-8b6d95ecdf67ae73a02cc2839b3562024aea5f69.jpg",
                "paste-9a233c952032603f4deaed9320c063eaa8224660.jpg",
                "paste-9c70b49f9bfd143789a2c862bbc2f4031c108701.jpg",
                "paste-a852427b74fe84afe8c863f5a48baf7259d78220.jpg",
                "paste-ae0cbbe8139587244ef8f7e8088f91c0029e40a6.jpg",
                "paste-bcab73c4ac083b2e719a76abd4ef0462b98e5ac9.jpg",
                "paste-c48f0b3405c8ca1878ea2b2328090a5099e2c0c6.jpg",
                "paste-cb4c48e204b2f3e767d981a521ba30f62722cd47.jpg",
                "paste-d8bf984b8aa087d3fc7388f7faa643ac41256bbf.jpg",
                "paste-d9090d41dbdb18c7150469ffc8d41ecaec4d9765.jpg",
                "paste-fac2fbe1870d7749967b0f81892f2380b39658e9.jpg"
            ],
            "name": "03/29 Dennedy Diabetes 1",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "DIABETES MELLITUS:{{c1::“Transient or permanent disease state of chronic hyperglycaemia characterised\nby insulin deficiency or insulin resistance or a combination of both.”}}<div><br></div><div>What are the type of drugs/treatment one would use for insulin deficiency?</div><div>{{c1::insulin, insulin secretagogues}}(2)<br></div><div><br></div><div>What type of drugs/treatment one would use for insulin resistance?</div><div>{{c1::insulin sensitizers}}<br></div><div>&nbsp;</div><div>type 1 diabetes is an {{c1::autoimmune}} mediated condition<br></div><div><br></div><div>What genetic defects will cause diabetes?&nbsp;</div><div>{{c1::GENETIC DEFECTS IN BETA CELL FUNCTION&nbsp;</div><div>GENETIC DEFECTS IN INSULIN ACTION}}(2)</div><div><br></div><div>Endocrinopathies that cause diabetes?{{c1::cushings and acromegally}}(2) What type?&nbsp;{{c1::insulin resistant}}</div><div><br></div><div>Exocrine pancreas diseases that cause diabetes?{{c1::chronic pancreatitis, alcoholism and cystic fibrosis}}(3) What type?&nbsp;{{c1::insulin deficient}}</div><div><br></div><div>The chronic administration of what type of drug may cause diabetes?&nbsp;{{c1::corticosteroids}}</div><div><br></div><div>When is a woman likely to get diabetes?{{c1::when pregnant}}</div>",
                        ""
                    ],
                    "guid": "pqT6YI-K4N",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Type 1 diabetes is always insulin&nbsp;{{c1::deficient}}<div>Type 2 diabetes is always insulin&nbsp;{{c1::resistant}}</div><div><br></div><div>T/F&nbsp;</div><div>Type 2 diabetes can be both insulin deficient and resistant&nbsp;{{c1::t}}</div><div>Why?{{c1::as disease progresses insulin making stuff goes to shit}}</div><div><br></div><div>A patient presents with slow onset chronic insulin deficiency, type 1 or type 2?</div><div>{{c1::Type 1}}<br></div><div>What is the name of this condition?</div><div>{{c1::latent autoimmune diabetes of Adulthood (LADA)}}<br></div><div><br></div><div>What mutations are monogenic diabetes associated with?{{c1::germ line mutations}}</div><div><br></div><div>Is gestational diabetes type 1 or type 2?{{c1::usually type 2 but can be type 1}}</div><div>Is maturity onset diabetes of the young type 1 or 2&nbsp;{{c1::2}}</div><div><br></div><div>How would one get secondary diabetes mellitus?{{c1::from another disease such as an endocrinopathy or a pancreas problem}}.</div>",
                        "<img src=\"paste-8b6d95ecdf67ae73a02cc2839b3562024aea5f69.jpg\">"
                    ],
                    "guid": "Q?;Z8me<j{",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "What are the three parameters you look at when dagnosing diabetes?<div>{{c1::FASTING GLUCOSE&nbsp;</div><div>POST-PRANDIAL GLUCOSE&nbsp;</div><div>HBA1C(glycosylated haemoglobin)}}(3)</div><div><br></div><div>What would you do to determine the aetiology of the diabetes?</div><div>{{c1::PROPER CLINICAL &amp; DRUG HISTORY&nbsp;</div><div>CLINICAL EXAMINATION&nbsp;</div><div>CALCULATION OF INSULIN RESISTANCE&nbsp;</div><div>AUTO-ANTIBODY TESTING</div><div>&nbsp;SPECIFIC GENETIC TESTING&nbsp;</div><div>SPECIFIC EVALUATION FOR ENDOCRINOPATHY}}(6)<br></div><div><br></div><div>Specific genetic testing should have been one of those, but you only do it if you suspect a specific type of diabetes, which one?{{c1::MODY}}</div><div><br></div>",
                        "HBA1c= how much Hb has a glucose moiety attached to it<div>post prandial= after eating</div><div><img src=\"paste-9c70b49f9bfd143789a2c862bbc2f4031c108701.jpg\"><br></div><div><br></div><div><br></div>"
                    ],
                    "guid": "y0:_NgIN(`",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Insulin:<div>{{c1::Peptide}} hormone</div><div>Synthesised, packaged and released from\n{{c1::pancreatic islets - β-cells}}.</div><div>Glucose Dependent Secretion<br></div><div><br></div><div>As it is a peptide hormone it cannot be&nbsp;{{c1::orally}} administered</div><div><br></div><div>Endogenous insulin is released into&nbsp;{{c1::portal}} circulation</div><div>Synthetic insulin is released into&nbsp;{{c1::systemic}} circulation</div><div><br></div><div>Proinsulin consists of an a,b and c chain</div><div>In insulin {{c1::a}} and {{c1::b}} chains are connected through&nbsp;{{c1::s=s}}bonds and the&nbsp;{{c1::c}} chain is cleaved</div><div><br></div><div>Therefore, what is a good indicator that patient taking synthetic insulin is starting to make their own insulin again?{{c1::the c chain}}</div>",
                        "<img src=\"paste-c48f0b3405c8ca1878ea2b2328090a5099e2c0c6.jpg\">"
                    ],
                    "guid": "D#qYM!r]Ia",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Endogenous Insulin Secretion:</b><div>Secreted into {{c1::portal circulation}}<b><br></b></div><div>{{c1::60}}% undergoes hepatic 1st pass metabolism<br></div><div><br></div><div>Step 1: Glucose enter&nbsp;{{c1::pancreatic}} cell through&nbsp;{{c1::GLUT 2}} channels.</div><div><br></div><div>Step 2: Glucose is broken down to&nbsp;{{c1::Glucose-6-Phosphate}} by {{c1::glucokinase}}(enzyme)</div><div><br></div><div>Step 3: ATP is formed through metabolism</div><div><br></div><div>Step 4: ATP opens&nbsp;{{c1::potassium}} channels</div><div><br></div><div>Step 5: The depolarization of the cell caused by the opening of&nbsp;{{c1::k}} channels, opens&nbsp;{{c1::Calcium}} channels.</div><div><br></div><div>Step 6: The influx of&nbsp;{{c1::calcium}} causes insulin to be released</div><div><br></div><div>In brief:</div><div>{{c1::Glucose}} stimulates the release of insulin.&nbsp;</div><div>{{c1::Glucagon}} inhibits its release.&nbsp;</div><div>Counter-regulatory hormones modulate the function of insulin<br></div><div><br></div><div><br></div>",
                        "<img src=\"paste-13ce0d8ee78adde84df5cabb9cfb31a786e3a24d.jpg\"><div><img src=\"paste-d9090d41dbdb18c7150469ffc8d41ecaec4d9765.jpg\"><br></div>"
                    ],
                    "guid": "vmAeo7U.t1",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "The insulin receptor:<div><br></div><div>TWO SUBUNITS&nbsp;</div><div>Alpha - {{c1::Binds Insulin&nbsp;}}</div><div>Beta - {{c1::Tyrosine Kinase}}<br></div><div><br></div><div>Bound together by&nbsp;{{c1::disulfate}} bonds</div><div><br></div><div>Phosphorylation cascade is triggered and 4 things happen</div><div><br></div><div>{{c1::Liberation GLUT 4</div><div>Glycogen Synthesis (Glycogen Synthase)&nbsp;</div><div>TG Synthesis (Acetyl CoA Carboxylase, LPL)&nbsp;</div><div>Inhibits lipolysis}}<br></div>",
                        "<img src=\"paste-cb4c48e204b2f3e767d981a521ba30f62722cd47.jpg\">"
                    ],
                    "guid": "f[CB|I;W:>",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>INSULIN RELEASE PATTERNS</b><div><br></div><div>CONSTANT BASAL RELEASE OF INSULIN:<b><br></b></div><div>Inhibits hepatic {{c1::gluconeogenesis&nbsp;}}</div><div>Prevents excessive {{c1::lipid}} breakdown<br></div><div>{{c1::prevents}}&nbsp;glycogenolysis<br></div><div>Prevents {{c1::Ketosis}}<br></div><div><br></div><div>INCREASED RATES OF INSULIN RELEASE IN RESPONSE TO\nCHO / GLUCOSE i.e. after eating</div><div><br></div><div>Promotes {{c1::glucose utilization&nbsp;}}</div><div>Promotes {{c1::glycogenesis}}<br></div>",
                        "<img src=\"paste-bcab73c4ac083b2e719a76abd4ef0462b98e5ac9.jpg\">"
                    ],
                    "guid": "eX,c<+g>{t",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "THERAPY OF DIABETES MELLITUS&nbsp;<div><br></div><div>AIMS OF THERAPY&nbsp;</div><div>1. Restore physiological patterns of insulin release or increase insulin release ({{c1::if insulin deficient}})</div><div>2. Restore sensitivity of target organs to insulin action&nbsp;</div><div>3. Replace insulin where it is completely deficient.. What type of diabetes would this occur in?{{c1::all type 1, pancreatic type 2}}</div><div>4. Reduce glucose by non-insulin dependent mechanisms, what two ways can you do this?{{c1::prevent uptake from GIT, piss it out more}}</div><div><br></div><div>HOW IS THIS ACHIEVED?&nbsp;</div><div>1. Insulin {{c1::secretagogues}} or incretin agents… (type 1)</div><div>2. Insulin {{c1::sensitising}} agents… (type 2)</div><div>3. Insulin in the form of long acting and short-acting insulin or CSII.&nbsp;</div><div>4. Inhibit absorption from GI tract or promote excretion from kidney..</div>",
                        ""
                    ],
                    "guid": "qAps@Uo6$#",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "TYPE 1 DIABETES MELLITUS MEANS {{c1::COMPLETE}} INSULIN {{c1::DEFICIENCY}}<div><br></div><div>What sort of therapy should type 1 diabetes be treated with?</div><div>{{c1::insulin therapy}}<br></div><div>How long should the patient be treated for?</div><div>{{c1::for life}}<br></div><div><br></div><div>DRIVEN BY AN AUTO-IMMUNE PROCESS&nbsp;</div><div>-{{c1::Anti-Glutamic Acid Decarboxylase (GAD)}} antibodies&nbsp;</div><div>-Associated with abnormalities of {{c1::HLA-DR3/DR4}}<br></div><div><br></div><div>When do patients generally get diagnosed?</div><div>{{c1::teens or twenties}}</div><div><br></div><div>Biggest complication of Type 1 Diabetes is:</div><div>Diabetic {{c1::ketoacidosis (DKA)}}&nbsp;</div><div><br></div><div>symptoms of which include</div><div>-Weight Loss, why?&nbsp;{{c1::body can't store and use glucose so breaks down fat}}</div><div>-Osmotic Symptoms, give two?&nbsp;{{c1::polydipsia, polyuria }}</div><div>-Dehydrated, why?{{c1::you piss glucose, has a severe diuretic effect}}</div><div>-Acidotic, why?&nbsp;{{c1::ketones are acidic}}</div><div>-Ketosis, why?{{c1::body can't use glucose, so has to use ketones}}<br></div>",
                        ""
                    ],
                    "guid": "QEGOWu82JH",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Insulin Therapy:</b><div><br></div><div>{{c1::Recombinant}} human insulin preparations are used</div><div><br></div><div>WHEN IS IT GIVEN?&nbsp;</div><div>To every patient with {{c1::type 1}} diabetes..&nbsp;</div><div>To most patients with {{c1::secondary}} diabetes..&nbsp;</div><div>To many patients with type {{c1::2}} diabetes..<br></div><div><br></div><div>T/F</div><div>Is given orally&nbsp;{{c1::f, given parenterally}}</div><div>No post prandial doses needed as basal dose is long acting{{c1::f, that's not how insulin works, see endogenous insulin slide for more}}</div><div>Can be administered by patient themselves&nbsp;{{c1::t}}</div>",
                        "<img src=\"paste-1c60af787d2cc4ed5d4c683acdaf1d1c6810e8be.jpg\">"
                    ],
                    "guid": "v1qY_P#d(g",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Does endogenous insulin or injected insulin last longer in the body?<div>{{c1::injected}}<br></div><div>Why?</div><div>{{c1::goes into systemic circulation rather than portal, so no fpm}}<br></div><div><br></div><div>Describe basal-bolus insulin dosage</div><div>{{c1::one or two basal long acting insulin injections, as well as further bolus short acting insulin injections at mealtimes to compensate for raised CHO&nbsp;</div><div><img src=\"paste-a852427b74fe84afe8c863f5a48baf7259d78220.jpg\">}}<br></div><div>What does the basal dosage inhibit?</div><div>{{c1::glycogenolysis and ketosis}}<br></div><div><br></div><div>Describe mixed insulin dosage</div><div>{{c1::two doses of mixed long and short acting insulin</div><div><img src=\"paste-ae0cbbe8139587244ef8f7e8088f91c0029e40a6.jpg\">}}<br></div><div>What patients might need mixed insulin dosage?</div><div>{{c1::those that are elderly, blind forgetful etc.}}<br></div><div><br></div><div>What is the biggest risk with mixed insulin dosage?<br>{{c1::hypoglycemia}}<br></div>",
                        "disclaimer, its very confusing"
                    ],
                    "guid": "v=K=&[r,&W",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "How long did the first human recombinant quick acting insulin to work?<div>{{c1::40 minutes and lasted for 6 hours}}<br></div><div><br></div><div>Give three ultra-quick acting insulin and the amino acids that they replace</div><div>{{c1::Insulin Aspart (Pro28 → Asp)</div><div>&nbsp;Insulin Lispro (Pro 28Lys29 Reversed)</div><div>&nbsp;Insulin Glulisine (Asn3 → Lys)}}<br></div><div><br></div><div>Why are certain amino acids replaced?</div><div>{{c1::to form dimers and prevent hexamer formation in the body, easier to be absorbed}}<br></div><div><br></div><div>Fast absorption - {{c1::20}} minutes&nbsp;</div><div>Peak Concentration - {{c1::40}} minutes&nbsp;</div><div>Duration of action - {{c1::2-3}} Hours<br></div><div><br></div><div>What is special about fiasp, the new insulin aspart?</div><div>{{c1::absorbtion in 5 minutes, can even be taken post prandially}}<br></div>",
                        ""
                    ],
                    "guid": "u;q]`L1t)P",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "The three peakless, long acting insulins are as follows, how are they be long acting rather than short acting?<div><br></div><div>Insulin Glargine - {{c1::Altered pH - Prolonged absorption&nbsp;}}<br></div><div>Insulin Detemir - {{c1::Albumin Bound - Longer serum t1/2&nbsp;}}</div><div>Insulin Degludec - {{c1::Zn Bound Hexamers then Phenol Bound - ↓ Solubility}}<br></div><div><br></div><div>What is th emost commonly used one?&nbsp;{{c1::degludec}}</div><div><br></div><div>What is their duration of action?&nbsp;{{c1::18 - 36 HOUR DURATION}}</div><div><br></div><div>You would only use intermediate acting insulins in difficult rare cases, give an example of an intermediate acting insulin.</div><div>{{c1::NPH Insulin - Zn Bound ↓ Solubility}}<br></div><div>What is its duration of action?{{c1::10 - 12 HOUR}}</div><div>What is the big risk acssociated with it?&nbsp;{{c1::RISK OF NOCTURNAL HYPOGLYCAEMIA}}</div>",
                        "<img src=\"paste-d8bf984b8aa087d3fc7388f7faa643ac41256bbf.jpg\">"
                    ],
                    "guid": "IsGIj1p(^$",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>PROBLEMS WITH INSULIN THERAPY</b><div>{{c1::PARENTERAL}} ADMINISTRATION ROUTE ONLY&nbsp;</div><div><br></div><div>LIPODYSTROPHY :{{c1::<span style=\"color: rgb(32, 33, 36);\">lump or small dent in the skin that forms when a person performs injections repeatedly in the same spot</span>}}</div><div>LIPOHYPERTROPHY :{{c1::<span style=\"color: rgb(32, 33, 36);\">&nbsp;</span><span style=\"color: rgb(32, 33, 36);\">lump under the skin caused by accumulation of extra fat at the site of many subcutaneous injections of insulin</span>}}</div><div><br></div><div>INSULIN ANTIBODIES - INFREQUENT WITH RECOMBINANT INSULINS..&nbsp;</div><div><br></div><div>THERAPY MUST BE CONSTANTLY MONITORED&nbsp;</div><div>Measurement of {{c1::capillary glucose}} - Painful&nbsp;</div><div>Monitoring of {{c1::HbA1c&nbsp;}}</div><div><br></div><div>DOSING IS MEAL DEPENDENT AND DEPENDENT ON PHYSIOLOGIC / PATHOLOGIC STATE\nHYPOGLYCAEMIA&nbsp;</div><div><br></div><div>⇧ APPETITE AND WEIGHT GAIN..<b><br></b></div>",
                        ""
                    ],
                    "guid": "jNCu:e#>*&",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Type 2 starts out as insulin&nbsp;{{c1::resistance}}<div>And progresses to insulin&nbsp;{{c1::deficiency}}</div><div><br></div><div>Type 2 diabetes is&nbsp;{{c1::progressive}} and patients&nbsp;{{c1::gain}} weight</div><div><br></div><div>What microvascular complications will diabetes cause?</div><div>{{c1::neuropathy, nephropathy and retinopathy}}<br></div><div><br></div><div>What macrovascular complications will diabetes cause?</div><div>{{c1::cvd }}<br></div><div><br></div><div>What level of HbA1c is needed for risk of microvascular complications to be reduced?&nbsp;{{c1::6}} %</div><div><br></div><div>T/F<br></div><div>Treatment of type 1 geberally stays the same{{c1::t}}</div><div>Treatment of type 2 generally stays the same{{c1::f}}</div><div><br></div><div>What were the three initial therapies for type 2 diabetes?</div><div>{{c1::Metformin&nbsp;</div><div>Sulphonylurea&nbsp;</div><div>Insulin}}<br></div><div><br></div><div>Why isn't insulin the best treatment for type 2 diabetes?</div><div>{{c1::it cuases weight gain and type 2 diabetres is driven by weight gain}}<br></div>",
                        ""
                    ],
                    "guid": "HM`d2@qC|@",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><b>Insulin Sensitisers:</b></div><div><br></div>What is the best insulin sensitisers?<div>{{c1::weight loss and excercise}}<br></div><div><br></div><div>Pharmaceuticals</div><div>&nbsp;</div><div>{{c1::BIGUANIDES / METFORMIN}}<br></div><div>Targets the mitochondrial respiratory chain and Increases Insulin Receptor TK activity<br></div><div><br></div><div>Advantages:&nbsp;<br></div><div>orally available</div><div>&nbsp;well tolerated</div><div>weight stable</div><div><br></div><div>Disadvantages:<br></div><div>Renal Excretion&nbsp;</div><div>Lactic Acidosis&nbsp;</div><div>GI Symptoms<br></div><div><br></div><div>{{c1::THIAZOLIDINEDIONES}}<br></div><div>Activate PPARγ<br></div><div><br></div><div>Advantages:</div><div>orally available</div><div>reduce HbA1c-0.5-0.8%</div><div><br></div><div>Disadvantages:</div><div>CVS effects</div><div>Fluid retention</div><div>Weight gain (1-2 kg)</div><div><br></div><div><br></div><div><br></div><div>SOME QUESTIONS</div><div>1. Drug 1,&nbsp;Acts through {{c1::OCT-1 / AMPK}} ➞ {{c1::de}}crease Hepatic Gluconeogenesis</div><div><br></div><div>2. Explain how lactic acidosis by using drug 1 could occur.{{c1::if its renally excreted and patient has renal failure then its kept in the body so lactic acidosis occurs}}</div><div><br></div><div>3.&nbsp;PPARγ moa</div><div>-{{c1::Nuclear Orphan}} Receptor&nbsp;</div><div>-Modulates insulin sensitivity through GLUT-{{c1::1}} &amp; GLUT-{{c1::4&nbsp;}}</div><div>-Stimulates {{c1::TAG}} storage in organs through {{c1::AGTL}}&nbsp;</div><div>-Governs first step of {{c1::adipo}}genesis&nbsp;</div><div>-Inhibits Hepatic {{c1::Gluconeo}}genesis<br></div><div><br></div><div>4. What is the specific receptor target of drug 1?{{c1::no one knows}}</div><div><br></div><div>5. Why would drug 2 be contraindicted in a patient with heart failure?{{c1::fluid retention}}</div><div><br></div><div>6. Which is the most commonly used drug for type 2 diabetes{{c1::BIGUANIDES / METFORMIN}}</div><div><br></div><div>7. Give 2 examples of drug 2.{{c1::rosiglitazone, pioglitazone}}</div>",
                        ""
                    ],
                    "guid": "KLvK_)N#,3",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>SULPHONYLUREAS: Insulin&nbsp;</b>{{c1::secretagogues}}<div><br></div><div>Safe and well tolerated oral agents '</div><div>Facilitate closure of {{c1::K-ATP}} channel<br></div><div>{{c1::de}}crease HbA1c ~ {{c1::1.5}}%&nbsp;</div><div>Weight gain&nbsp;</div><div>Significant risk of {{c1::hypoglycaemia}}…<br></div><div><br></div><div>Can it be used for both type 1 and 2&nbsp;{{c1::no just type 2}}</div><div>Why?</div><div>{{c1::needs functioning beta-cells for it to work}}<br></div><div><br></div><div>Pharmacokinetics&nbsp;</div><div>Metabolised in liver ({{c1::P450}} enymes)&nbsp;</div><div>Excreted in liver and kidneys&nbsp;</div><div>Duration of action {{c1::12 - 24&nbsp;}}hours<br></div><div><br></div><div>First Generation:</div><div>&nbsp;{{c1::Tolbutamide &amp; Chlorpropamide}}&nbsp;</div><div>Second Generation:</div><div>&nbsp;{{c1::Glibenclamide &amp; Glipizide}}&nbsp;</div><div>Third Generation: {{c1::Gliclazide}}<br></div><div><br></div><div>Give three drugs that will increase sulphonylureas affect and three that will reduce it</div>",
                        "<img src=\"paste-fac2fbe1870d7749967b0f81892f2380b39658e9.jpg\"><div><img src=\"paste-6226ed517b45b8fa32c4c64dc3ed4fb35f6b8d56.jpg\"><br><div><br></div></div>"
                    ],
                    "guid": "bkw1XCX]dS",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Describe the incretin effect&nbsp;{{c1::release of insuilin is 3x greater with oral glucose than iv glucose}}<div><br></div><div>Incretin Hormones</div><div><br></div><div>GLP-1&nbsp;{{c1::glucagon like peptide 1}}</div><div>Released from&nbsp;{{c1::Terminal Ileum}}</div><div><font color=\"#aa0000\">Post-translational Processing\nPro-Glucagon</font><br></div><div>Degraded by {{c1::DPP-IV}}&nbsp;</div><div>Ubiquitously Expressed on&nbsp;{{c1::White blood cells}}</div><div>T1/2 - 1.5 minutes<font color=\"#aa0000\"><br></font></div><div><font color=\"#aa0000\">Released for a number of hours after eating</font></div><div><font color=\"#aa0000\"><br></font></div><div>{{c1::Lower}} post-prandial glucose&nbsp;<font color=\"#aa0000\"><br></font></div><div>{{c1::Low}} risk of hypoglycaemia<br></div><div>{{c1::high}} release of c-peptide, so what?&nbsp;{{c1::c-peptide good marker for endogenous insulin production}}<br></div><div>Causes weight&nbsp;{{c1::loss}}</div><div><br></div><div>Is it class&nbsp;{{c1::yes}}</div><div><br></div><div>So what was the issue?{{c1::too short acting}}</div><div><br></div><div><br></div>",
                        "<img src=\"paste-4cf616574eb517bd77dca52115982aabe88067ec.jpg\"><div><img src=\"paste-9a233c952032603f4deaed9320c063eaa8224660.jpg\"><br></div>"
                    ],
                    "guid": "tSp~-wi)hP",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>HOW TO MAKE GLP-1 last longer</b><div><b><br></b></div><div>1. Use synthetic forms of GLP-1 that block degradation of DPP-4</div><div><br></div><div>such as&nbsp;</div><div>{{c1::liraglutide}}- Which has a glutamate chain that blocks DPP-4<br></div><div>{{c1::Exenatide}}- which only has to administered twice daily and is taken from the saliva of the gila monster<br></div><div><br></div><div>2.DPP IV ANTAGONISTS</div><div>Name:{{c1::gliptins}}</div><div>{{c1::Competitive}} Inhibitors of DPP-IV&nbsp;</div><div>Increase physiological GLP-1&nbsp;</div><div>{{c1::De}}crease HbA1c ~ {{c1::1}}%&nbsp;</div><div>{{c1::Orally}} available (admin)</div><div>Well tolerated&nbsp;</div><div>Weight {{c1::neutral}}<br></div><div><br></div><div>3. GLP-1 AGONISTS&nbsp;</div><div>Name:{{c1::GLUTIDES&nbsp;}}</div><div>Structural analogues of {{c1::GLP-1&nbsp;}}</div><div>{{c1::Parenterally}} administered&nbsp;</div><div>{{c1::De}}crease HbA1c ~ {{c1::1.5 - 2}}%&nbsp;</div><div>&nbsp;weight&nbsp;{{c1::loss}}&nbsp;</div><div>Inhibit gastric emptying&nbsp;</div><div>Safe in moderate renal failure&nbsp;</div><div><br></div><div>BUT….\nNausea and diarrhoea&nbsp;</div><div>Risk of {{c1::pancreatitis&nbsp;}}</div><div>Associated with ↑ {{c1::calcitonin}} and MTC<br></div>",
                        ""
                    ],
                    "guid": "GPowX@;g,]",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        },
        {
            "__type__": "Deck",
            "children": [],
            "crowdanki_uuid": "136a60c3-948a-11eb-8937-ad9d49024ac7",
            "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "desc": "",
            "dyn": 0,
            "extendNew": 0,
            "extendRev": 0,
            "media_files": [
                "paste-173124d048694d62b56ded7842cdafb2d11f52b5.jpg",
                "paste-29d7b2bf6647150ea310f0b3cf3c9e458bdf5aa5.jpg",
                "paste-6005b30343c5d711d94084341a125c78856527f9.jpg",
                "paste-7e39aa3b2025a53ce535128ca71ca96b5ee3ea1a.jpg",
                "paste-88f589626b17529944256fc225965adede3da880.jpg",
                "paste-8a470cdc241eeb396ac413f959be600cb61a560f.jpg",
                "paste-a594fa8b9e2446775d2e29f6aa56455e4e5a346e.jpg"
            ],
            "name": "03/30 Dennedy Thyroid",
            "notes": [
                {
                    "__type__": "Note",
                    "fields": [
                        "The thyroid has right and left lobes, and an&nbsp;{{c1::isthmus}} that connects them<div>Sometimes has a {{c1::Pyramidal}} Lobe that is a&nbsp; Remnant of the {{c1::Thyroglossal}} Duct<br></div><div><br></div><div>In the thyroid there are four&nbsp;{{c1::parathyroid}} glands which contains&nbsp;{{c1::parathyroid}} hormone and is responsible for&nbsp;{{c1::calcium}} metabolism</div><div><br></div><div><br></div><div><img src=\"paste-8a470cdc241eeb396ac413f959be600cb61a560f.jpg\"><br></div>",
                        "<img src=\"paste-29d7b2bf6647150ea310f0b3cf3c9e458bdf5aa5.jpg\">"
                    ],
                    "guid": "L/fr1_M+#0",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Thyroid Glamd Physiology and control<div><br></div><div>1. Hypothalamus releases&nbsp;{{c1::tyrotropin releasing hormone}} which causes the&nbsp;{{c1::anterior pituatary}} gland to release {{c1::thyroid stimulating}} hormone.</div><div><br></div><div>2. This hormone acts on a G{{c1::s}} coupled receptor in the thyroid</div><div><br></div><div>3. Two pathways are stimulated</div><div>&nbsp;-Adenylate cyclase--{{c1::cAMP}} which does what?&nbsp;{{c1::upregulation of transcription factor for thyroid hormone to be synthesized}}</div><div><br></div><div>-PLC--{{c1::DAG/IP3}} which does what?&nbsp;{{c1::increases intracellular calcium which stimulates release of thyoid hormone}}</div><div><br></div><div><br></div><div>What are the two types of thyroid hormone?{{c1::T4 amd T3}}</div><div>Which is the abundant one&nbsp;{{c1::T4}}</div><div>Which is the active one&nbsp;{{c1::T3}}&nbsp;</div><div>WHat converts one to the other{{c1::Di and Dii}}</div><div>So which one do we give therapeutically?{{c1::T4 becuase body is used to it}}</div><div><br></div><div><br></div><div>What sort of hormones are thyrtoid hormone?&nbsp;{{c1::nuclear hormones}}</div><div><br></div><div>EFFECTS (5)</div><div>{{c1::<div>Oxygen Consumption&nbsp;</div><div>Thermogenesis&nbsp;</div><div>CHO, Fat, Protein Metabolism&nbsp;</div><div>Growth / Differentiation&nbsp;</div><div>Modulation hormonal action</div>}}<br></div><div><br></div>",
                        "<img src=\"paste-173124d048694d62b56ded7842cdafb2d11f52b5.jpg\"><div>T4 and T3 shut off this process</div>"
                    ],
                    "guid": "u>U^}Img&>",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "THYROID HORMONE SYNTHESIS&nbsp;<div>MAIN SYNTHETIC STEPS&nbsp;</div><div>put in correct order and whether its cAMP or PLC mediated</div><div><br></div><div>Oxidation of iodine and iodination of tyrosine residues&nbsp;{{c1::3cAMP}}<br></div><div>Plasma Iodide Uptake and Concentration&nbsp;{{c1::1 cAMP}}</div><div>Proteolysis of thyroglobulin to release T3 and T4&nbsp;{{c1::5 PLC}}<br></div><div>Thyroglobulin Synthesis&nbsp;{{c1::2 cAMP}}</div><div>Secretion of thyroid hormone&nbsp;{{c1:: 6 PLC}}</div><div>Coupling of iodotyrosines to make T3 and T4&nbsp;{{c1::4 cAMP}}</div><div><br></div><div>Occurs within the {{c1::follicular}} cells - cuboidal / columnar epithelial cells surrounding\nthe colloid-containing follicle<br></div>",
                        ""
                    ],
                    "guid": "csh*;{.U&4",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "THYROID HORMONE SYNTHESIS IN DEPTH<div><br></div><div>TSHR is stimulated which causes upregulation of cAMP, how does this lead to iodide collecting in the colloid?</div><div>{{c1::cAMP stimulates Na+-I- symporter, which brings in iodide first to the follicular cell and then to the colloid and Na-K atpase pumps back out sodium so that it can be used again for the symporter}}<br></div><div><br></div><div>cAMP also stimulates release of&nbsp;thyroglobulin from the&nbsp;{{c1::ER and Golgi}} into the colloid.</div><div><br></div><div>The&nbsp;</div>",
                        ""
                    ],
                    "guid": "OJ|oso=U#F",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "T4 - {{c1::80}}% OF SECRETED THYROID HORMONE<div><br></div><div><font color=\"#aa0000\">BUT…..\nT3 BINDS WITH HIGH AFFINITY TO THYROID HORMONE RECEPTOR</font><br></div><div><br></div><div>DE-IODINATION (HIGHLY EFFICIENT PROCESS)<br></div><div><br></div><div>Done by&nbsp;{{c1::5’-deiodinases}} - Family of selenoproteins</div><div><br></div><div>D1-{{c1::80}}% circulating T3</div><div><br></div><div>Expressed in {{c1::Liver, Kidney, Thyroid Gland}}(3)</div><div>Inhibited by {{c1::PTU, Amiodarone, Glucocorticoids}}(3)</div><div><br></div><div>D2 - Tissue Specific Role - Lower affinity than D{{c1::1}}&nbsp;</div><div><br></div><div>Expressed in {{c1::Cardiac/Skeletal Muscle, Brain, Pituitary}}(3)<br></div><div><br></div><div>D3 - Produces inactive reverse T3 (rT3)&nbsp;</div><div>Expressed in {{c1::Placenta, Skin, Uterus, Brain, Inflammed Tissue}}(5)<br></div><div><br></div><div>What happens in&nbsp;THYROTOXICOSIS&nbsp;{{c1::D1 and 2 decrease}}</div><div>What happens in&nbsp;HYPOTHYROIDISM&nbsp;{{c1::D1 and 2 increase}}</div><div>What happens in illness and pregnancy&nbsp;{{c1::D3 increases}}</div>",
                        ""
                    ],
                    "guid": "cvQ^TyW1&P",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<div><b>THYROID HORMONE TRANSPORTATION IN BLOOD&nbsp;</b></div><div>HIGHLY PROTEIN BOUND:<br></div><div>STRONG NON-COVALENT BONDS WITH PLASMA PROTEINS<br></div><div><br></div><div>T4 BOUND WITH {{c1::HIGHER}} AVIDITY THAN T3<br></div><div>{{c1::0.03}}% T4 UNBOUND &amp; {{c1::0.3}}% T3 UNBOUND<br></div><div><br></div><div>Is bound or unbound more biologically active? {{c1::unbound}}</div><div><br></div><div>THREE MAIN PROTEINS:<br></div><div><br></div><div>{{c1::Thyroxine-Binding Globulin (TBG)}}:</div><div>Binds a single T4 with high avidity\nBiological levels of T4 highly influenced by circulating TBG&nbsp;</div><div><br></div><div>{{c1::Transthyreitin}}:</div><div>Higher concentration but lower affinity&nbsp;</div><div>Found in patients with ATTR</div><div><br></div><div>{{c1::Albumin}}:</div><div>Low Affinity Binding<br></div><div>It's the one you're thinking of</div>",
                        ""
                    ],
                    "guid": "wLGkf|`Z;e",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "Give three drug and two systemic factors that increase thebinding of thyroids to the proteins",
                        "<img src=\"paste-88f589626b17529944256fc225965adede3da880.jpg\">"
                    ],
                    "guid": "Hph@s(iM7e",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "T4 ELIMINATION&nbsp;<div>Occurs slowly with T1/2 circa {{c1::8}} days&nbsp;</div><div>T1/2 reduced to {{c1::3}} days in thyrotoxicosis&nbsp;</div><div>T1/2 increased to {{c1::9}} days in hypothyroidism&nbsp;</div><div><br></div><div>T3 ELIMINATION&nbsp;</div><div>Occurs quickly with T1/2 circa 1 day\nDue predominantly to {{c1::reduced protein binding}}</div><div><br></div><div>NON-DEIODINATIVE DEGRADATION&nbsp;</div><div>Occurs within the {{c1::liver&nbsp;}}</div><div>{{c1::Conjugates}} excreted in bile<br></div>",
                        "<img src=\"paste-a594fa8b9e2446775d2e29f6aa56455e4e5a346e.jpg\">"
                    ],
                    "guid": "jp%x$p~ic_",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "NUCLEAR RECEPTOR<div>T3 Dimerises with {{c1::RXR}} and binds to {{c1::Thyroxine Response Element}}<br></div><div><br></div><div>THYROID RECEPTOR SUBTYPES<br></div><div>TRβ2 expressed in&nbsp;{{c1::HYPOTHALAMUS &amp; PITUITARY}}<br></div><div>TRβ1 expressed in&nbsp;{{c1::BRAIN, LIVER &amp; KIDNEY}}<br></div><div>TRα1 expressed in&nbsp;{{c1::CARDIAC AND SKELETAL MUSCLE}}<br></div><div><br></div><div>RESISTANCE TO THYROID RECEPTOR BETA AND ALPHA CAN OCCUR<br></div>",
                        "<img src=\"paste-6005b30343c5d711d94084341a125c78856527f9.jpg\">"
                    ],
                    "guid": "C1l$S~-t%2",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Etiology of Thyrotoxicosis</b><div><br><div>Definitions</div><div>Graves’ Thyrotoxicosis&nbsp;&nbsp;{{c1::<span style=\"color: rgb(32, 33, 36);\">&nbsp;</span><span style=\"color: rgb(32, 33, 36);\">immune system disorder that results in the overproduction of thyroid hormones</span>}}</div><div>Toxic Adenoma&nbsp;{{c1::<span style=\"color: rgb(32, 33, 36);\">This occurs when a single nodule (or lump) grows on the thyroid gland causing it to become enlarged and produce excess thyroid hormones.</span>}}</div><div>Toxic Multinodular Goitre&nbsp;{{c1::<span style=\"color: rgb(32, 33, 36);\">one or more nodules (typically benign growths) in the thyroid gland that make thyroid hormone without responding to the signal to keep thyroid hormone balanced.</span>}}</div><div>Inflammatory thyroiditis&nbsp;{{c1::<span style=\"color: rgb(32, 33, 36);\">swelling (</span><b>inflammation</b><span style=\"color: rgb(32, 33, 36);\">) of the&nbsp;</span><b>thyroid</b><span style=\"color: rgb(32, 33, 36);\">&nbsp;gland. It causes either unusually high or low levels of&nbsp;</span><b>thyroid</b><span style=\"color: rgb(32, 33, 36);\">&nbsp;hormones in the blood</span>}}</div><div>Hashitoxicosis\nFactitious /\nOver-replaced LT4&nbsp;{{c1::<span style=\"color: rgb(32, 33, 36);\">&nbsp;</span><span style=\"color: rgb(32, 33, 36);\">transient hyperthyroidism caused by inflammation associated with Hashimoto's thyroiditis disturbing the thyroid follicles, resulting in excess release of thyroid hormone.</span>}}</div><div>Drug Induced&nbsp;</div><div>Post-partum Thyroiditis{{c1::post pregnancy}}<br></div><div><br></div><div>All of these are caused by too much free t4 and too little TSH</div><div>But there is one thyrotoxicosis that is caused by an increase in both?&nbsp;{{c1::TSHoma}}</div><div><br></div><div><br></div><div><br></div><div><br></div></div>",
                        ""
                    ],
                    "guid": "pG^s-)8S~z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "HYPOTHYROIDISM ETIOLOGY&nbsp;<div><br></div><div>{{c1::<div>Autoimmune Thyroiditis&nbsp;</div><div>Post-RAI Rx&nbsp;</div><div>Post-Thyroidectomy&nbsp;</div><div>Inflammatory Thyroiditis&nbsp;</div><div>Haemmorrhage /\nInfiltration&nbsp;</div><div>Under-replacement\nIodine Deficiency&nbsp;</div><div>Pituitary hypothyroidism&nbsp;</div><div>Thyroid Hormone Resistance&nbsp;</div><div>Post-partum Thyroiditis</div>}}(4/9)<br></div><div><br></div>",
                        ""
                    ],
                    "guid": "gTAM11X8^M",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>HYPOTHYROIDISM</b><div><b><br></b></div><div>CLINICAL FEATURES:<b><br></b></div><div>{{c1::Cold}} intolerance&nbsp;</div><div>{{c1::Brady}}cardia&nbsp;</div><div>Constipation&nbsp;</div><div>Weight {{c1::Gain}}&nbsp;</div><div>Poor Concentration&nbsp;</div><div>{{c1::Lethargy&nbsp;}}(less energy)</div><div>{{c1::Decreased}} Appetite&nbsp;</div><div>{{c1::Myxoedema}}(heart)&nbsp;</div><div>Peripheral Oedema, does it pit?&nbsp;{{c1::no}}</div><div>{{c1::Dry}} Skin / Hair<br></div><div><br></div><div>PRINCIPAL CAUSES&nbsp;</div><div>{{c1::Autoimmune Thyroiditis&nbsp;</div><div>Radioiodine Therapy / Surgery&nbsp;</div><div>Pituitary Hypothyroidism}}(3)<br></div><div><br></div><div>TREATMENT</div><div><font color=\"#aa0000\">&nbsp;THYROID HORMONE REPLACEMENT</font><br></div><div><font color=\"#aa0000\"><br></font></div><div>Oral T4&nbsp;</div><div>drug name:&nbsp;{{c1::LEVO-THYROXINE}}</div><div>{{c1::Long}} T1/2</div><div>{{c1::&nbsp;Once daily}} dosage<br></div><div><br></div><div>What can you not take with oral T4?{{c1::anything with calcium and anything that interferes with stomach acid}}</div><div><br></div><div>When would you give Oral T3?&nbsp;{{c1::when patient is in myxoedema coma}}</div><div><br></div><div>What do they give now to patients undergoing radioiodine therepay for thyroid cancer?&nbsp;{{c1::Recombinant TSH}}</div>",
                        ""
                    ],
                    "guid": "Ao;+TQJd)Z",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "THYROTOXICOSIS\nCLINICAL FEATURES&nbsp;<div>{{c1::Heat}} intolerance&nbsp;</div><div>{{c1::Tachy}}cardia / Atrial Fibrillation&nbsp;</div><div>Diarrhoea&nbsp;</div><div>Weight {{c1::Loss}}&nbsp;</div><div>Tremor&nbsp;</div><div>Anxiety / Agitation&nbsp;</div><div>{{c1::Increased}} Appetite&nbsp;</div><div>Thyroid Storm, mortality?{{c1::75%}}<div>High-output {{c1::HF}}<br></div><div><br></div><div><br></div><div>&nbsp;TREATMENT\nBASED ON UNDERLYING CAUSE…\nOPTIONS: {{c1::</div><div>Thioureylenes&nbsp;</div><div>Radioiodine / 131I&nbsp;</div><div>Potassium Iodide / Lugol’s Iodine&nbsp;</div><div>Thyroidectomy&nbsp;</div>}}(4)</div><div><br></div><div>PRINCIPAL CAUSES&nbsp;</div><div>{{c1::<div>Graves’ Thyrotoxicosis&nbsp;</div><div>Toxic Adenoma&nbsp;</div><div>Toxic Multinodular Goitre&nbsp;</div><div>Thyroiditis&nbsp;</div><div>Amiodarone</div>}}(5)<br></div><div><br></div>",
                        ""
                    ],
                    "guid": "jJD3olk!>2",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Grave's Disease or Autoimmune Thyrotoxicosis</b><div><br></div><div>Driven by&nbsp;{{c1::tyrotropin}} receptor antibodies (CTLA, HLA-DR3)</div><div><br></div><div>{{c1::Young}} age of onset - Incidence Women : Men is {{c1::9}}:1<br></div><div><br></div><div>Can go into remission but relapses in &gt; {{c1::50}}%<br></div><div><br></div><div><br></div><div>What happens to the eyes in Grave's Disease?</div><div>{{c1::opthalmopathy, bulging eyeballs. TRAb stimulate adipocytes and fibroblast in the orbit to store fat in the muscles so eyes bulge and opthalmoplegia can occur}}<br></div><div><br></div><div>What problems do these cause?{{c1::patient soemtimes lose their eyes and they can't close them at night. }}</div><div><br></div><div>How would you treat it?&nbsp;{{c1::hydrosteroids, orbital decompression, and hyaluronic acid to moisten eyes}}</div><div><br></div><div>What sort of Goitre do you get with Grave's&nbsp;{{c1::smooth}}</div><div><br></div><div>There are two ways to treat Grave's</div><div><br></div><div>Just Thioureylenes:{{c1::Start at high dose thioureylene and reduce over time to maintain euthyroid state\nRequires 18 months therapy}}</div><div><br></div><div>Combination with LT4:{{c1::Start at high dose thioureylene until euthyroid\nThen continue at high-dose, but add LT4 and titrate the LT4 to maintain euthyroid state\nRequires 12 months therapy}}<br></div>",
                        "<img src=\"paste-7e39aa3b2025a53ce535128ca71ca96b5ee3ea1a.jpg\">"
                    ],
                    "guid": "h,V!ml~a|}",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "GUESS THE THIOURYLENE<div><br></div><div><br></div><div>{{c1::CARBIMAZOLE}}<br></div><div>Plasma half life 4-6 hours</div><div>Vd 40L</div><div>metabolism decreased in liver failure&nbsp;</div><div>No plasma protein binding</div><div>Admin once or twice daily</div><div>Low placental and breast milk levels</div><div>Not used during first trimester of pregnancy, why?{{c1::associated with poor skin development}}</div><div><br></div><div>{{c1::Propylthiouracil}}<br></div><div>Plasma protein binding 75%</div><div>Plasma half life 75 minutes&nbsp;</div><div>Vd 20L</div><div>Admin 1-4 times daily</div><div>low placental and breast milk levels</div><div>Advantagious affects in thyroid storm</div><div><br></div><div>WHich is more commonly used?{{c1::Carbimazole}}</div><div>Where are both concentrsted?{{c1::thyroid}}</div><div><br></div><div><br></div><div>Adverse Effects:</div><div>Agranulocytosis ({{c1::0.2}}%)&nbsp;</div><div>{{c1::In}}creased Liver Blood Tests&nbsp;</div><div>Rash&nbsp;</div><div>Hair {{c1::Loss&nbsp;}}</div><div>Skin {{c1::Pigmentation&nbsp;}}</div><div>Headache<br></div><div><br></div><div>Inhibition of {{c1::NIS (sodium iodine syporter}}&nbsp; &nbsp; &nbsp;&nbsp;</div><div>Inhibition of the enzyme&nbsp;{{c1::TPO}}</div><div>Immunoregulatory Effect reduces production of&nbsp;{{c1::TRAb}} - Additional benefit in Graves’ Disease<br></div><div><br></div><div>PTU inhibits D{{c1::1}} but not D{{c1::2}}</div><div><br></div><div>What should you treat the symptoms of thyrotoxicosis with while waiting for thioureylenes to take effect?</div><div>{{c1::beta-adrenoceptors antagonists}}<br></div><div><br></div><div><br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "j|s|L@i<JM",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>TOXIC ADENOMA / TOXIC MULTINODULAR GOITRE:</b>{{c1::SINGLE OR MULTIPLE HYPER FUNCTIONING THYROID NODULES}}<div><br></div><div>They supersede normal {{c1::pituitary}} thyroid regulation</div><div><br></div><div>{{c1::Older}} age of onset<br></div><div>Often presents with {{c1::AFib}} and {{c1::stroke}} or {{c1::Osteoporosis}}<br></div><div><br></div><div>RESPONDS TO THIOUREYLENE THERAPY AT RELATIVELY LOW DOSE&nbsp;<br></div><div>So why don't they use it?</div><div>{{c1::relapse as soon as they come off it}}<br></div><div><br></div><div>So what do we do instead?</div><div>{{c1::SURGERY OR RADIOIODINE THERAPY}}<br></div>",
                        ""
                    ],
                    "guid": "M(S4#V{~/3",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "RADIOIODINE THERAPY<div><br></div><div>When do you use it?{{c1::GRAVES’ RELAPSE OR IN TA / TMNG}}</div><div><br></div><div><font color=\"#aa0000\">131I - Emits β and γ radiation </font>Was possibly going to make this a cloze, but we're not chemists<br></div><div><br></div><div>Destroys {{c1::functioning}} thyroid tissue&nbsp;<br></div><div><br></div><div>Dosage</div><div>{{c1::300}}MBq&nbsp;Higher dose required with PTU<br></div><div>T1/2 ~ {{c1::8}} Days<br></div><div>Therapeutic Effect @ {{c1::8 - 12}} weeks<br></div><div>Need cover with {{c1::thioureylene +/- β blocker}}<br></div><div><br></div><div>PRECAUTIONS / CONTRAINDICATIONS<br></div><div>{{c1::Pregnancy}}</div><div>Thyroid eye disease, why?&nbsp;{{c1::Increased levels of TRAb}}</div><div><font color=\"#aa0000\">For mild case of thyroid eye disease you can pre treat with steroids to put it into remission for duration of treatment</font></div><div><br></div><div>Contact with children&nbsp;</div><div>&lt; 5yo: {{c1::No prolonged close contact for 3 weeks}}&nbsp;</div><div>&gt; 5yo: {{c1::No prolonged close contact for 10 days}}&nbsp;</div><div>&lt; 2yo: {{c1::No contact for 7 days}}<br></div><div><br></div><div>COMPLICATIONS&nbsp;</div><div>Radiation {{c1::thyroiditis}}</div><div>Worsening or emergence {{c1::opthalmopathy}}&nbsp;</div><div>Post-RAI hypothyroidism: does this happen more whilst treating TA/TMNG or Graves?{{c1::Graves}}, why?{{c1::In Graves all of thyroid is active, In TA/TMNG only affected nodules are actually actuve as they shut down the rest}}<br></div><div><br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "KK*R1ObtwY",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>Lugol's Iodine</b><div><br></div><div>When do you use it?{{c1::When patient is in umar na haimléise and needs a thyroidectomy, this will tide them over}}</div><div><br></div><div>How does it work?{{c1::Collects in colloid, doesn't become thyorid hormone so large collection of iodine so TSH receptor and sodium-iodide symporter stops, basically thyroid fxn stops}}</div><div><br></div><div>What is this effect called?{{c1::Wolff-chaikoff effect}}</div><div>Dosed @ {{c1::150}}mg / day as tincture<br></div><div>Produces a temporary effect for ~ {{c1::2}} weeks only<br></div><div><br></div><div>What happens if surgery doesn't happen before effect wears off?</div><div>{{c1::resistant hyperthyroidism, thyroid storm}}<br></div><div><font color=\"#aa0000\">This is called Jod Basedow effect</font></div><div>What can you do for patient in this situation?</div><div>{{c1::β-blocker to treat adrenergic symptoms but other than that, pray}}<br></div><div><br></div><div><br></div>",
                        ""
                    ],
                    "guid": "nVYV@D=p]8",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "<b>AMIODARONE</b>&nbsp;<div>Class III anti {{c1::arrhythmic}} used in treatment of {{c1::supra ventricular and ventricular\narrhythmias}}</div><div><br></div><div>37% iodine by weight so may cause&nbsp;{{c1::Jod Basedow effect}}<br></div><div><br></div><div>{{c1::In}}crease D3 and {{c1::de}}crease D1, so what forms of thyroid hormone are increased?&nbsp;{{c1::T4 and rT3}} and T{{c1::3}} is decreased.&nbsp;</div><div>This is good as sometimes too much T{{c1::3}} can cause the&nbsp;{{c1::arrythmias}}</div><div>But this might be confusing for doctors, why?{{c1::may prescribe thyroid hormone as levels are low}}</div><div><br></div><div>Accelerates onset of hypothyroidism in {{c1::autoimmune thyroiditis}}<br></div><div><br></div><div>AMIODARONE INDUCED THYROTOXICOSIS&nbsp;</div><div><br></div><div>Type 1</div><div>Severe treatment resistant thyrotoxicosis due to {{c1::Jod Basedow}} Effect&nbsp;</div><div>{{c1::Premorbid nodular}} gland&nbsp;</div><div><br></div><div>Type 2&nbsp;</div><div>Amiodarone-induced thyroiditis - Direct toxic effect of amiodarone on {{c1::follicular}} cells&nbsp;</div><div>Transient effect<br></div>",
                        ""
                    ],
                    "guid": "m-+&Btlh[V",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                },
                {
                    "__type__": "Note",
                    "fields": [
                        "PREGNANCY\nHYPOTHYROIDISM&nbsp;<div><br></div><div>Higher binding globulins and higher D{{c1::3}} from placenta&nbsp;</div><div><br></div><div>Requirement for higher doses of LT4\nIncrease dose by ~ {{c1::30}}%&nbsp;</div><div><br></div><div>In women with Graves’ rendered hypothyroid by surgery or RAI\nNeed to check TRAb in 1st trimester and 30 weeks\nRisk of neonatal thyrotoxicosis (transient)..&nbsp;</div><div><br></div><div>{{c1::Radioiodine}} absolutely contraindicated&nbsp;</div><div><br></div><div>TRY TO AVOID PREGNANCY UNTIL EUTHYROID&nbsp;</div><div><br></div><div>Should not become pregnant for {{c1::6}} months after radio iodine&nbsp;</div><div><br></div><div>If resistant, severe thyrotoxicosis, aim for surgery in 2nd trimester&nbsp;</div><div>Can treat with lowest dose PTU which keeps FT4 in Upper Ref Range&nbsp;</div><div><br></div><div>{{c1::Thioureylenes}} cross placenta - can cause fetal goitre&nbsp;</div><div><br></div><div>Carbimazole may cause {{c1::aplasia cutis}}</div>",
                        ""
                    ],
                    "guid": "hkA,s95k~W",
                    "note_model_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
                    "tags": []
                }
            ]
        }
    ],
    "crowdanki_uuid": "9698beb1-7dd0-11eb-935e-af478fea30f9",
    "deck_config_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
    "deck_configurations": [
        {
            "__type__": "DeckConfig",
            "autoplay": true,
            "crowdanki_uuid": "f5213817-7dcf-11eb-8bb1-af478fea30f9",
            "dyn": false,
            "interdayLearningMix": 0,
            "lapse": {
                "delays": [
                    10.0
                ],
                "leechAction": 1,
                "leechFails": 8,
                "minInt": 1,
                "mult": 0.0
            },
            "maxTaken": 60,
            "name": "Default",
            "new": {
                "bury": false,
                "delays": [
                    1.0,
                    10.0
                ],
                "initialFactor": 2500,
                "ints": [
                    1,
                    1,
                    0
                ],
                "order": 0,
                "perDay": 100
            },
            "newMix": 0,
            "newPerDayMinimum": 0,
            "replayq": true,
            "rev": {
                "bury": false,
                "ease4": 1.3,
                "hardFactor": 1.2,
                "ivlFct": 1.0,
                "maxIvl": 5,
                "perDay": 500
            },
            "reviewOrder": 0,
            "timer": 0
        }
    ],
    "desc": "",
    "dyn": 0,
    "extendNew": 0,
    "extendRev": 0,
    "media_files": [],
    "name": "2.2::Drugs and Disease",
    "note_models": [
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "f51973f3-7dcf-11eb-96c6-af478fea30f9",
            "css": ".card {\n  font-family: arial;\n  font-size: 20px;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n.cloze {\n font-weight: bold;\n color: blue;\n}\n.nightMode .cloze {\n color: lightblue;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "Text",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Back Extra",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Cloze",
            "req": [
                [
                    0,
                    "any",
                    [
                        0
                    ]
                ]
            ],
            "sortf": 0,
            "tags": [],
            "tmpls": [
                {
                    "afmt": "{{cloze:Text}}<br>\n{{Back Extra}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Cloze",
                    "ord": 0,
                    "qfmt": "{{cloze:Text}}"
                }
            ],
            "type": 1
        },
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "f5199df6-7dcf-11eb-a338-af478fea30f9",
            "css": ".card {\n  font-family: arial;\n  font-size: 20px;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "Front",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Back",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Basic-b2764",
            "req": [
                [
                    0,
                    "any",
                    [
                        0
                    ]
                ]
            ],
            "sortf": 0,
            "tags": [],
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Back}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 1",
                    "ord": 0,
                    "qfmt": "{{Front}}"
                }
            ],
            "type": 0
        },
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "f5199df9-7dcf-11eb-9a20-af478fea30f9",
            "css": "/* GENERAL CARD STYLE */\n.card {\n  font-family: \"Helvetica LT Std\", Helvetica, Arial, Sans;\n  font-size: 150%;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n\n/* OCCLUSION CSS START - don't edit this */\n#io-overlay {\n  position:absolute;\n  top:0;\n  width:100%;\n  z-index:3\n}\n\n#io-original {\n  position:relative;\n  top:0;\n  width:100%;\n  z-index:2;\n  visibility: hidden;\n}\n\n#io-wrapper {\n  position:relative;\n  width: 100%;\n}\n/* OCCLUSION CSS END */\n\n/* OTHER STYLES */\n#io-header{\n  font-size: 1.1em;\n  margin-bottom: 0.2em;\n}\n\n#io-footer{\n  max-width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.8em;\n  font-style: italic;\n}\n\n#io-extra-wrapper{\n  /* the wrapper is needed to center the\n  left-aligned blocks below it */\n  width: 80%;\n  margin-left: auto;\n  margin-right: auto;\n  margin-top: 0.5em;\n}\n\n#io-extra{\n  text-align:center;\n  display: inline-block;\n}\n\n.io-extra-entry{\n  margin-top: 0.8em;\n  font-size: 0.9em;\n  text-align:left;\n}\n\n.io-field-descr{\n  margin-bottom: 0.2em;\n  font-weight: bold;\n  font-size: 1em;\n}\n\n#io-revl-btn {\n  font-size: 0.5em;\n}\n\n/* ADJUSTMENTS FOR MOBILE DEVICES */\n\n.mobile .card, .mobile #content {\n  font-size: 120%;\n  margin: 0;\n}\n\n.mobile #io-extra-wrapper {\n  width: 95%;\n}\n\n.mobile #io-revl-btn {\n  font-size: 0.8em;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "ID (hidden)",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Header",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Image",
                    "ord": 2,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Question Mask",
                    "ord": 3,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Footer",
                    "ord": 4,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Remarks",
                    "ord": 5,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Sources",
                    "ord": 6,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Extra 1",
                    "ord": 7,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Extra 2",
                    "ord": 8,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Answer Mask",
                    "ord": 9,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Original Mask",
                    "ord": 10,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Image Occlusion Enhanced",
            "req": [
                [
                    0,
                    "any",
                    [
                        2
                    ]
                ]
            ],
            "sortf": 1,
            "tmpls": [
                {
                    "afmt": "{{#Image}}\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Answer Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n{{#Footer}}<div id=\"io-footer\">{{Footer}}</div>{{/Footer}}\n<button id=\"io-revl-btn\" onclick=\"toggle();\">Toggle Masks</button>\n<div id=\"io-extra-wrapper\">\n  <div id=\"io-extra\">\n    {{#Remarks}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Remarks</div>{{Remarks}}\n      </div>\n    {{/Remarks}}\n    {{#Sources}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Sources</div>{{Sources}}\n      </div>\n    {{/Sources}}\n    {{#Extra 1}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 1</div>{{Extra 1}}\n      </div>\n    {{/Extra 1}}\n    {{#Extra 2}}\n      <div class=\"io-extra-entry\">\n        <div class=\"io-field-descr\">Extra 2</div>{{Extra 2}}\n      </div>\n    {{/Extra 2}}\n  </div>\n</div>\n\n<script>\n// Toggle answer mask on clicking the image\nvar toggle = function() {\n  var amask = document.getElementById('io-overlay');\n  if (amask.style.display === 'block' || amask.style.display === '')\n    amask.style.display = 'none';\n  else\n    amask.style.display = 'block'\n}\n\n// Prevent original image from loading before mask\naFade = 50, qFade = 0;\nvar mask = document.querySelector('#io-overlay>img');\nfunction loaded() {\n    var original = document.querySelector('#io-original');\n    original.style.visibility = \"visible\";\n}\nif (mask === null || mask.complete) {\n    loaded();\n} else {\n    mask.addEventListener('load', loaded);\n}\n</script>\n{{/Image}}\n",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "IO Card",
                    "ord": 0,
                    "qfmt": "{{#Image}}\n<div id=\"io-header\">{{Header}}</div>\n<div id=\"io-wrapper\">\n  <div id=\"io-overlay\">{{Question Mask}}</div>\n  <div id=\"io-original\">{{Image}}</div>\n</div>\n<div id=\"io-footer\">{{Footer}}</div>\n\n<script>\n// Prevent original image from loading before mask\naFade = 50, qFade = 0;\nvar mask = document.querySelector('#io-overlay>img');\nfunction loaded() {\n    var original = document.querySelector('#io-original');\n    original.style.visibility = \"visible\";\n}\nif (mask === null || mask.complete) {\n    loaded();\n} else {\n    mask.addEventListener('load', loaded);\n}\n</script>\n{{/Image}}\n"
                }
            ],
            "type": 0
        },
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "afe9bf23-7dce-11eb-b4f3-a0b2d6ecb02c",
            "css": ".card {\n  font-family: arial;\n  font-size: 20px;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "Front",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Back",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Basic (and reversed card)-defa1",
            "req": [
                [
                    0,
                    "any",
                    [
                        0
                    ]
                ],
                [
                    1,
                    "any",
                    [
                        1
                    ]
                ]
            ],
            "sortf": 0,
            "tags": [],
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Back}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 1",
                    "ord": 0,
                    "qfmt": "{{Front}}"
                },
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Front}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 2",
                    "ord": 1,
                    "qfmt": "{{Back}}"
                }
            ],
            "type": 0
        },
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "39db5048-81a3-11eb-b5a8-af478fea30f9",
            "css": ".card {\n  font-family: arial;\n  font-size: 20px;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "Front",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Back",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Basic (and reversed card)",
            "req": [
                [
                    0,
                    "any",
                    [
                        0
                    ]
                ],
                [
                    1,
                    "any",
                    [
                        1
                    ]
                ]
            ],
            "sortf": 0,
            "tags": [],
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Back}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 1",
                    "ord": 0,
                    "qfmt": "{{Front}}"
                },
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Front}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 2",
                    "ord": 1,
                    "qfmt": "{{Back}}"
                }
            ],
            "type": 0
        },
        {
            "__type__": "NoteModel",
            "crowdanki_uuid": "136833ad-948a-11eb-b54e-ad9d49024ac7",
            "css": ".card {\n  font-family: arial;\n  font-size: 20px;\n  text-align: center;\n  color: black;\n  background-color: white;\n}\n",
            "flds": [
                {
                    "font": "Arial",
                    "name": "Front",
                    "ord": 0,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Back",
                    "ord": 1,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                },
                {
                    "font": "Arial",
                    "name": "Add Reverse",
                    "ord": 2,
                    "rtl": false,
                    "size": 20,
                    "sticky": false
                }
            ],
            "latexPost": "\\end{document}",
            "latexPre": "\\documentclass[12pt]{article}\n\\special{papersize=3in,5in}\n\\usepackage[utf8]{inputenc}\n\\usepackage{amssymb,amsmath}\n\\pagestyle{empty}\n\\setlength{\\parindent}{0in}\n\\begin{document}\n",
            "latexsvg": false,
            "name": "Basic (optional reversed card)",
            "req": [
                [
                    0,
                    "any",
                    [
                        0
                    ]
                ],
                [
                    1,
                    "all",
                    [
                        1,
                        2
                    ]
                ]
            ],
            "sortf": 0,
            "tags": [],
            "tmpls": [
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Back}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 1",
                    "ord": 0,
                    "qfmt": "{{Front}}"
                },
                {
                    "afmt": "{{FrontSide}}\n\n<hr id=answer>\n\n{{Front}}",
                    "bafmt": "",
                    "bfont": "",
                    "bqfmt": "",
                    "bsize": 0,
                    "did": null,
                    "name": "Card 2",
                    "ord": 1,
                    "qfmt": "{{#Add Reverse}}{{Back}}{{/Add Reverse}}"
                }
            ],
            "type": 0
        }
    ],
    "notes": []
}